hMOB2 Knockdown Induces Cell Cycle Arrest: A Comprehensive Guide from Mechanism to Clinical Application

Abstract

This article provides a comprehensive resource for researchers investigating the role of the Mps one binder 2 (MOB2) protein in cell cycle regulation. We detail how hMOB2 knockdown triggers a p53/p21-dependent G1/S cell cycle arrest by preventing the accumulation of endogenous DNA damage and disrupting double-strand break repair via homologous recombination. A robust methodological framework for executing and validating a MOB2 knockdown cell cycle arrest assay is presented, including optimized protocols for flow cytometry and troubleshooting common pitfalls. Furthermore, we explore the translational potential of these findings, highlighting how hMOB2 deficiency sensitizes cancer cells to DNA-damaging agents and PARP inhibitors, positioning MOB2 as a promising predictive biomarker for patient stratification in cancer therapy.

Unraveling the Role of hMOB2 in Cell Cycle Progression and DNA Damage Response

The Monopolar spindle one binder (MOB) protein family comprises highly conserved eukaryotic kinase adaptor proteins essential for cell and organism survival [1] [2]. First identified in a 1998 yeast two-hybrid screen for Mps1 kinase-interacting proteins, MOB proteins have since been characterized across diverse species [3] [1]. Human genomes encode seven MOB proteins, classified into four evolutionarily conserved subfamilies: MOB1 (MOB1A/B), MOB2, MOB3 (MOB3A/B/C), and MOB4 (Phocein) [4] [3].

Table 1: Human MOB Protein Family Classification and Key Characteristics

MOB Subfamily	Members	Key Binding Partners	Reported Functions	Structural Features
MOB1	MOB1A, MOB1B	LATS1/2, NDR1/2, MST1/2 [3]	Tumor suppression, Hippo pathway regulation, mitotic exit [1]	Conserved four-helix bundle with negative electrostatic surface [5]
MOB2	MOB2	NDR1/2 (STK38/STK38L) [4]	DDR, HR repair, cell cycle regulation, cell morphology [6] [7]	Shares core Mob fold; specific surface properties distinct from MOB1
MOB3	MOB3A, MOB3B, MOB3C	MST1 (MOB3A), RNase P complex (MOB3C) [4]	Apoptosis regulation (MOB3A), tRNA maturation (MOB3C) [4] [1]	Poorly characterized; MOB3C association with RNase P is unique
MOB4	MOB4 (Phocein)	STRIPAK complex [3] [1]	Antagonizes Hippo signaling, regulates cell polarity & morphogenesis [3]	Most divergent class; functions as part of phosphatase complex

MOB proteins are small (~20-25 kDa) single-domain proteins that function primarily as scaffolds or adaptors, mediating the assembly and regulation of multi-protein complexes [4]. A defining structural characteristic is a conserved globular fold featuring a four-helix bundle core stabilized by a zinc atom [5] [3]. Despite structural similarities, different MOB classes have distinct surface properties that dictate specific protein-protein interactions, leading to functional diversification [3].

hMOB2: Key Functions and Mechanisms

hMOB2 is emerging as a critical regulator of genomic integrity with dual roles in maintaining cell proliferation under normal conditions and orchestrating DNA damage response (DDR) under genotoxic stress [6] [7].

hMOB2 in DNA Damage Response and Double-Strand Break Repair

A pivotal function of hMOB2 is its role in the cellular response to DNA damage, particularly double-strand breaks (DSBs). Research has revealed that hMOB2 promotes DDR signaling, cell survival, and cell cycle arrest following exogenously induced DNA damage [6]. Under normal conditions, hMOB2 prevents the accumulation of endogenous DNA damage, thereby avoiding a p53/p21-dependent G1/S cell cycle arrest [6].

The mechanistic basis for hMOB2's role in DDR involves its interaction with the MRE11-RAD50-NBS1 (MRN) complex, a primary sensor of DSBs [6]. A yeast two-hybrid screen identified RAD50 as a direct binding partner of hMOB2 [6]. This interaction facilitates the recruitment of the complete MRN complex and activated ATM kinase to damaged chromatin, initiating downstream DDR signaling [6].

More recently, hMOB2 has been identified as a specific regulator of homologous recombination (HR) repair [7]. hMOB2 supports the phosphorylation and stable accumulation of the RAD51 recombinase on resected single-strand DNA overhangs, a critical step in HR [7]. Cells deficient in hMOB2 display impaired RAD51 focus formation and compromised HR repair, sensitizing them to DSB-inducing agents.

hMOB2 and NDR Kinase Signaling

Biochemically, hMOB2 was initially characterized as a binding partner for NDR1/2 kinases (STK38/STK38L), where it competes with hMOB1 for NDR binding [6] [3]. The hMOB1/NDR complex is associated with increased NDR kinase activity, while hMOB2 binding was thought to block NDR activation [6]. Significantly, many DDR and cell cycle regulatory functions of hMOB2, including its role in preventing endogenous DNA damage accumulation, are not phenocopied by manipulations of NDR kinases, indicating these functions are performed independent of NDR signaling [6].

Diagram Title: hMOB2 Functional Roles in Genome Maintenance and DNA Damage Response

Experimental Protocols for hMOB2 Functional Analysis

Protocol 1: Assessing hMOB2 Deficiency in DNA Damage Response and Cell Cycle Arrest

This protocol outlines methods to evaluate the functional consequences of hMOB2 knockdown, particularly its role in inducing cell cycle arrest and sensitizing cells to DNA-damaging agents.

1. hMOB2 Knockdown

• Cell Lines: Use hTert-immortalized retinal pigment epithelial cells (RPE1-hTert), BJ fibroblasts, or relevant cancer cell lines (e.g., ovarian cancer lines) [6] [7].
• Knockdown Method: Employ tetracycline-inducible shRNA systems or transient siRNA transfection [6].
  • Transfection: Use Lipofectamine RNAiMax or Fugene 6 according to manufacturer's instructions.
  • siRNA Sequences: Use validated siRNAs; sequences available upon request from original publications [6].
• Controls: Include non-targeting siRNA/scrambled shRNA controls. Consider NDR1/2 knockdown controls to distinguish NDR-independent phenotypes [6].

2. DNA Damage Induction

• Agents:
  • Doxorubicin: 0.1-1 µM for 4-24 hours to induce DSBs [6].
  • Ionizing Radiation (IR): 2-10 Gy using X-ray machine (e.g., 215 kV, 12.0 mA) [6].
  • PARP Inhibitors: Olaparib or rucaparib at clinically relevant concentrations (e.g., 1-10 µM) [7] [8].
• Treatment Schedule: Treat cells 48-72 hours post-knockdown to ensure sufficient hMOB2 depletion.

3. Cell Cycle Analysis via Flow Cytometry

• Harvesting: Trypsinize cells 24-48 hours post-DNA damage.
• Fixation: Use 70% ethanol at -20°C for at least 2 hours.
• Staining: Resuspend cells in PBS containing propidium iodide (50 µg/mL) and RNase A (100 µg/mL).
• Analysis: Acquire data on flow cytometer and analyze cell cycle distribution using ModFit or FlowJo software. Expect G1/S arrest in hMOB2-deficient cells without exogenous damage [6].

4. Clonogenic Survival Assay

• Seeding: Seed appropriate cell numbers based on expected toxicity (200-1000 cells for controls, higher for treatments).
• Treatment: Expose to DNA-damaging agents 24 hours post-seeding.
• Culture: Allow 10-14 days for colony formation (>50 cells per colony).
• Staining and Counting: Fix with methanol/acetic acid (3:1), stain with crystal violet (0.5%), count colonies.
• Analysis: Calculate surviving fraction normalized to untreated controls. hMOB2 deficiency should potentiate toxicity of PARP inhibitors and other DSB-inducing agents [6] [7].

Protocol 2: Analyzing hMOB2 Role in Homologous Recombination

This protocol assesses hMOB2's specific function in RAD51 recruitment and focus formation, a key step in homologous recombination.

1. Immunofluorescence for RAD51 Foci

• Cell Preparation: Culture cells on glass coverslips.
• Damage Induction: Irradiate with 4-8 Gy IR or treat with 1 µM doxorubicin.
• Fixation and Permeabilization: Fix with 4% paraformaldehyde at specific timepoints post-damage (e.g., 2, 4, 8 hours), permeabilize with 0.5% Triton X-100.
• Staining: Incubate with anti-RAD51 primary antibody, then appropriate fluorescent secondary antibody. Counterstain with DAPI for nuclei.
• Imaging and Quantification: Acquire images by confocal microscopy. Quantify cells with >5 distinct RAD51 foci. hMOB2-deficient cells show significantly reduced RAD51 foci formation [7].

2. Chromatin Fractionation

• Cell Lysis: Harvest cells with ice-cold PBS, resuspend in Buffer A (10 mM Pipes, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.1% Triton X-100, protease/phosphatase inhibitors) [6].
• Fractionation: Incubate 10 min on ice, centrifuge 5 min at 1,300 × g at 4°C.
• Chromatin Isolation: Wash pellet with Buffer A, lyse in Buffer B (3 mM EDTA, 0.2 mM EGTA, inhibitors) for 10 min at 4°C.
• Analysis: Centrifuge 5 min at 1,700 × g; supernatant contains chromatin fraction. Analyze by immunoblotting for hMOB2, RAD51, γH2AX, and chromatin markers [6].

3. Co-Immunoprecipitation for Protein Interactions

• Cell Lysis: Use mild lysis buffer (e.g., 20 mM Tris pH 7.5, 150 mM NaCl, 1% NP-40, protease inhibitors).
• Antibody Coupling: Incubate anti-hMOB2 or control IgG with Protein A/G beads.
• Immunoprecipitation: Incubate cleared lysates with antibody-bound beads for 2-4 hours at 4°C.
• Washing and Elution: Wash beads 3-4 times with lysis buffer, elute with SDS sample buffer.
• Analysis: Detect interacting proteins (RAD50, RAD51) by immunoblotting [6].

Diagram Title: hMOB2 Functional Analysis Experimental Workflow

Research Reagent Solutions

Table 2: Essential Research Reagents for hMOB2 Functional Studies

Reagent Category	Specific Examples	Function/Application	Key Considerations
Knockdown Tools	Validated siRNAs (Qiagen) [6]; Tetracycline-inducible shRNAs in pTER/pMKO.1 vectors [6]	Deplete hMOB2 to study loss-of-function phenotypes	Use inducible systems for essential gene study; include NDR knockdown controls
Cell Lines	RPE1-hTert, BJ-hTert fibroblasts [6]; Ovarian cancer lines [7]	Model untransformed and cancer contexts	Check p53 status; ovarian lines relevant for PARP inhibitor studies
DNA Damage Agents	Doxorubicin (Sigma) [6]; PARP inhibitors (Olaparib, Rucaparib) [7]; X-ray irradiation [6]	Induce DSBs to probe DDR and HR functionality	Titrate concentration to achieve sublethal damage for repair studies
Antibodies	Anti-RAD51 (IF), anti-γH2AX (IF/WB), anti-RAD50 (Co-IP/WB) [6] [7]; anti-hMOB2 [6]	Detect protein localization, modification, and interactions	Validate for specific applications (IF vs. WB)
Assay Kits/Reagents	Propidium iodide (flow cytometry) [6]; Clonogenic assay materials (crystal violet) [6]; Chromatin fractionation buffers [6]	Quantify cell cycle, survival, and chromatin association	Include protease/phosphatase inhibitors in fractionation buffers

Therapeutic Implications and Biomarker Potential

The role of hMOB2 in HR repair has significant translational implications, particularly for cancer therapy. hMOB2 expression supports cancer cell survival in response to DSB-inducing chemotherapeutic agents [7]. Consequently, loss of hMOB2 renders ovarian and other cancer cells more vulnerable to FDA-approved PARP inhibitors through synthetic lethality [7].

Clinically, reduced hMOB2 expression correlates with increased overall survival in ovarian carcinoma patients, suggesting hMOB2 expression may serve as a candidate stratification biomarker for HR-deficiency targeted therapies [7]. This positions hMOB2 as a potential predictive biomarker for PARP inhibitor efficacy, similar to BRCA1/2 mutations and HRD status [8]. Assessing hMOB2 levels could help identify patients most likely to benefit from PARP inhibitor treatments, potentially improving therapeutic outcomes and patient stratification [7] [8].

Table 3: Quantitative Phenotypes of hMOB2 Deficiency in Cellular Models

Experimental Readout	hMOB2-Proficient Cells	hMOB2-Deficient Cells	Experimental Context
Endogenous DNA Damage	Low [6]	Accumulation, triggering p53/p21-dependent G1/S arrest [6]	Normal growth conditions
Cell Survival Post-Damage	Higher survival fraction [6] [7]	Potentiated toxicity to PARP inhibitors and DSB agents [6] [7]	PARP inhibitor treatment or irradiation
RAD51 Focus Formation	Robust formation on resected ssDNA [7]	Significantly impaired [7]	Post-ionizing radiation or doxorubicin
HR Repair Efficiency	Functional HR [7]	Compromised [7]	HR-specific reporter assays
MRN Complex Recruitment	Efficient to damage sites [6]	Impaired [6]	Chromatin fractionation after damage
Sensitivity to PARP Inhibitors	Moderate [7]	Highly sensitized [7]	Ovarian cancer cell models

hMOB2 as a Key Guardian Against Endogenous DNA Damage

Human Mps one binder 2 (hMOB2) is an evolutionarily conserved scaffold protein with emerging roles as a crucial regulator of genomic integrity. Recent research has unveiled its fundamental function in protecting cells from endogenous DNA damage accumulation, positioning hMOB2 as a key guardian of the genome under normal physiological conditions [6] [9]. In the absence of exogenous genotoxic stress, hMOB2 deficiency triggers the accumulation of spontaneous DNA lesions, activating a p53/p21-dependent G1/S cell cycle arrest that serves as a protective mechanism against genomic instability [6] [10]. This application note details the molecular mechanisms, experimental approaches, and technical protocols for investigating hMOB2's role in DNA damage prevention, providing researchers with essential tools for exploring this critical pathway in cancer biology and therapeutic development.

Key Findings and Quantitative Data

hMOB2 Deficiency and Endogenous DNA Damage

Research has demonstrated that hMOB2 plays a vital role in preventing the accumulation of endogenous DNA damage during normal cell growth, independent of externally applied genotoxic stress [6]. Under standard culture conditions, hMOB2 loss triggers a DNA damage response that includes ATM and CHK2 kinase activation, ultimately leading to a p53/p21-dependent G1/S cell cycle arrest [9]. This finding suggests that hMOB2 functions as a continuous genomic sentinel, protecting against spontaneously occurring DNA lesions that arise during normal cellular metabolism and replication.

Table 1: Cellular Phenotypes Associated with hMOB2 Deficiency

Phenotype	Experimental System	Key Readouts	Biological Significance
Endogenous DNA Damage Accumulation	hMOB2-depleted untransformed cells	↑γH2AX foci, ↑COMET assay signals	Indicates failure to repair spontaneous DNA lesions
Cell Cycle Arrest	hMOB2-deficient RPE1-hTert, U2-OS	G1/S arrest via p53/p21 pathway	Prevents replication of damaged DNA
DDR Pathway Activation	siRNA-mediated hMOB2 knockdown	Phospho-ATM, Phospho-CHK2 elevation	Demonstrates activation of damage signaling without exogenous damage
Sensitivity to DNA Damaging Agents	hMOB2-depleted cancer cells	↑Sensitivity to PARP inhibitors, bleomycin	Suggests HR repair defect

Mechanistic Insights: hMOB2 in DNA Damage Sensing and Repair

hMOB2's protective function is mechanistically linked to its interaction with the MRE11-RAD50-NBS1 (MRN) complex, the primary sensor for DNA double-strand breaks [6]. Through yeast two-hybrid screening and co-immunoprecipitation studies, researchers identified RAD50 as a direct binding partner of hMOB2 [6]. This interaction facilitates the recruitment of both the MRN complex and activated ATM to damaged chromatin, enabling efficient DNA damage signaling and repair [6].

More recent research has revealed that hMOB2 specifically regulates homologous recombination (HR) repair by stabilizing RAD51 on resected single-strand DNA overhangs [7] [9]. This function explains the accumulation of DNA damage in hMOB2-deficient cells and their heightened sensitivity to PARP inhibitors, which target HR-deficient cancers [7].

Table 2: hMOB2-Mediated DNA Damage Response Mechanisms

Mechanistic Aspect	Molecular Partners	Functional Outcome	Experimental Evidence
Damage Sensor Recruitment	RAD50, MRN complex, ATM	Enhanced damage recognition and signaling	Co-IP, chromatin fractionation, immunofluorescence
Repair Pathway Regulation	RAD51, BRCA2	Homologous recombination promotion	RAD51 focus formation, HR reporter assays
Cell Cycle Checkpoint Control	p53, p21	G1/S arrest implementation	Flow cytometry, western blotting of cell cycle markers
NDR Kinase-Independent Function	NDR1/2 (not required)	DDR functions separate from known MOB2-NDR axis	NDR knockdown/overexpression comparisons

Experimental Protocols

Protocol 1: Assessing Endogenous DNA Damage in hMOB2-Deficient Cells

Principle: This protocol details the detection and quantification of endogenous DNA damage in hMOB2-knockdown cells under normal growth conditions without exogenous DNA damage induction.

Materials:

• RPE1-hTert or U2-OS cell lines
• hMOB2-specific siRNA or shRNA constructs
• Control non-targeting siRNA
• Lipofectamine RNAiMax transfection reagent
• Immunofluorescence buffers and fixatives
• Primary antibodies: anti-γH2AX (DNA damage marker), anti-53BP1 (DNA repair factor)
• Fluorescently-labeled secondary antibodies
• DAPI staining solution
• Confocal or epifluorescence microscope

Procedure:

• Cell Preparation and Transfection:
  • Seed cells at 30-40% confluence in complete growth medium 24 hours prior to transfection.
  • Transfert cells with 50 nM hMOB2-specific siRNA or control siRNA using Lipofectamine RNAiMax according to manufacturer's protocol.
  • Incubate cells for 72-96 hours to ensure efficient protein knockdown.

• Immunofluorescence Staining:

  • Wash cells with PBS and fix with 4% paraformaldehyde for 15 minutes at room temperature.
  • Permeabilize cells with 0.5% Triton X-100 in PBS for 10 minutes.
  • Block with 5% BSA in PBS for 1 hour at room temperature.
  • Incubate with primary antibodies (anti-γH2AX and anti-53BP1, 1:1000 dilution) overnight at 4°C.
  • Wash 3× with PBS and incubate with appropriate secondary antibodies (1:2000 dilution) for 1 hour at room temperature.
  • Counterstain nuclei with DAPI (1 μg/mL) for 5 minutes.
  • Mount slides with antifade mounting medium.

• Image Acquisition and Analysis:

  • Acquire images using a 63× oil immersion objective on a confocal microscope.
  • Count γH2AX and 53BP1 foci in at least 100 cells per condition.
  • Score cells with >10 γH2AX foci as DNA damage-positive.
  • Quantify integrated fluorescence intensity per nucleus using ImageJ software.

Expected Results: hMOB2-deficient cells should display significantly increased γH2AX and 53BP1 foci compared to control cells, indicating accumulation of endogenous DNA damage [6] [9].

Protocol 2: Cell Cycle Analysis in hMOB2-Modified Cells

Principle: This protocol enables detection of G1/S cell cycle arrest in hMOB2-deficient cells through flow cytometric analysis of DNA content.

Materials:

• hMOB2-knockdown and control cells
• Trypsin-EDTA solution
• PBS, ice-cold
• 70% ethanol in PBS
• RNase A solution (100 μg/mL)
• Propidium iodide staining solution (50 μg/mL)
• Flow cytometer with 488 nm excitation
• Software for cell cycle analysis (e.g., ModFit, FlowJo)

Procedure:

• Cell Harvest and Fixation:
  • Harvest cells by trypsinization 96 hours post-transfection.
  • Wash cells twice with ice-cold PBS.
  • Resuspend cell pellet in 0.5 mL PBS and add dropwise to 4.5 mL ice-cold 70% ethanol while vortexing gently.
  • Fix cells at 4°C for at least 2 hours or overnight.

• DNA Staining:

  • Pellet fixed cells by centrifugation at 500 × g for 5 minutes.
  • Remove ethanol and wash once with PBS.
  • Resuspend cell pellet in 0.5 mL PBS containing RNase A (100 μg/mL).
  • Incubate at 37°C for 30 minutes.
  • Add propidium iodide to a final concentration of 50 μg/mL.
  • Incubate in the dark at room temperature for 10 minutes.

• Flow Cytometry and Analysis:

  • Analyze samples using a flow cytometer with 488 nm excitation.
  • Collect at least 10,000 events per sample.
  • Exclude doublets and debris by gating on singlet population in FSC-A vs FSC-H plot.
  • Analyze DNA content histograms using appropriate cell cycle modeling software.
  • Calculate percentage of cells in G1, S, and G2/M phases.

Expected Results: hMOB2-deficient cells should show a significant increase in the G1 population and corresponding decrease in S-phase cells, indicating p53/p21-dependent G1/S arrest [6] [9].

Signaling Pathways and Molecular Mechanisms

The diagram below illustrates the molecular mechanism by which hMOB2 protects against endogenous DNA damage and the consequences of its deficiency:

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagents for Studying hMOB2 in DNA Damage Response

Reagent/Category	Specific Examples	Function/Application	Experimental Notes
Knockdown Tools	hMOB2-specific siRNAs (Qiagen), shRNA lentiviral particles (pSuper.retro.puro)	hMOB2 loss-of-function studies	Validate knockdown efficiency by immunoblotting; use for 72-96 hours
Expression Constructs	pEGFP-C1-MOB2, pCDH-MOB2 (with V5-tag)	hMOB2 overexpression studies	Use in cells with low endogenous MOB2 (e.g., SF-539, SF-767)
Cell Lines	RPE1-hTert, U2-OS, HCT116, Ovarian cancer lines (HOC7, OVCAR series)	Model systems for DDR studies	RPE1-hTert ideal for cell cycle analysis; U2-OS for clonogenic assays
DNA Damage Markers	Anti-γH2AX, anti-53BP1, anti-phospho-ATM (Ser1981)	Immunofluorescence detection of DNA damage	Use foci counting for quantitative assessment; minimum 100 cells/sample
Cell Cycle Analysis	Propidium iodide, anti-p21 antibodies, anti-p53 antibodies	Cell cycle distribution assessment	Combine flow cytometry with western blotting for p53/p21
HR Repair Reporters	U2OS DR-GFP, RAD51 antibodies	Homologous recombination efficiency	RAD51 foci formation assays in S/G2 phase cells
Inhibitors	Olaparib, rucaparib (PARPi), bleomycin, KU-55933 (ATM inhibitor)	DNA damage induction and pathway inhibition	PARPi sensitivity indicates HR deficiency
Phycocyanobilin	Phycocyanobilin, MF:C33H38N4O6, MW:586.7 g/mol	Chemical Reagent	Bench Chemicals
(rel)-Oxaliplatin	(rel)-Oxaliplatin, CAS:694-83-7, MF:C6H14N2, MW:114.19 g/mol	Chemical Reagent	Bench Chemicals

Research Applications and Therapeutic Implications

The role of hMOB2 in preventing endogenous DNA damage accumulation has significant implications for cancer research and therapeutic development. Research indicates that low hMOB2 expression correlates with increased overall survival in ovarian carcinoma patients, suggesting its potential value as a prognostic biomarker [7] [9]. Furthermore, hMOB2-deficient cancer cells show heightened sensitivity to PARP inhibitors, indicating that hMOB2 status may serve as a predictive biomarker for patient stratification in HR-targeted therapies [7] [9].

From a drug discovery perspective, targeting the hMOB2-RAD50 interaction or exploiting the synthetic lethality between hMOB2 deficiency and PARP inhibition represents promising therapeutic avenues. The experimental protocols outlined in this application note provide the foundational methodology for screening compounds that modulate hMOB2 function or exploit hMOB2 deficiency in cancer cells.

hMOB2 emerges as a critical guardian of genomic integrity through its role in preventing endogenous DNA damage accumulation. Its functions in facilitating MRN complex recruitment, promoting homologous recombination repair, and triggering appropriate cell cycle checkpoints position hMOB2 as a significant factor in maintaining genome stability. The experimental approaches and methodologies detailed in this application note provide researchers with robust tools to investigate hMOB2's mechanisms and therapeutic potential in cancer and other genome instability-related disorders.

The maintenance of genomic integrity is a fundamental cellular process, and the DNA damage response (DDR) is a critical mechanism for preserving it. Within the DDR, the repair of DNA double-strand breaks (DSBs) via the homologous recombination (HR) pathway is essential for error-free correction. This application note delves into the mechanistic role of human MOB2 (hMOB2), an evolutionarily conserved protein, in facilitating HR. We will explore its interactions with the MRN (MRE11-RAD50-NBS1) complex and the RAD51 recombinase, providing a detailed protocol for studying these interactions within the context of MOB2 knockdown and cell cycle arrest assays. This framework is vital for research aimed at understanding cancer cell survival and developing targeted therapies, such as PARP inhibitors.

Key Mechanistic Insights and Biological Significance

hMOB2 as a Novel DNA Damage Response Protein

hMOB2 has been identified as a crucial player in the DDR, particularly in responding to exogenously induced DNA damage and in preventing the accumulation of endogenous DNA damage under normal growth conditions. Loss of hMOB2 leads to heightened sensitivity to DNA-damaging agents like ionizing radiation and doxorubicin, impairs cell cycle checkpoint activation, and compromises cell survival following damage [6] [10]. Under unperturbed conditions, hMOB2 deficiency results in the accumulation of DNA damage, triggering a p53/p21-dependent G1/S cell cycle arrest [6] [10]. This underscores its role in maintaining genomic stability even in the absence of external threats.

Interaction with the MRN Complex and ATM Activation

A pivotal mechanistic insight reveals that hMOB2 interacts directly with RAD50, a core component of the MRN complex [6] [10]. The MRN complex is one of the primary sensors of DSBs and is responsible for recruiting and activating the central DDR kinase, ATM (ataxia-telangiectasia mutated) [11].

This hMOB2-RAD50 interaction facilitates the recruitment of the activated MRN complex and ATM to sites of damaged chromatin [6] [10]. Consequently, hMOB2 depletion leads to suboptimal ATM activation and impaired downstream DDR signaling, mirroring phenotypes observed in MRN-deficient cells [10]. This places hMOB2 as a key supporter of MRN functionality at the earliest stages of DSB recognition and signaling.

Role in Homologous Recombination and RAD51 Stabilization

Beyond its role in early signaling, hMOB2 is a specific regulator of the HR repair pathway. It is required for the phosphorylation and stable accumulation of the RAD51 recombinase on resected single-strand DNA (ssDNA) overhangs [9] [7]. RAD51 is the central catalytic engine of HR, forming a nucleoprotein filament that performs the strand invasion reaction. hMOB2 promotes the stabilization of this RAD51 nucleofilament on damaged chromatin, a critical step for successful homology-directed repair [9] [7]. Therefore, hMOB2 deficiency directly impairs HR-mediated DSB repair.

Table 1: Functional Consequences of hMOB2 Deficiency

Cellular Process	Effect of hMOB2 Loss	Key Readouts
Endogenous Genomic Stability	Accumulation of DNA damage; G1/S cell cycle arrest	↑γH2AX foci; ↑p53/p21 protein levels [6] [10]
Response to Exogenous Damage	Hypersensitivity to DSB-inducing agents (e.g., IR, Bleomycin)	Reduced clonogenic survival; increased apoptosis [6] [10]
ATM Signaling Pathway	Impaired activation and recruitment of ATM/MRN	Reduced p-ATM (Ser1981) foci; defective MRN foci formation [6] [10]
Homologous Recombination	Defective RAD51 foci formation & stabilization	↓RAD51 foci post-irradiation; impaired HR repair efficiency [9] [7]
Cancer Therapy Response	Sensitization to PARP inhibitors	Reduced IC50 for Olaparib, Rucaparib, Veliparib [9] [7]

Therapeutic Implications and Biomarker Potential

The role of hMOB2 in HR makes it a therapeutically relevant target. Loss of hMOB2 renders cancer cells, particularly ovarian carcinoma cells, more vulnerable to FDA-approved PARP inhibitors (e.g., Olaparib, Rucaparib, Veliparib) [9] [7]. This is due to synthetic lethality, where the combined deficiency of hMOB2 and PARP-mediated repair pathways leads to cell death. Clinically, reduced MOB2 expression correlates with increased overall survival in ovarian carcinoma patients, suggesting that hMOB2 expression may serve as a predictive biomarker for patient stratification in HR-deficiency targeted therapies [9] [7].

Experimental Protocol: Analyzing hMOB2-Mediated HR and Cell Cycle Arrest

This protocol outlines the methodology for establishing the functional link between hMOB2 knockdown, impaired RAD51 foci formation, and the induction of a G1/S cell cycle arrest.

hMOB2 Knockdown and DNA Damage Induction

• Cell Lines: U2OS, RPE1-hTert, or relevant ovarian cancer cell lines (e.g., OVCAR8) are suitable [9] [6].
• Knockdown: Transfect cells with validated hMOB2-specific siRNAs (sequences available upon request from Qiagen) using Lipofectamine RNAiMax, following manufacturer's instructions [9] [6]. Include a non-targeting siRNA control.
  • Transfection Details: Plate exponentially growing cells at a consistent confluence (e.g., 30-50%) and transfect with 20-50 nM siRNA. Analyze knockdown efficiency via immunoblotting 48-72 hours post-transfection [6].
• DNA Damage Induction: 48 hours post-transfection, induce DSBs.
  • Ionizing Radiation (IR): Expose cells to a defined dose (e.g., 2-10 Gy) using an X-ray machine (e.g., 5 Gy/min) [6] [10].
  • Chemical Agents: Treat cells with 1-2 µM Doxorubicin for 2-4 hours [10].

Immunofluorescence Staining for RAD51 Foci Analysis

This procedure assesses the functional output of hMOB2 in HR.

• Fixation: At desired timepoints post-damage (e.g., 2, 4, 8 hours), wash cells with PBS and fix with 4% paraformaldehyde for 15 minutes at room temperature.
• Permeabilization and Blocking: Permeabilize cells with 0.5% Triton X-100 in PBS for 10 minutes. Block with 5% Bovine Serum Albumin (BSA) in PBS for 1 hour.
• Antibody Staining:
  • Incubate with primary anti-RAD51 antibody (e.g., Millipore, 1:500) diluted in blocking buffer overnight at 4°C.
  • Wash with PBS and incubate with a fluorescently-labeled secondary antibody (e.g., Alexa Fluor 488, 1:1000) and DAPI (for nuclear counterstaining) for 1 hour at room temperature in the dark.
• Imaging and Quantification: Image cells using a high-content or confocal fluorescence microscope. Score at least 200 cells per condition for the presence of >5 distinct RAD51 nuclear foci. Results are typically presented as the percentage of cells with RAD51 foci [9].

Cell Cycle Analysis via Flow Cytometry

This procedure quantifies the G1/S arrest resulting from endogenous DNA accumulation upon hMOB2 knockdown.

• Cell Harvesting: 72-96 hours post-siRNA transfection (without exogenous damage), harvest cells by trypsinization.
• Fixation and Staining: Fix cells in 70% ice-cold ethanol for at least 2 hours. Pellet cells, wash with PBS, and resuspend in a staining solution containing Propidium Iodide (PI) (e.g., 50 µg/mL) and RNase A (e.g., 100 µg/mL) to label DNA and degrade RNA, respectively. Incubate for 30 minutes at 37°C in the dark.
• Flow Cytometry: Analyze DNA content using a flow cytometer. A minimum of 10,000 events per sample should be collected.
• Data Analysis: Use software (e.g., FlowJo) to model cell cycle distribution. hMOB2-depleted cells will show a significant increase in the G1 population and a decrease in the S-phase population compared to control cells [6] [10].

Table 2: Key Research Reagent Solutions

Reagent / Tool	Function / Application	Example & Source
hMOB2-specific siRNAs	Targeted knockdown of hMOB2 gene expression	Validated sequences (Qiagen) [9] [6]
Anti-RAD51 Antibody	Detection of RAD51 nucleofilament formation via IF	Rabbit monoclonal (Millipore, 07-1780) [9]
Anti-p-ATM (Ser1981)	Marker for activated ATM kinase at damage sites	Mouse monoclonal (Santa Cruz, sc-47739) [9]
PARP Inhibitors	Induce synthetic lethality in HR-deficient cells	Olaparib, Rucaparib, Veliparib (Selleckchem) [9]
Lipofectamine RNAiMax	Transfection reagent for siRNA delivery	Invitrogen [9] [6]
Doxorubicin	DSB-inducing chemotherapeutic agent	Sigma-Aldrich [10]

Signaling Pathway and Workflow Visualization

The following diagrams illustrate the molecular mechanism of hMOB2 and the experimental workflow for its functional analysis.

Diagram 1: hMOB2 in the DNA Damage Response Pathway

Diagram 2: Experimental Workflow for hMOB2 Functional Analysis

Within the framework of knockdown MOB2 cell cycle arrest assay research, understanding the precise molecular consequences of hMOB2 depletion is fundamental. The Mps one binder 2 (MOB2) protein is a highly conserved signal transducer, and recent evidence has positioned it as a novel and critical player in maintaining genomic integrity [6] [12]. Loss-of-function studies have revealed that hMOB2 deficiency triggers a specific and robust cell cycle arrest at the G1/S phase transition [6] [12]. This arrest is mechanistically driven by the accumulation of endogenous DNA damage, which in turn activates the canonical p53/p21 signaling axis [6]. This application note consolidates key quantitative data, detailed protocols, and essential resources for researchers investigating the role of hMOB2 in DNA damage response (DDR) and cell cycle control, providing a foundation for assays focused on MOB2 knockdown and its functional outcomes.

Key Experimental Findings & Quantitative Data

The cellular phenotype resulting from hMOB2 loss is characterized by specific molecular events. The tables below summarize the core quantitative findings and the associated molecular markers that are validated readouts for hMOB2 knockdown experiments.

Table 1: Key Phenotypic Consequences of hMOB2 Knockdown

Assay Type	Experimental Finding	Quantitative Outcome	Biological Significance
Cell Proliferation	Defective cell proliferation [12]	Significant reduction in cell number [6]	Indicates activation of cell cycle checkpoints
Cell Cycle Analysis	G1/S phase cell cycle arrest [6] [12]	Increased proportion of cells in G1 phase [6]	Direct evidence of checkpoint activation
Apoptosis Assay	Increased apoptosis [6]	Elevated levels of caspase cleavage/Annexin V [6]	Suggests irreparable damage in a subset of cells
Clonogenic Survival	Reduced cell survival after DNA damage [6]	Decreased colony-forming ability post-IR/doxorubicin [6]	Demonstrates role in DNA damage response and repair

Table 2: Molecular Markers Altered Upon hMOB2 Loss

Molecular Marker	Change in hMOB2-Deficient Cells	Functional Assay	Interpretation
p53 Protein	Upregulated and activated [6] [12]	Western Blot, Phospho-specific antibodies	Central tumor suppressor activation
p21 (Cip1) Protein	Upregulated [6] [12]	Western Blot, qPCR	CDK inhibitor, effector of G1/S arrest
γH2AX	Increased foci formation [6]	Immunofluorescence, Western Blot	Marker of DNA double-strand breaks
Phospho-ATM/CHK2	Activated [6] [12]	Western Blot	Activation of DNA damage signaling pathway
RAD51 Foci	Impaired formation [7]	Immunofluorescence	Indicator of defective homologous recombination repair

Experimental Protocol: hMOB2 Knockdown and Cell Cycle Analysis

This section provides a detailed methodology for establishing the p53/p21-dependent G1/S arrest phenotype following hMOB2 knockdown in untransformed human cells.

Cell Culture and hMOB2 Depletion

• Cell Lines: Use untransformed human cell lines such as hTert-immortalized retinal pigment epithelial cells (RPE1-hTert) or BJ fibroblasts to model physiologically relevant cell cycle checkpoints [6].
• Knockdown Method:
  • siRNA Transfection: Transfect cells with validated hMOB2-specific siRNAs using a transfection reagent like Lipofectamine RNAiMax [6].
  • Stable Knockdown: Generate stable knockdown cell lines using retroviral (e.g., pMKO.1 puro) or lentiviral vectors expressing hMOB2-specific shRNAs [6]. Include a non-targeting shRNA/siRNA as a negative control.
  • Culture Conditions: Maintain cells in appropriate media (e.g., DMEM for RPE1-hTert) supplemented with 10% Fetal Calf Serum (FCS) and antibiotics [6].

Analysis of Cell Cycle Arrest and DNA Damage

• Sample Preparation: Harvest hMOB2 knockdown and control cells 72-96 hours post-transfection during exponential growth.
• Cell Cycle Profiling by Flow Cytometry:
  • Fixation: Fix cells in 70% ice-cold ethanol.
  • Staining: Resuspend cell pellets in a solution containing Propidium Iodide (PI) (e.g., 10 μg/ml) and RNase (e.g., 300 μg/ml) to stain DNA and degrade RNA, respectively [13].
  • Analysis: Acquire data on a flow cytometer from 10,000 events per sample. Analyze the cell cycle distribution using software such as ModFit [13]. The expected result is a significant increase in the G1 population in hMOB2-deficient cells compared to controls.
• DNA Damage Assessment via Comet Assay:
  • Embed Cells: Mix harvested cells with low-melting-point agarose and solidify on a microscope slide.
  • Lysis and Electrophoresis: Lyse cells in a high-salt, detergent-based buffer to remove cellular membranes, then subject to electrophoresis under neutral or alkaline conditions to detect double or single-strand breaks, respectively.
  • Staining and Imaging: Stain DNA with a fluorescent dye like SYBR Gold and image using a fluorescence microscope. Quantify DNA damage by measuring tail moment [6].

Validation of Molecular Mechanisms

• Protein Analysis by Immunoblotting:
  • Lysis: Lyse cells in RIPA buffer supplemented with protease and phosphatase inhibitors.
  • Electrophoresis and Transfer: Separate proteins by SDS-PAGE and transfer to a PVDF membrane.
  • Antibody Probing: Probe the membrane with primary antibodies against p53, p21, phospho-ATM (Ser1981), phospho-CHK2 (Thr68), and γH2AX (Ser139). Use GAPDH or Actin as a loading control.
  • Detection: Use HRP-conjugated secondary antibodies and chemiluminescence detection to visualize protein levels. Expect increased levels of all these markers in hMOB2 knockdown cells [6] [12].
• Functional Rescue Experiments:
  • Co-knockdown: Perform simultaneous knockdown of hMOB2 and p53 (or p21) using siRNAs. Analysis should show that the G1/S arrest and proliferation defect are abrogated, confirming the dependence on the p53/p21 pathway [12].

Signaling Pathway and Experimental Workflow

The following diagrams illustrate the molecular pathway triggered by hMOB2 loss and the sequential steps for the knockdown assay.

Signaling Pathway Upon hMOB2 Loss

hMOB2 Knockdown Assay Workflow

The Scientist's Toolkit: Essential Research Reagents

The table below catalogues critical reagents and their functions for studying hMOB2-mediated cell cycle arrest.

Table 3: Key Research Reagent Solutions for hMOB2 Studies

Reagent / Tool	Function / Application	Example / Note
hMOB2 siRNAs/shRNAs	Specific depletion of hMOB2 mRNA	Validated sequences available from Qiagen; use retroviral pMKO.1 for stable knockdown [6]
Anti-hMOB2 Antibody	Confirmation of knockdown efficiency via Western Blot	Critical for validating experimental setup [6]
Anti-p53 Antibody	Detection of p53 protein stabilization and total levels	Marker for DDR activation [6] [12]
Anti-p21 Antibody	Detection of p21 CDK inhibitor upregulation	Key effector of G1/S arrest [6] [12] [14]
Anti-γH2AX Antibody	Immunofluorescence and Western blot detection of DNA DSBs	Gold standard for visualizing DNA damage foci [6]
Anti-phospho-ATM/CHK2	Readout for DNA damage kinase pathway activation	Indicates upstream DDR signaling [6] [12]
Propidium Iodide (PI)	DNA staining for cell cycle analysis by flow cytometry	Used with RNase for DNA content quantification [13]
Lipofectamine RNAiMax	Transfection reagent for siRNA delivery into mammalian cells	High-efficiency transfection for siRNA experiments [6]
Merulidial	Merulidial, CAS:68053-32-7, MF:C15H20O3, MW:248.32 g/mol	Chemical Reagent
SQ28603	SQ28603 NEP Inhibitor|For Research Use	SQ28603 is a potent neutral endopeptidase (NEP) inhibitor for cardiovascular research. This product is for Research Use Only (RUO).

Distinguishing hMOB2 Functions from NDR Kinase Signaling Pathways

Mps one binder 2 (hMOB2) is an evolutionarily conserved protein with complex and dualistic roles in cellular signaling. Initially characterized primarily as a binding partner and negative regulator of Nuclear Dbf2-related (NDR) kinases, recent research has revealed that hMOB2 also possesses critical NDR-independent functions, particularly in the DNA damage response (DDR) [15] [6]. This application note delineates the distinct signaling pathways governed by hMOB2 and provides detailed methodologies for researchers investigating hMOB2 functions in cell cycle regulation, DDR, and kinas signaling. Within the context of MOB2 knockdown research, understanding these divergent pathways is essential for interpreting experimental outcomes related to cell cycle arrest and genomic instability.

Dual Signaling Pathways of hMOB2

hMOB2 engages in two functionally distinct cellular signaling mechanisms: one through direct interaction with NDR kinases, and another through NDR-independent pathways involving the MRE11-RAD50-NBS1 (MRN) complex.

NDR-Kinase Dependent Signaling

In the canonical NDR kinase pathway, hMOB2 functions as a competitive inhibitor of hMOB1A/B. Biochemical studies demonstrate that hMOB2 binds to the N-terminal regulatory domain of NDR1/2 kinases, effectively competing with the activator hMOB1A for the same binding site [15]. However, unlike hMOB1A, hMOB2 binds preferentially to unphosphorylated NDR and does not stimulate its kinase activity. RNA interference-mediated depletion of hMOB2 results in increased NDR kinase activity, confirming its role as a physiological negative regulator [15]. Functionally, this regulation impacts biological processes including death receptor signaling and centrosome duplication [15].

NDR-Kinase Independent Signaling & DNA Damage Response

Surprisingly, numerous phenotypes observed upon hMOB2 manipulation are not recapitulated by NDR perturbation. Research has unveiled that hMOB2 plays a crucial NDR-independent role in maintaining genomic integrity through the DDR [6]. hMOB2 deficiency leads to accumulation of endogenous DNA damage and triggers a p53/p21-dependent G1/S cell cycle arrest under normal growth conditions [6]. Following exogenously induced DNA damage, hMOB2 promotes cell survival, checkpoint activation, and DDR signaling. Mechanistically, hMOB2 interacts directly with RAD50, facilitating the recruitment of the complete MRN complex and activated ATM to sites of DNA damage [6]. More recent work has further specified that hMOB2 is required for efficient double-strand break repair via homologous recombination (HR) by stabilizing RAD51 on resected single-strand DNA overhangs [7].

The following diagram illustrates the two distinct pathways regulated by hMOB2:

Diagram Title: Dual hMOB2 Signaling Pathways

The distinct functional roles of hMOB2 are supported by multiple quantitative experimental findings. The following table consolidates key phenotypic data from hMOB2 manipulation studies:

Table 1: Cellular Phenotypes Following hMOB2 Depletion

Phenotype / Assay Readout	Experimental System	Key Quantitative Findings	NDR-Dependent?	Citation
NDR Kinase Activity	HEK 293 cells	Increased NDR1/2 kinase activity upon hMOB2 RNAi	Yes	[15]
Endogenous DNA Damage(γH2AX foci)	RPE1-hTert (untreated)	Significant accumulation of DNA damage in hMOB2-deficient cells	No	[6]
Cell Cycle Arrest(G1/S phase)	BJ-hTert fibroblasts	p53/p21-dependent G1/S arrest after hMOB2 knockdown	No	[6]
Cell Survival Post-IR(Clonogenic assay)	RPE1-hTert	Enhanced sensitivity to ionizing radiation in hMOB2-deficient cells	No	[6]
HR Repair Efficiency(DR-GFP reporter)	U2-OS & Ovarian Cancer Cells	Significant reduction in HR-mediated repair in hMOB2-deficient cells	No	[7]
PARP Inhibitor Sensitivity(Cell viability)	OVCAR-8, other cancer lines	Markedly increased sensitivity to PARP inhibitors (Olaparib) with hMOB2 loss	No	[7]

Detailed Experimental Protocols

Protocol 1: hMOB2 Knockdown and Cell Cycle Analysis

This protocol details the methodology for assessing hMOB2 deficiency-induced cell cycle arrest, a crucial assay within the broader thesis research on MOB2 knockdown.

4.1.1. Research Reagent Solutions

Table 2: Essential Reagents for hMOB2 Knockdown Studies

Reagent / Material	Specifications / Function	Example Source / Catalog
Cell Lines	hTert-immortalized retinal pigment epithelial (RPE1) or fibroblast (BJ) cells; maintain genomic stability for DDR studies	ATCC
hMOB2-Targeting siRNA	Validated siRNA or shRNA for efficient knockdown; pTER vector system for inducible expression	Qiagen, custom pTER constructs [6]
Control siRNA	Non-targeting scrambled sequence control	Qiagen
Transfection Reagent	For efficient siRNA/shRNA delivery (e.g., Lipofectamine RNAiMax, Fugene 6)	Invitrogen, Promega
Antibodies for Analysis	Anti-hMOB2: Confirm knockdown efficiency Anti-γH2AX (Ser139): Marker of DNA double-strand breaks Anti-p53 (Phospho-S15): Marker of activated p53 Anti-p21 Waf1/Cip1: CDK inhibitor, cell cycle arrest marker	Multiple commercial sources
Propidium Iodide (PI)	DNA staining for cell cycle profiling by flow cytometry	Sigma-Aldrich
RNase A	Digest RNA for clean PI DNA staining	Qiagen
Flow Cytometer	Analyze DNA content and cell cycle distribution	BD Biosciences

4.1.2. Step-by-Step Workflow

• Cell Seeding and Transfection: Seed RPE1-hTert or BJ-hTert cells at 40-50% confluence in appropriate dishes 24 hours prior to transfection to ensure optimal growth conditions. Transfert cells using Lipofectamine RNAiMax with either:

  • Experimental: hMOB2-targeting siRNA (e.g., 50 nM final concentration).
  • Control: Non-targeting scrambled siRNA (50 nM).
  • Include a replicate set for potential doxorubicin treatment (e.g., 0.5 µM for 4 hours) to induce exogenous DNA damage as a positive control [6].

• Incubation: Allow knockdown to proceed for 72-96 hours to ensure sufficient protein turnover and manifestation of phenotypic consequences. Refresh culture medium at 48 hours post-transfection if needed.

• Cell Harvesting and Fixation: Trypsinize and harvest cells. Wash once with ice-cold PBS. Gently resuspend the cell pellet in 70% ethanol (added drop-wise while vortexing) and fix at -20°C for a minimum of 2 hours or overnight.

• Cell Cycle Staining: Pellet the fixed cells and wash with PBS to remove ethanol. Resuspend the cell pellet in 500 µL of PI/RNase staining solution (e.g., containing 50 µg/mL PI and 100 µg/mL RNase A in PBS). Incubate for 30 minutes at 37°C in the dark.

• Flow Cytometry Analysis: Analyze the DNA content of at least 10,000 cells per sample using a flow cytometer. Use the FL2 or FL3 channel for PI detection. Determine the percentage of cells in G1, S, and G2/M phases using appropriate cell cycle analysis software (e.g., ModFit LT).

• Parallel Sample Processing for Immunoblotting: Harvest a separate aliquot of cells 72-96 hours post-transfection for protein extraction. Perform immunoblotting to:

  • Confirm hMOB2 knockdown efficiency.
  • Assess upregulation of p53 (particularly phospho-S15), p21, and γH2AX levels in the hMOB2-depleted sample compared to control.

The experimental workflow for this protocol is visualized below:

Diagram Title: hMOB2 Knockdown Cell Cycle Assay Workflow

Protocol 2: Co-Immunoprecipitation to Elucidate hMOB2 Interactions

This protocol is essential for differentiating between hMOB2-NDR and hMOB2-RAD50 complexes.

4.2.1. Research Reagent Solutions

Reagent / Material	Specifications / Function	Example Source
Expression Plasmids	pcDNA3 vectors encoding: myc- or HA-tagged hMOB2, NDR1, RAD50	[15] [6]
Cell Lysis Buffer	Modified RIPA buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% Na-deoxycholate) + fresh protease/phosphatase inhibitors
Immunoprecipitation Antibody	High-quality antibody against the tag (e.g., anti-myc, anti-HA) or endogenous protein (anti-hMOB2, anti-NDR1, anti-RAD50)	Sigma, Cell Signaling
Control IgG	Species-matched normal IgG for control IP
Protein A/G Beads	Agarose beads for antibody-antigen complex pulldown	Thermo Fisher
SDS-PAGE & Western Blotting System	For protein separation and detection	Bio-Rad

4.2.2. Step-by-Step Workflow

• Cell Transfection and Lysis: Co-transfect HEK 293T cells (chosen for high transfection efficiency) with plasmids encoding:

  • Test: myc-hMOB2 + HA-NDR1 or myc-hMOB2 + HA-RAD50.
  • Controls: Individual plasmids with empty vector counterparts.
  • At 24-48 hours post-transfection, lyse cells in ice-cold lysis buffer for 30 minutes. Clear lysates by centrifugation at 14,000 x g for 15 minutes at 4°C.

• Pre-Clearing and Immunoprecipitation: Pre-clear the supernatant with Protein A/G beads for 1 hour. Incubate the pre-cleared lysate with the primary antibody (e.g., 1-2 µg of anti-myc antibody) overnight at 4°C with gentle rotation.

• Bead Capture and Washing: Add Protein A/G beads the next morning and incubate for 2-4 hours. Pellet beads and wash extensively (3-5 times) with cold lysis buffer to reduce non-specific binding.

• Elution and Denaturation: Elute bound proteins by boiling beads in 2X Laemmli SDS sample buffer for 5-10 minutes.

• Immunoblot Analysis: Resolve eluted proteins and input controls by SDS-PAGE. Transfer to PVDF membrane and probe with antibodies against the potential binding partners (e.g., anti-HA to detect co-precipitated NDR1 or RAD50, and anti-myc to confirm hMOB2 pulldown).

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Research Tools for hMOB2/NDR Pathway Analysis

Category / Reagent	Specific Example(s)	Primary Function in Research
Cell Line Models	RPE1-hTert, BJ-hTert, U2-OS, HEK 293	RPE1/BJ ideal for DDR studies; HEK 293 for protein interaction/overexpression; U2-OS for DR-GFP HR repair assay [6] [7].
Knockdown Tools	pTER-shRNA vectors (inducible); commercial siRNAs (Qiagen)	Efficient and sometimes inducible depletion of hMOB2 or NDR kinases for functional studies [15] [6].
Expression Plasmids	pcDNA3-myc-hMOB2, pT-Rex-DEST30-hMOB2, pcDNA3-HA-NDR1	For overexpression, structure-function analysis (e.g., hMOB2(H157A) mutant), and rescue experiments [15].
Key Antibodies	Anti-hMOB2: Validate knockdown Anti-NDR1/2: Monitor NDR expression/phosphorylation Anti-RAD50: Study MRN complex interaction Anti-γH2AX (Ser139): Quantify DNA damage Anti-p21 / p53 (Phosho-S15): Assess cell cycle arrest Anti-RAD51: Evaluate HR repair functionality [7]	Critical for measuring pathway activity and functional outputs via immunoblotting, immunofluorescence, and IP.
Chemical Inhibitors / Treatments	Doxorubicin, Etoposide, PARP inhibitors (Olaparib), Ionizing Radiation	Induce DNA damage to probe DDR roles of hMOB2 and its therapeutic implications [6] [7].
Specialized Assay Kits	Clonogenic survival assay, Comet assay, HR repair reporter (DR-GFP)	Functional readouts for survival, DNA damage, and repair pathway proficiency [6] [7].
MDL-860	MDL-860, CAS:78940-62-2, MF:C13H6Cl2N2O3, MW:309.10 g/mol	Chemical Reagent
Antiviral agent 41	Antiviral agent 41, CAS:68622-73-1, MF:C20H24O4, MW:328.4 g/mol	Chemical Reagent

A Step-by-Step Protocol for hMOB2 Knockdown and Cell Cycle Analysis

Designing Effective siRNA or shRNA for hMOB2 Knockdown

The Mps one binder 2 (MOB2) protein is a highly conserved regulator of essential signaling pathways. Recent research has uncovered its critical functions in the DNA damage response (DDR) and cell cycle regulation [6]. hMOB2 promotes DDR signaling, cell survival, and cell cycle arrest following exogenously induced DNA damage. Under normal growth conditions, hMOB2 plays a crucial role in preventing the accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest [6]. Furthermore, hMOB2 has been identified as a regulator of double-strand break (DSB) repair by homologous recombination (HR) [7]. It supports the phosphorylation and accumulation of the RAD51 recombinase on resected single-strand DNA (ssDNA) overhangs, a vital step in HR-mediated repair [7]. Physiologically, hMOB2 expression supports cancer cell survival in response to DSB-inducing anti-cancer compounds, and its loss renders ovarian and other cancer cells more vulnerable to FDA-approved PARP inhibitors [7]. Therefore, efficient knockdown of hMOB2 provides a powerful tool for investigating its biological functions, particularly in the context of DNA damage-induced cell cycle arrest, and represents a potential therapeutic strategy for cancer treatment.

Key Design Principles for hMOB2-Targeting shRNA/siRNA

The design of effective shRNA or siRNA is a critical step for successful gene knockdown. While several algorithms exist for siRNA design, their predictive power for shRNA efficacy is less established. A comprehensive study constructing 27 shRNAs against 11 human genes demonstrated that published algorithms for siRNA oligonucleotide design showed little or no efficacy at predicting shRNA knockdown outcome [16]. However, the application of a modification based on the stability of the 6 central bases of each shRNA provided fair-to-good predictions of knockdown efficacy for some algorithms [16]. The following principles should guide the design of hMOB2-targeting sequences:

• Target Sequence Selection: Choose target sequences within the coding region of the hMOB2 transcript (e.g., GenBank accession number). Ensure the selected sequences are devoid of single nucleotide polymorphisms and correspond to all known splice variants if comprehensive knockdown is desired [16].
• Sequence Composition: Designs should broadly conform to seminal studies of sequence features for siRNA efficacy. Sequences should be low in runs and have a G/C ratio of approximately 50% [16].
• Specificity Control: Always design a mutant control shRNA with one or more base mismatches within the target recognition site. This controls for off-target effects and confirms the specificity of the observed phenotype [16].

Table 1: Design Parameters for Effective shRNA against hMOB2

Parameter	Optimal Characteristic	Rationale	Example Sequence (from literature)
Length	19-22 base duplex	Standard length for RISC processing and target recognition [16]	19-mer
GC Content	~50%	Avoids overly stable or unstable duplexes; balances efficacy and specificity [16]	Varies by target
Internal Stability	Low ΔG in central 6 bases	Favors RISC unwinding and guide strand loading; critical for shRNA efficacy [16]	N/A
Specificity Control	3-4 base mismatch mutant	Controls for off-target effects and confirms phenotype specificity [16]	N/A

Experimental Protocols

Simultaneous Construction of Wild-Type and Mutant shRNA Vectors

This protocol describes a time- and cost-efficient method for preparing wild-type and mutant control shRNA vectors simultaneously [16].

Materials:

• Oligonucleotides: Designed complementary oligonucleotides for the wild-type hMOB2 target and a mutant version with 3-4 base mismatches.
• Vector: A suitable retroviral shRNA expression vector (e.g., pSUPER.retro.puro).
• Enzymes: Restriction enzymes (e.g., BglII and HindIII), T4 DNA ligase.
• Bacterial Cells: Competent E. coli for transformation.

Procedure:

• Annealing and Phosphorylation: Hybridize the complementary oligonucleotides for both wild-type and mutant shRNAs. The hybridization reaction should create duplexes with BglII and HindIII-compatible overhangs.
• Vector Preparation: Digest the retroviral vector with BglII and HindIII restriction enzymes and purify the linearized backbone.
• Ligation: Ligate the annealed oligonucleotide duplexes into the prepared vector backbone. Set up separate reactions for the wild-type and mutant constructs.
• Transformation: Transform the ligation products into competent E. coli cells and plate on selective antibiotic media.
• Screening and Verification: Pick colonies, prepare plasmid DNA, and verify the insert sequence by sequencing. Note that sequencing through the shRNA hairpin can be problematic due to intrinsic secondary structure. Use a combination of modified BigDye chemistries (dITP/dGTP) and DNA relaxing agents to enable read-through [16].
• Plasmid Amplification: Amplify and purify the verified wild-type and mutant shRNA plasmid constructs for subsequent viral production and cell transduction.

Gene Knockdown and Cell Cycle Arrest Assay in Human Cells

This protocol outlines the steps for establishing stable hMOB2 knockdown cells and assessing the resulting cell cycle phenotype.

Materials:

• Cell Line: Relevant human cell line (e.g., RPE1-hTert, BJ-hTert fibroblasts) [6].
• shRNA Plasmids: Verified wild-type and mutant hMOB2 shRNA constructs, and a non-targeting control shRNA plasmid.
• Transfection/Viral Reagents: Lipofectamine 2000 or Fugene 6 for transfection [6], or packaging plasmids and Lipofectamine 2000 for retroviral production [16].
• Antibiotics: Puromycin for selection of transduced cells [6].
• Assay Kits: Real-time PCR reagents for mRNA quantification, antibodies for hMOB2 and p21/western blotting, propidium iodide solution for cell cycle analysis by flow cytometry.

Procedure:

• Stable Cell Line Generation:
  • Option A: Transient Transfection. Transfect cells with shRNA plasmids using Fugene 6 or Lipofectamine 2000 according to the manufacturer's instructions [6].
  • Option B: Retroviral Transduction. Produce retrovirus by transecting packaging cells (e.g., PT67) with the shRNA constructs. Harvest the viral supernatant and transduce the target cells. 24-48 hours post-transduction, begin selection with the appropriate antibiotic (e.g., 1-2 µg/mL puromycin) to generate stable polyclonal pools [6] [16].
• Knockdown Validation:
  • mRNA Level: 72-96 hours post-transduction/transfection, harvest cells and extract total RNA. Perform quantitative real-time PCR (qRT-PCR) to measure hMOB2 mRNA levels relative to a housekeeping gene (e.g., GAPDH).
  • Protein Level: Analyze hMOB2 protein expression by immunoblotting. This confirms the functional consequence of the mRNA knockdown.
• Cell Cycle Analysis:
  • Harvest the validated hMOB2 knockdown cells and control cells (mutant shRNA and non-targeting shRNA).
  • Fix the cells in 70% ethanol overnight at -20°C.
  • Treat cells with RNase A and stain cellular DNA with propidium iodide (e.g., 50 µg/mL).
  • Analyze the DNA content by flow cytometry.
  • Use software to model the cell cycle phase distribution (G1, S, G2/M).
• Phenotype Validation:
  • In hMOB2-deficient cells, expect to observe an accumulation of DNA damage (e.g., increased γH2AX foci) and a p53/p21-dependent G1/S cell cycle arrest under normal growth conditions [6].
  • Confirm increased p21 expression by immunoblotting in knockdown cells compared to mutant and non-targeting controls.

Signaling Pathways and Experimental Workflows

hMOB2 in DNA Damage Response and Cell Cycle Regulation

Experimental Workflow for hMOB2 Knockdown Studies

Research Reagent Solutions

Table 2: Essential Reagents for hMOB2 Knockdown Studies

Reagent / Material	Function / Application	Examples / Specifications
shRNA Expression Vector	Stable delivery of shRNA sequence into target cells.	pSUPER.retro.puro, pMKO.1 puro [6] [16]
Oligonucleotides	Template for wild-type and mutant shRNA inserts.	Designed 19-mer sequences with BglII/HindIII overhangs [16]
Restriction Enzymes	Vector linearization for shRNA insert cloning.	BglII, HindIII [16]
Transfection Reagent	Plasmid DNA delivery into packaging or target cells.	Fugene 6, Lipofectamine 2000, Lipofectamine RNAiMax [6]
Cell Culture Media	Maintenance and expansion of relevant cell lines.	DMEM + 10% FCS (for RPE1-hTert, COS-7, U2-OS) [6]
Selection Antibiotic	Selection of successfully transduced cells.	Puromycin, Blasticidin, G418 [6]
DNA Sequencing Kit	Verification of shRNA insert sequence.	Modified BigDye chemistry with dITP/dGTP & relaxing agents [16]
qRT-PCR Kit	Quantification of hMOB2 mRNA knockdown efficacy.	One-step SYBR Green or TaqMan assays
Antibodies	Detection of hMOB2, p21, γH2AX, and loading controls.	Primary antibodies for immunoblotting/immunofluorescence
Flow Cytometry Reagents	Cell cycle analysis via DNA content measurement.	Propidium iodide, RNase A, ethanol for fixation

Cell Culture and Transfection Strategies for Robust Gene Silencing

Within the context of investigating cell cycle arrest mechanisms, robust gene silencing is a cornerstone technique for functional genomics research. This document provides detailed application notes and protocols for achieving reliable knockdown of target genes, with a specific focus on Mps one binder 2 (MOB2), a protein with established roles in DNA damage response (DDR) and cell cycle progression [6]. Research indicates that loss of hMOB2 function leads to the accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest in untransformed cells [6] [7]. These phenotypes make MOB2 an excellent model for developing and validating gene silencing strategies aimed at studying cell cycle control. The protocols herein are designed for researchers, scientists, and drug development professionals, providing methodologies to probe such biological questions with high precision.

Key Quantitative Data for MOB2 Silencing Phenotypes

The following tables summarize core experimental data and reagent information relevant to MOB2 knockdown assays, providing a reference for designing and interpreting experiments.

Table 1: Key Phenotypes Associated with MOB2 Deficiency

Phenotype Category	Specific Readout	Experimental System	Citation
Cell Cycle Arrest	p53/p21-dependent G1/S arrest	Untransformed cells (e.g., RPE1-hTert, BJ-hTert)	[6]
DNA Damage Response	Impaired DDR signaling; Accumulation of endogenous DNA damage	RPE1-hTert cells	[6]
DNA Repair	Deficiency in Homologous Recombination (HR); impaired RAD51 stabilization	Ovarian and other cancer cells	[7]
Cell Survival	Reduced clonogenic survival post-DNA damage	RPE1-hTert cells treated with Doxorubicin or IR	[6]
Therapeutic Response	Increased sensitivity to PARP inhibitors	Ovarian carcinoma cells	[7]

Table 2: Research Reagent Solutions for Gene Silencing

Reagent / Solution	Function / Application	Key Considerations
Self-delivering ASOs (sdASO)	mRNA Knockdown without transfection reagents; ideal for primary/tough cells [17].	AUMsilence protocol; 50-95% typical knockdown efficiency [17].
Transfection-Optimized ASOs (toASO)	Cost-effective knockdown for easy-to-transfect cell lines [17].	Requires lipid-based transfection (e.g., Lipofectamine 2000/RNAiMAX) [17].
CRISPRoff System	Heritable gene silencing via epigenetic editing without DNA breaks [18].	Ideal for primary cells (T cells, HSCs); avoids genomic instability [18].
Lipofectamine RNAiMAX	Transfection reagent for siRNA/sgRNA delivery.	Suitable for reverse transfection in multi-well plates [6].
Tetracycline (Tet)-on System	Inducible expression of shRNAs or cDNAs [6].	Allows control over timing of gene silencing; used in RPE1-hTert models [6].

Detailed Gene Silencing Methodologies

Protocol 1: MOB2 Knockdown Using Self-Delivering Antisense Oligonucleotides (sdASOs) in Cell Culture

This protocol is optimized for silencing MOB2 in difficult-to-transfect cells, including primary and non-dividing cells, and is based on established sdASO technology [17].

Workflow Overview:

Step-by-Step Procedure:

• Cell Seeding (Day 0):

  • Harvest exponentially growing cells (e.g., RPE1-hTert, BJ-hTert fibroblasts, or relevant cancer cell lines) using standard trypsinization.
  • Seed cells into multi-well plates at a consistent confluence of 30-50% in complete medium without antibiotics. For a 24-well plate, this is typically 5.0 × 10⁴ - 1.0 × 10⁵ cells per well.
  • Allow cells to adhere overnight in a humidified incubator at 37°C with 5% COâ‚‚.

• sdASO Treatment (Day 1):

  • Prepare the sdASO working solution. For MOB2 knockdown, resuspend the target-specific AUMsilence sdASO [17] and a non-targeting scrambled control sdASO in nuclease-free water or a recommended buffer to create a stock solution (e.g., 100 µM).
  • Dilute the sdASO stock directly into the pre-warmed complete cell culture medium to achieve the final working concentration. A typical starting concentration is 10-100 nM, which must be optimized for the specific cell type and sdASO.
  • Remove the culture medium from the cells and replace it with the sdASO-containing medium. Gently swirl the plate to ensure even distribution.
  • Return the cells to the incubator.

• Incubation and Analysis (Day 2-4):

  • Incubate cells for 24-72 hours. Protein knockdown for stable proteins like MOB2 may require longer incubation (48-72 hours).
  • Harvest cells for downstream analysis:
    • mRNA Quantification: Extract total RNA and perform qRT-PCR using primers specific for MOB2 and a housekeeping gene (e.g., GAPDH). Calculate knockdown efficiency using the 2^−ΔΔCt method [19].
    • Protein Validation: Lyse cells for Western blotting. Resolve proteins by SDS-PAGE and immunoblot using anti-MOB2 [6] and a loading control (e.g., β-Actin).
    • Functional Assay: Proceed with cell cycle arrest or DNA damage assays as described in Section 4.

Protocol 2: MOB2 Silencing via CRISPRoff Epigenetic Editing

For sustained, heritable silencing without altering the DNA sequence, the CRISPRoff system is an excellent choice, particularly in sensitive primary cells [18].

Workflow Overview:

Step-by-Step Procedure:

• sgRNA Design and Cloning:

  • Design 3-5 sgRNAs targeting the promoter region of the MOB2 gene, within a 1-kb window centered on the transcriptional start site (TSS) [18]. Use bioinformatic tools to predict on-target efficiency and minimize off-target effects.
  • Clone the top sgRNA sequences into an appropriate expression plasmid (e.g., Addgene #217306) containing a U6 pol III promoter for sgRNA expression.

• Delivery of CRISPRoff:

  • For immortalized cell lines (HEK 293T, RPE1-hTert), co-transfect the CRISPRoff expression plasmid (encoding dCas9-KRAB-Dnmt3a-D3L) and the sgRNA plasmid using a standard DNA transfection reagent like Fugene 6 or Lipofectamine 2000 [6] [18].
  • For primary cells or cells sensitive to plasmid DNA, synthesize CRISPRoff as in vitro transcribed (IVT) mRNA and deliver it via electroporation or lipid nanoparticles alongside synthetic sgRNAs to reduce toxicity [18].

• Validation of Stable Silencing:

  • 48-72 hours post-transfection, passage the cells and, if applicable, begin antibiotic selection to isolate a pool of transfected cells.
  • Expand the cells for at least 7-10 days to allow for the establishment of repressive epigenetic marks (DNA methylation and H3K9me3) [18].
  • Validate durable MOB2 silencing using qRT-PCR and Western blotting, as described in Protocol 1. Confirm epigenetic modifications via bisulfite sequencing (for DNA methylation) or ChIP-seq (for H3K9me3) at the MOB2 promoter [18].

Downstream Functional Assay: Cell Cycle Analysis Post-MOB2 Knockdown

This protocol assesses the functional consequence of MOB2 knockdown, specifically the p53/p21-dependent G1/S arrest [6].

Procedure:

• Silencing and Induction:

  • Perform MOB2 knockdown in untransformed RPE1-hTert or BJ-hTert cells using Protocol 1 or 2.
  • Optionally, to amplify the phenotype, induce exogenous DNA damage 24 hours before analysis. Treat cells with 0.5 µM Doxorubicin for 4-6 hours [6].

• Cell Harvest and Fixation:

  • At the experimental endpoint (e.g., 72-96 hours post-knockdown), harvest cells by trypsinization.
  • Wash the cell pellet once with ice-cold PBS.
  • Gently resuspend the cells in 70% ethanol added drop-wise while vortexing. Fix the cells at -20°C for a minimum of 2 hours or overnight.

• Cell Cycle Staining and Analysis:

  • Pellet the fixed cells and wash twice with PBS to remove residual ethanol.
  • Resuspend the cell pellet in 500 µL of PBS containing 50 µg/mL Propidium Iodide (PI), 100 µg/mL RNase A, and 0.1% Triton X-100.
  • Incubate the stained cells for 30-45 minutes at 37°C in the dark.
  • Analyze the DNA content using a flow cytometer. Acquire at least 10,000 events per sample.
  • Use flow cytometry analysis software (e.g., ModFit) to deconvolute the histograms and quantify the percentage of cells in G0/G1, S, and G2/M phases.

Expected Outcome: Successful MOB2 knockdown should result in a significant increase in the proportion of cells in the G0/G1 phase and a concomitant decrease in S-phase cells, indicative of a G1/S arrest [6].

The MOB2 Signaling Pathway and Experimental Logic

The following diagram integrates MOB2's molecular function with the experimental strategy for its functional characterization.

MOB2 in DNA Damage and Cell Cycle Pathway:

Troubleshooting Guide

Problem	Potential Cause	Solution
Low Knockdown Efficiency	Poor delivery or ineffective design.	Include a fluorescent control oligo to confirm delivery. For ASOs, try an alternate sequence; for CRISPRoff, pool multiple sgRNAs [17] [18].
High Cell Death	Cytotoxicity from transfection or reagent.	For sdASOs, titrate the concentration downward. For plasmid transfections, switch to mRNA delivery [18]. Ensure cells are healthy and not over-confluent at seeding.
No Cell Cycle Phenotype	Redundant pathways or protein persistence.	Extend the knockdown time to >72h to deplete stable MOB2 protein. Use a second, independent silencing method (e.g., siRNA + CRISPRoff) for confirmation [6].

Inducing and Quantifying DNA Damage in Experimental Setup

This document provides detailed Application Notes and Protocols for inducing and quantifying DNA damage, specifically framed within research investigating cell cycle arrest upon knockdown of the MOB2 protein. MOB2 has been identified as a significant player in the cellular DNA damage response (DDR); it is implicated in promoting DDR signaling, cell survival, and cell cycle arrest following DNA damage [6]. Furthermore, MOB2 interacts with RAD50, facilitating the recruitment of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex and activated ATM to damaged chromatin, a crucial early step in the DDR [6]. Recent studies also establish that hMOB2 is required for the stabilization of RAD51 on damaged chromatin, thereby regulating double-strand break (DSB) repair by homologous recombination (HR) [7]. Its deficiency potentiates the anti-tumor effects of DNA-damaging agents and PARP inhibitors [7]. These protocols are designed for researchers, scientists, and drug development professionals aiming to elucidate MOB2's functional role in genome maintenance.

Quantification of DNA Damage: A Comparative Analysis

Selecting the appropriate method to quantify DNA damage is critical for experimental success. The table below summarizes key techniques, including established and emerging technologies.

Table 1: Methods for Quantifying DNA Damage

Method Name	Type of Damage Detected	Throughput & Speed	Key Advantages	Key Limitations
LM-qPCR Standard Curve [20]	DNA Double-Strand Breaks (DSBs)	High-throughput; relatively fast	Simple, low-cost, easily standardized; quantifies absolute number of DSBs per genome.	Does not provide single-nucleotide resolution.
Click-Code-Seq [21]	DNA oxidation and base loss (abasic sites)	High-throughput; sequencing-based	Single-nucleotide resolution mapping of damage; reveals strand biases.	Requires specialized expertise and sequencing infrastructure.
Nanopore Sensing [22]	DNA fragmentation (e.g., from radiation)	Rapid (minutes); potential for portability	Real-time measurement; effective for doses of 2-10 Gy; high accuracy.	Emerging technology, currently a proof-of-concept on purified DNA.
γ-H2AX Flow Cytometry [20]	DNA Double-Strand Breaks (DSBs)	Medium throughput	Widely used and accepted; can be combined with cell cycle analysis.	Semi-quantitative; measures a surrogate marker (γ-H2AX foci).
Neutral Comet Assay [20]	DNA Double-Strand Breaks (DSBs)	Low throughput; slow	Sensitive at the single-cell level.	Semi-quantitative; can have high variability.

Detailed Experimental Protocols

Protocol 1: Quantifying Genome-Wide DSBs via LM-qPCR

This protocol uses Ligation-Mediated quantitative PCR (LM-qPCR) with a standard curve to provide an absolute count of DSBs in a sample [20].

Workflow Overview:

Materials:

• DNA Extraction Kit: For high-quality, intact genomic DNA.
• Blunt-End Restriction Enzymes (e.g., AluI, HaeIII, PvuII): To generate standard DSB fragments.
• T4 DNA Ligase: For ligation of linkers to DSB ends.
• qPCR Master Mix & Thermocycler
• Custom DNA Linkers: Double-stranded oligos with known sequence compatible with ligation to blunt ends.

Procedure:

• Standard Curve Generation:
  • Digest genomic DNA from your organism of interest (e.g., human, mouse) with a set of blunt-end restriction enzymes to create DNA fragments with known numbers of DSBs.
  • Calculate the Theoretical Number of DSBs (NDSBs) for each standard based on the restriction site frequency in the genome.
  • Proceed with steps 2-4 for each standard.

• Blunt-End Repair (if necessary): Treat the experimental genomic DNA samples (e.g., from MOB2 knockdown cells) and standards with a DNA polymerase to ensure all DSB ends are blunt.

• Linker Ligation: Ligate the custom DNA linkers to the blunt ends of the DSBs in both experimental and standard samples. This attaches a universal priming site.

• Quantitative PCR: Perform qPCR on all samples using one primer specific to a known genomic locus and another primer complementary to the ligated linker.

  • The Ct value is inversely proportional to the amount of that specific fragment present, which in turn relates to the number of DSBs near that locus.

• Data Analysis:

  • Plot the Ct values of the standard samples against the log-transformed Theoretical NDSBs to generate a standard curve with high linearity (R² > 0.95).
  • Use the linear regression equation from the standard curve to calculate the absolute number of DSBs in the experimental samples based on their Ct values.

Protocol 2: MOB2 Knockdown and DNA Damage Induction

This protocol outlines the process of generating a stable MOB2 knockdown cell line and inducing DNA damage to study subsequent cell cycle arrest.

Workflow Overview:

Materials:

• Lentiviral Vectors: expressing MOB2-specific shRNA or CRISPR/Cas9 components [23] [24].
• Polycation Transfection Reagent: (e.g., Polybrene) to enhance viral infection efficiency.
• Puromycin: For selecting successfully transduced cells.
• DNA Damaging Agents:
  • Doxorubicin: A topoisomerase II inhibitor that induces DSBs [6].
  • Ionizing Radiation (IR): Directly induces DSBs and other DNA lesions.
• Antibodies: for MOB2 (validation) and γ-H2AX (damage confirmation).

Procedure:

• Stable MOB2 Knockdown:
  • Transduce target cells (e.g., SMMC-7721, RPE-1, or GBM lines like LN-229) with lentivirus carrying MOB2-targeting shRNA or sgRNA [23] [24].
  • 48 hours post-transduction, begin selection with culture medium containing puromycin (e.g., 1.0 µg/ml) for up to two weeks to establish a stable population [24].
  • Validate the knockdown efficiency by Western blot analysis of MOB2 protein levels.

• DNA Damage Induction:

  • Treat MOB2 knockdown (KD) and control cells with a DNA-damaging agent.
  • For Doxorubicin: A common range is 0.2 - 1.0 µM for 4-24 hours [6].
  • For Ionizing Radiation (IR): A typical dose is 2-10 Gy. After irradiation, return cells to the incubator and harvest after a recovery period (e.g., 1-24 hours) to allow for damage response [6].

• Downstream Analysis:

  • Cell Cycle Analysis: Harvest cells, fix, and stain DNA with Propidium Iodide (PI). Analyze the DNA content by flow cytometry to determine the percentage of cells in G1, S, and G2/M phases. MOB2 loss is expected to cause an accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest [6].
  • DSB Quantification: Harvest genomic DNA from treated and untreated cells and apply Protocol 1 (LM-qPCR) to quantify the number of DSBs incurred and their persistence.

MOB2 in the DNA Damage Response Network

MOB2 operates through multiple, interconnected signaling pathways to regulate genome stability. The following diagram integrates its key functions and interactions.

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Reagents for MOB2 and DNA Damage Response Research

Reagent / Tool	Function / Application	Example Use Case
MOB2 shRNA/sgRNA	Specific knockdown or knockout of MOB2 gene expression.	Generating stable MOB2-deficient cell lines to study loss-of-function phenotypes [23] [24].
Doxorubicin	Chemotherapeutic agent that induces DNA double-strand breaks.	Experimentally inducing DNA damage to probe the integrity of the DDR in MOB2 KD cells [6].
PARP Inhibitors	Small molecules that inhibit PARP enzyme activity, inducing synthetic lethality in HR-deficient cells.	Testing the hypothesis that MOB2-deficient cells show enhanced vulnerability, potentially for therapeutic applications [7].
Forskolin / H89	cAMP pathway activator and PKA inhibitor, respectively.	Investigating the cross-talk between MOB2, cAMP/PKA signaling, and the FAK/Akt pathway in cell migration [23].
Phospho-Specific Antibodies	Detect activated signaling molecules.	E.g., anti-γ-H2AX (DSBs), anti-p-NDR1/2, anti-p-YAP. Used in Western blot or immunofluorescence to monitor pathway activity [6] [24].
SPIDR Library	A combinatorial CRISPRi library targeting DNA repair genes.	Systematically mapping genetic interactions and synthetic lethal partners of MOB2 within the broader DDR network [25].
ILK-IN-3	4-[(4-Methoxyphenyl)hydrazono]-4h-pyrazole-3,5-diamine
BAY-43-9695	BAY-43-9695, MF:C22H25N3O4S, MW:427.5 g/mol	Chemical Reagent

Cell Cycle Profiling using Propidium Iodide Staining and Flow Cytometry

Cell cycle analysis is a cornerstone of cellular biology, particularly in cancer research and drug development. The quantification of DNA content via flow cytometry using a fluorescent DNA stain like propidium iodide (PI) provides a powerful, reliable method for determining the distribution of cells across the G0/G1, S, and G2/M phases of the cell cycle [26]. This technique is based on the stoichiometric binding of PI to DNA; the fluorescence intensity directly correlates with the amount of DNA in a cell, allowing clear discrimination between the different cell cycle phases [26]. Cells in G1 phase have the lowest DNA content, followed by those in S phase (actively synthesizing DNA), with G2/M phase cells having approximately double the DNA content of G1 cells [26].

This application note details the use of PI-based flow cytometry for cell cycle profiling within the context of research on the Mps one binder 2 (MOB2) protein. Recent investigations have revealed that MOB2 plays a significant role in the DNA damage response (DDR) and cell cycle regulation [6]. Under normal growth conditions, the loss of MOB2 function leads to the accumulation of endogenous DNA damage, subsequently triggering a p53/p21-dependent G1/S cell cycle arrest [6]. This molecular phenotype makes flow cytometric cell cycle analysis an essential tool for validating and quantifying the cellular consequences of MOB2 knockdown in functional assays.

Scientific Background and Rationale

The MOB2 Protein and Cell Cycle Regulation

The MOB family of proteins are conserved regulators of critical signaling pathways. While MOB1 has established roles as a tumor suppressor, the biological functions of MOB2 have been less clear [6]. Emerging evidence now positions MOB2 as a key player in maintaining genomic integrity. It has been demonstrated that hMOB2 promotes DDR signaling, cell survival, and cell cycle arrest following exogenously induced DNA damage [6].

Mechanistically, hMOB2 interacts with RAD50, a core component of the MRE11-RAD50-NBS1 (MRN) complex, which is a primary sensor of DNA double-strand breaks [6]. This interaction facilitates the recruitment of the MRN complex and activated ATM to sites of DNA damage [6]. Therefore, depleting MOB2 impairs the cell's ability to efficiently respond to DNA damage, leading to an accumulation of genetic lesions. These lesions, in turn, activate the p53 tumor suppressor pathway, inducing the expression of the cyclin-dependent kinase inhibitor p21, which ultimately blocks the G1 to S phase transition [6]. This provides a strong mechanistic rationale for observing a G1/S arrest in MOB2 knockdown experiments using PI staining.

Principle of DNA Content Analysis with Propidium Iodide

Flow cytometric cell cycle analysis by quantitation of DNA content was one of the earliest applications of flow cytometry [26]. Propidium iodide is a membrane-impermeant DNA fluorochrome that intercalates between the base pairs of double-stranded nucleic acids. A critical aspect of the protocol is the treatment with RNase to eliminate PI's background signal from RNA binding [26]. Following excitation by a blue laser (488 nm), PI emits red fluorescence, typically detected with a 585/40 nm or similar bandpass filter [26] [27]. The resulting DNA content histogram allows for the clear identification of a diploid DNA content peak (G0/G1 cells), a tetraploid peak (G2/M cells), and the cells with intermediate DNA content (S phase) [26].

The following diagram illustrates the core workflow and underlying principle of the experiment, from cell preparation to the final analysis of the cell cycle histogram.

Materials and Reagents

Research Reagent Solutions

The following table lists the essential materials and reagents required for successful cell cycle analysis using propidium iodide.

Table 1: Key Research Reagents for PI-Based Cell Cycle Analysis

Reagent/Material	Function/Description	Key Consideration
Propidium Iodide (PI)	DNA-binding fluorochrome that stains nucleic acids stoichiometrically.	Requires cell permeabilization; also binds RNA, making RNase treatment essential. [26]
RNase A	Enzyme that degrades RNA, preventing non-specific PI staining and high background.	Crucial for obtaining clean DNA histograms with low CV. [26]
70% Ethanol	Fixative and permeabilizing agent. Dehydrates cells and allows PI access to nuclear DNA.	Must be prepared in distilled water, not PBS, to prevent protein precipitation. [26]
Phosphate Buffered Saline (PBS)	Isotonic washing and suspension buffer.	Should be without Ca²⁺ or Mg²⁺ for most protocols. [28]
Hypotonic Lysis Buffer	Alternative to ethanol fixation; rapidly permeabilizes cells using detergent and low ionic strength.	Enables quick staining (<20 min) and is compatible with concurrent antibody staining. [27]
Phospho-Histone H3 (Ser28) Antibody	Mitotic marker (when conjugated to a fluorochrome like Alexa Fluor 647).	Used in conjunction with PI to distinguish G2 phase cells from M phase cells. [27]
7-Aminoactinomycin D (7-AAD)	Viability dye and alternative DNA stain. Can be used to identify dead cells in fixed preparations. [28]

Methodologies

This section provides two detailed protocols for PI-based cell cycle analysis: a standard ethanol fixation method and a rapid hypotonic lysis method suitable for combining DNA content with mitotic marker staining.

Standard Protocol: Ethanol Fixation and PI Staining

This is a robust and widely used protocol ideal for high-throughput analysis and samples that need to be stored. [26] [28]

• Cell Harvesting: Harvest cells using standard methods (e.g., trypsin for adherent cells). Wash the cell pellet once with cold, protein-free PBS. Centrifuge at 200-300 x g for 5 minutes. [28]
• Fixation: Gently resuspend the cell pellet in a small volume of cold PBS. While vortexing the tube at a low speed, add cold 70% ethanol dropwise to the cell suspension until a final concentration of at least 70% ethanol is reached. Note: 70% ethanol must be made with distilled water, not PBS. Fix cells for a minimum of 30 minutes at 4°C; fixed cells can be stored for several weeks at -20°C to -40°C. [26] [28]
• Preparation for Staining: Centrifuge the fixed cells at 850 x g for 5 minutes and carefully aspirate the ethanol. Wash the cell pellet twice with PBS to remove residual ethanol. [26]
• Staining: Resuspend the cell pellet in a PBS-based staining solution containing:
  • RNase A (e.g., 50 µL of a 100 µg/mL stock).
  • Propidium Iodide (e.g., 200 µL of a 50 µg/mL stock). [26]
• Incubation: Incubate the cells in the dark for 30 minutes at room temperature or 4°C.
• Analysis: Filter the cell suspension through a mesh cap (e.g., 35-70 µm) into FACS tubes and analyze on a flow cytometer equipped with a 488 nm laser, collecting PI fluorescence using a 585/40 nm or similar filter. [28] [27]

Rapid Protocol: Hypotonic Lysis and PI Staining

This protocol is faster and allows for simultaneous staining of DNA and intracellular proteins, such as the mitotic marker phospho-Histone H3. [27]

• Cell Preparation: Harvest and wash cells as in the standard protocol. Suspend 0.4 x 10⁶ cells in 1 mL of PBS in a 5 mL tube.
• Centrifugation: Centrifuge at 200 x g for 5 minutes and aspirate the supernatant.
• Permeabilization and Staining: Resuspend the cell pellet in 100 µL of Hypotonic Lysis/PI Buffer (see Recipe Table 2). Add an antibody against a target of interest (e.g., 0.5 µL of Alexa Fluor 647 anti-phospho-Histone H3).
• Incubation: Place the tubes in the dark at room temperature for 20 minutes to 2 hours. No washing is required prior to analysis. [27]
• Analysis: Analyze directly on a flow cytometer. Collect PI fluorescence in the PE channel (e.g., 585/40 nm) and the antibody signal in the APC channel (e.g., 675/30 nm). [27]

Recipe for Key Solutions

Table 2: Solution Recipes for Cell Cycle Staining

Solution	Composition	Storage & Notes
Hypotonic Lysis/PI Buffer [27]	- 0.1% (w/v) Sodium Citrate- 0.1% (v/v) Triton X-100- 50 µg/mL Propidium Iodide- In Deionized/Distilled Water	Can be kept at 4°C for months. Handle PI with care as a suspected carcinogen.
Propidium Iodide Staining Solution [28]	- 10 mM PIPES- 100 mM NaCl- 2 mM MgCl₂- 0.2% Triton X-100- 50 µg/mL PI- 50 U/mL RNase (DNAse-free)- pH to 6.8	Prepare fresh or store aliquots at -20°C.
70% Ethanol Fixative [26]	- 70 parts Absolute Ethanol- 30 parts Distilled Water	Prepare fresh and keep cold. Do not use PBS as a diluent.

Data Analysis and Interpretation

Gating Strategy and Cell Cycle Modeling

Proper data analysis is critical for accurate cell cycle phase quantification.

• Exclude Debris and Clumps: First, gate on the cell population based on Forward Scatter (FSC) and Side Scatter (SSC) to exclude small debris [27]. Next, use pulse processing (e.g., FSC-Area vs. FSC-Height or FSC-Width) to exclude cell doublets and aggregates, ensuring analysis is performed on single cells. [26] [27]
• Analyze DNA Content: On the gated single-cell population, plot a histogram of PI fluorescence (typically FL2 or FL3). The histogram will show two main peaks and a connecting plateau.
• Model Cell Cycle Phases: Use flow cytometry analysis software (e.g., FlowJo, ModFit) to apply a cell cycle model. The software will use algorithms to fit Gaussian curves to the G0/G1 and G2/M peaks and model the S phase population, providing the percentage of cells in each phase. [26]

The following diagram illustrates the logical sequence of data analysis, from raw data acquisition to the final interpretation of cell cycle distribution, including the expected outcome in a MOB2 knockdown model.

Presentation of Quantitative Data

When reporting results, especially in a knockdown assay, summarizing quantitative data in a clear table is essential. The table below provides a hypothetical example of how data from a MOB2 knockdown experiment might be presented.

Table 3: Example Cell Cycle Distribution in MOB2 Knockdown Assay

Cell Line / Treatment	G0/G1 Phase (%)	S Phase (%)	G2/M Phase (%)	Sub-G1 (%)	Number of Experiments (n)
Control (Scramble shRNA)	58.5 ± 3.2	25.1 ± 2.5	16.4 ± 1.8	1.2 ± 0.5	n=5
MOB2-knockdown (shMOB2)	78.3 ± 4.1*	12.8 ± 1.9*	8.9 ± 1.3*	2.5 ± 1.1	n=5
MOB2-knockdown + p53 inhibitor	61.2 ± 3.8	23.5 ± 2.7	15.3 ± 1.6	1.8 ± 0.7	n=3

Data presented as Mean ± SD. *p < 0.05 vs. Control, indicating a statistically significant G1/S arrest.

Application in MOB2 Knockdown Research

Integrating PI-based cell cycle profiling into a MOB2 research project provides a direct, quantitative readout of the functional consequences of MOB2 loss. As outlined in the background, MOB2 deficiency leads to endogenous DNA damage and a p53/p21-mediated G1/S arrest [6]. The protocols described here are perfectly suited to detect this phenotype.

In practice, after performing MOB2 knockdown (e.g., using siRNA or shRNA) in an appropriate cell line (e.g., RPE1-hTert, BJ-hTert, or a relevant cancer cell line [6]), researchers can apply either the standard or rapid protocol to prepare cells for flow cytometry. The expected result is a significant increase in the percentage of cells in the G0/G1 phase and a concomitant decrease in the percentages of cells in S and G2/M phases, as illustrated in Table 3. This profile is characteristic of a G1/S block. To further confirm the mechanism, one could combine PI staining with an antibody against phospho-Histone H3 to precisely quantify mitotic cells or perform western blot analysis on parallel samples to validate the upregulation of p21. This combined approach solidifies the link between MOB2 knockdown, DNA damage response pathway activation, and resultant cell cycle arrest.

Advanced Multiplexed Immunofluorescence for Cell Cycle Marker Analysis

The cell cycle is a fundamental process governing cell growth and division, and its precise regulation is crucial for maintaining genomic integrity. Recent advances in single-cell analysis have revealed significant heterogeneity in cell cycle progression, even within genetically identical populations [29]. Understanding this plasticity is particularly important in cancer research, where tumor cells often exploit alternative cell cycle paths to proliferate and resist therapies.

This application note details how advanced multiplexed immunofluorescence (mIF) can be deployed to analyze cell cycle dynamics, with specific emphasis on applications in MOB2 functional studies. The Mps one binder 2 (MOB2) protein has emerged as a critical regulator of the DNA damage response (DDR) and cell cycle progression [6]. Evidence indicates that hMOB2 promotes double-strand break repair via homologous recombination and supports cell survival following DNA damage [7]. Knockdown of hMOB2 leads to accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest in untransformed cells [6]. This makes mIF an ideal tool for visualizing the complex phenotypic consequences of MOB2 manipulation within the tissue context.

Technical Foundations of Multiplexed Immunofluorescence

Multiplexed immunofluorescence transcends the limitations of traditional immunohistochemistry by enabling simultaneous detection of multiple biomarkers on a single tissue section. This approach provides spatially resolved, single-cell data that is essential for analyzing complex biological processes like the cell cycle within the tumor microenvironment [30] [31].

Key advantages of mIF include:

• High-Plex Data from Scarce Samples: The ability to apply multiple markers on a single section is particularly beneficial when tissue samples are limited [32].
• Spatial Context Preservation: Unlike dissociative single-cell methods, mIF retains the architectural context of cells, allowing for analysis of cell-cell interactions and spatial relationships [30].
• Enhanced Quantitative Analysis: Spectral unmixing and advanced imaging reduce autofluorescent background and spectral bleed-through, resulting in a high signal-to-noise ratio and reliable quantitative data [31].

Instrumentation and Workflow

Advanced platforms like the Orion instrument and the AKOYA PhenoImager HT facilitate whole-slide imaging of 16-18 and 6-8 fluorescent channels, respectively [30] [31]. The typical mIF workflow involves:

• Staining: Automated staining using validated antibody panels.
• Imaging: Multispectral slide scanning to capture all fluorescence channels.
• Spectral Unmixing: Computational extraction of individual fluorophore signals.
• Image Analysis: Cell segmentation and phenotyping using specialized software [30] [31].

Critical to this workflow is nuclear segmentation, the process of identifying individual nuclei, which forms the foundation for all subsequent single-cell analysis. Recent benchmarking studies indicate that deep learning models such as Mesmer generally outperform classical algorithms for this task, achieving higher accuracy across diverse tissue types [32].

Application to Cell Cycle and MOB2 Research

Designing Cell Cycle Marker Panels

Comprehensive cell cycle analysis requires antibody panels that can discriminate all cell cycle phases and arrest states. The tables below summarize essential markers for dissecting cell cycle progression.

Table 1: Core Markers for General Cell Cycle Phasing

Marker	Expression Pattern	Primary Function	Cell Cycle Phase
Ki-67	Nuclear, absent in G0	Marks proliferating cells	All active phases (G1, S, G2, M)
Phospho-Histone H3 (pH3)	Nuclear, peaks during mitosis	Chromosome condensation	M phase
Cyclin D1 (CCND1)	Nuclear, early G1	CDK activator, G1 progression	Early to mid-G1
Cyclin E (CCNE)	Nuclear, G1/S transition	CDK2 activation, G1/S transition	Late G1 to early S
Cyclin A (CCNA)	Nuclear, S/G2	CDK2/CDK1 activation, DNA replication	S and G2 phases
p21	Nuclear, induced by p53	CDK inhibitor, cell cycle arrest	G1 arrest (e.g., DNA damage)

Table 2: Specialized Markers for Detailed Cell Cycle Arrest and DNA Damage Studies

Marker	Expression/Activation Context	Interpretation in MOB2 Knockdown
p53	Stabilized and phosphorylated upon DNA damage	Indicates activation of DDR pathways [6]
pRB / pRB	Hypophosphorylated in G1, hyperphosphorylated in S/G2	Can indicate G1/S arrest dynamics
γH2AX	Foci form at sites of DNA double-strand breaks	Marker for DNA damage accumulation [6] [7]
RAD51	Foci form during homologous recombination repair	Assess HR repair proficiency [7]

These markers can be combined into optimized panels, such as the pre-validated "Cell Cycle 1" panel (MCM2, pRB, RB, CCND1, CCNE, Ki67, pHH3, PanCK) or the "Cell Cycle 4" panel (p21, p16, CCNE, CCND1, GMNN, CDK2, RB, PanCK), which are available for both human and mouse samples [31].

Visualizing the Role of MOB2 in DNA Damage and Cell Cycle Signaling

The diagram below illustrates the molecular role of MOB2 in the DNA damage response and the expected cellular phenotype upon its knockdown, which can be measured using multiplexed immunofluorescence.

Experimental Workflow for MOB2 Knockdown Analysis

The following diagram outlines the complete end-to-end workflow for analyzing cell cycle arrest in MOB2 knockdown models using multiplexed immunofluorescence.

Detailed Protocols

Protocol: Multiplexed Immunofluorescence for Cell Cycle Analysis

This protocol is adapted from established methods [29] [33] [31] and optimized for use with the AKOYA PhenoImager HT platform.

I. Sample Preparation and Staining

• Tissue Sectioning: Cut 4-5 µm thick sections from FFPE tissue blocks of MOB2 knockdown and control cell pellets or xenografts. Mount on charged slides and dry overnight at 37°C.
• Deparaffinization and Antigen Retrieval: Perform deparaffinization in xylene and graded alcohols. Use a pressure cooker or automated decloaking chamber for heat-induced epitope retrieval (HIER) in Tris-EDTA buffer (pH 9.0) or citrate buffer (pH 6.0), optimized for the antibody panel.
• Multiplexed Immunofluorescence Staining (6-8 plex): a. Blocking: Incubate sections with a protein block (e.g., 10% normal goat serum) for 30 minutes at room temperature to reduce non-specific binding. b. Primary Antibody Incubation: Apply the first primary antibody from the pre-optimized panel (e.g., anti-Ki-67). incubate for 1 hour at room temperature or overnight at 4°C. c. Secondary Detection: Apply a fluorophore-conjugated secondary antibody (e.g., ArgoFluor-conjugated) for 1 hour at room temperature, protected from light. d. Repetition for Sequential Staining: For one-shot imaging, repeat steps b and c for all primary antibodies in the panel. For cyclic staining (e.g., CyCIF), after imaging, remove antibodies by gentle stripping buffer or microwave treatment before the next cycle. e. Nuclear Counterstaining: Apply DAPI (1-5 µg/mL) for 10 minutes to stain all nuclei. f. Mounting: Coverslip using a compatible, hard-set mounting medium.

II. Image Acquisition and Unmixing

• Slide Scanning: Scan slides using the PhenoImager HT with a 20x objective. Define the appropriate exposure times for each channel to avoid saturation.
• Spectral Library Creation: Create a spectral library using single-stained controls for each fluorophore to account for emission spectra overlap.
• Spectral Unmixing: Process the raw image files using the instrument's software (e.g., inForm) to extract pure signal for each biomarker by subtracting autofluorescence and resolving spectral bleed-through [31].

III. Image and Data Analysis

• Nuclear Segmentation: Process the unmixed DAPI image using a pre-trained deep learning model (e.g., Mesmer) for highly accurate nuclear segmentation, which is critical for downstream analysis [32].
• Cell Phenotyping: Using the single-cell data output, define cell phenotypes based on marker expression thresholds (e.g., Ki-67+/pH3- for G2 phase; Ki-67+/pH3+ for M phase; p21+/Cyclin E- for G1 arrest).
• Cell Cycle Mapping and Spatial Analysis: a. Manifold Learning: Apply non-linear dimensionality reduction techniques (e.g., UMAP, PHATE) to the single-cell protein expression data to visualize the continuous trajectory of cell cycle progression and identify distinct arrest states [29] [34]. b. Spatial Statistics: Quantify the spatial distribution of cells in specific cell cycle states relative to features like blood vessels or tumor-stroma boundaries.

Protocol: Validating MOB2 Knockdown Phenotypes

This adjunct protocol is designed to specifically interrogate the DNA damage and arrest phenotypes associated with MOB2 loss-of-function.

• Induction of DNA Damage: Treat MOB2 knockdown and control cells with a DNA-damaging agent such as doxorubicin (e.g., 0.5 µM for 24 hours) or ionizing radiation (e.g., 2-4 Gy) [6] [7]. Include untreated controls.
• Multiplexed Panel for DDR: Utilize an antibody panel that includes hMOB2, γH2AX, p53, p21, RAD51, and a proliferation marker (Ki-67).
• Quantitative Analysis: a. DNA Damage Foci Quantification: Count the number of γH2AX foci per nucleus in MOB2-deficient versus control cells, both at baseline and post-treatment. b. Cell Cycle Distribution: Calculate the percentage of cells in G0/G1 (p21+), S (Cyclin A+), and G2/M (Cyclin A+/pH3-) phases. c. HR Efficiency: Score the percentage of cells with >5 RAD51 foci in S/G2 phase nuclei after damage induction [7].
• Validation: Correlate the loss of hMOB2 signal with the expected phenotypes: increased γH2AX foci, elevated p53/p21 expression, reduced RAD51 foci formation, and a higher proportion of cells in G1/S arrest.

The Scientist's Toolkit

Table 3: Essential Research Reagent Solutions for mIF Cell Cycle Analysis

Item Category	Specific Examples	Critical Function
Validated Antibodies	Ki-67, Phospho-Histone H3 (Ser10), Cyclin D1, Cyclin E, p53, p21, γH2AX, RAD51, Pan-Cytokeratin (AE1/AE3)	Specific detection of key cell cycle phases, DNA damage response, and lineage markers. Knockout-validated antibodies are essential for specificity [30] [31].
Fluorophore Conjugates	ArgoFluor series, Alexa Fluor series	Bright, photostable dyes for antibody conjugation. Must be selected for minimal spectral overlap to enable high-plex imaging [30].
Automated Stainers	Leica BOND RXm	Ensures highly reproducible and timely staining of multiplexed panels, critical for reducing technical variability [31].
Imaging Platforms	AKOYA PhenoImager HT, Orion Platform	Perform multispectral or one-shot high-plex whole-slide imaging, enabling the acquisition of spatially resolved single-cell data [30] [31].
Analysis Software & Algorithms	MCMICRO, inForm, Cellpose, Mesmer, StarDist	Open-source and commercial software for image processing, spectral unmixing, cell segmentation, and single-cell analysis [32] [30] [31].
Nuclear Segmentation Models	Mesmer, StarDist, Cellpose	Pre-trained deep learning models that provide high-accuracy nuclear segmentation, forming the foundation for reliable single-cell data extraction [32].
Ro 23-9358	Ro 23-9358, CAS:153125-17-8, MF:C30H51NO6, MW:521.7 g/mol	Chemical Reagent
Tyrphostin 63	Tyrphostin 63, CAS:5553-97-9, MF:C10H8N2O, MW:172.18 g/mol	Chemical Reagent

Expected Results and Data Interpretation

Successful application of this methodology will enable the construction of a cell cycle map that visualizes the diverse paths and states cells occupy. In the context of MOB2 knockdown, the data should reveal:

• A significant increase in the proportion of cells clustering in a p21-high, Cyclin E-low region of the map, consistent with a G1/S arrest state [6].
• At the single-cell level, an increase in γH2AX signal intensity and foci count in MOB2-deficient cells, even in the absence of exogenous damage, indicating accumulation of endogenous DNA damage [6] [7].
• A reduction in RAD51 foci formation in MOB2 knockdown cells after irradiation, confirming a defect in homologous recombination repair [7].
• Spatial analysis might reveal that arrested cells are not randomly distributed but could form clusters, suggesting micro-environmental influences on the arrest phenotype.

This detailed, high-content data moves beyond simple cell cycle phasing to provide a systems-level view of how perturbation of a single gene like MOB2 rewires the cell cycle network, offering deep mechanistic insights into its function.

Solving Common Challenges in Cell Cycle Assay Execution and Data Interpretation

Optimizing Cell Suspension and Fixation to Minimize Aggregates

In cell cycle research, particularly in assays designed to study phenotypes like the G1/S arrest induced by hMOB2 knockdown, the accuracy of data is paramount. A common and critical technical challenge in such studies is the formation of cell aggregates during suspension preparation and fixation. These aggregates can severely compromise flow cytometry analysis by leading to clogged instruments, aberrant DNA histograms, and ultimately, unreliable cell cycle distribution data [35] [26]. This application note provides detailed, actionable protocols to minimize aggregation, ensuring the integrity of your cell cycle arrest assays.

The Impact of Aggregation on Cell Cycle Analysis

Cell aggregation directly threatens the success of cell cycle analysis. The presence of clumps can result in several analytical issues:

• Inaccurate DNA Content Measurement: Flow cytometers analyze cells based on the assumption of a single-cell suspension. Cell doublets or aggregates are indistinguishable from a single cell with a higher DNA content (e.g., a G2/M phase cell), leading to overestimation of the G2/M population and distorting the true cell cycle profile [26].
• Obscured Cell Cycle Phenotypes: The key readout of a knockdown MOB2 assay—a p53/p21-dependent G1/S arrest—can be masked or misrepresented by data artifacts stemming from aggregation [6] [7].
• Reduced Experimental Reproducibility: Aggregation introduces significant variability in cell handling and analysis, reducing the reliability and reproducibility of experimental results [35].

Characterizing and Troubleshooting Cell Aggregation

Understanding the root cause of aggregation is the first step toward prevention. The table below outlines common causes and their respective solutions.

Table 1: Common Causes of Cell Aggregation and Proposed Solutions

Category	Specific Cause	Proposed Solution
Intrinsic Cell Properties	Naturally aggregate-forming cell lines (e.g., AtT-20, U2932) [35].	Consult cell line databases; if intrinsic, anti-clumping agents can be used.
Cellular Stress	Stress from non-preheated media, incorrect PBS temperature, or mechanical agitation [35].	Pre-warm all media and buffers to 37°C; minimize harsh mechanical force.
Improper Dissociation	Over-dissociation damages cells; Under-dissociation leaves clumps [35].	Optimize enzyme concentration and incubation time; re-dissociate if needed.
Fixation Technique	Adding ethanol fixation solution too rapidly [26].	Add cold ethanol drop-wise to the cell pellet while gently vortexing.
Serum Variability	Differences between brands or batches of serum [35].	Avoid frequent switching; transition gradually by mixing old and new serum.

Optimized Protocol for Single-Cell Suspension and Fixation

This protocol is optimized for adherent cells like hTERT-RPE1, a common model for cell cycle studies, and is designed to minimize aggregation for subsequent flow cytometric cell cycle analysis [6] [36] [26].

Materials

• Cell Culture: hMOB2 knockdown and control cell lines (e.g., RPE1-hTert).
• Buffers and Reagents: Dulbecco's Phosphate Buffered Saline (PBS), trypsin-EDTA solution (or Gentle Cell Dissociation Reagent for sensitive cells), complete growth medium.
• Fixation Solution: Ice-cold 70% ethanol (prepared in distilled water, not PBS, to prevent precipitation).
• Staining Solution: Propidium Iodide (PI) stock solution (50 µg/mL), Ribonuclease A (RNase A, 100 µg/mL).
• Equipment: Flow cytometer capable of pulse shape analysis.

Workflow Diagram: Cell Cycle Analysis

Step-by-Step Procedure

• Cell Harvesting:

  • Culture and treat cells according to your experimental design (e.g., transfection with hMOB2-targeting shRNAs) [6].
  • Upon assay completion, carefully aspirate the culture medium and wash the cell monolayer gently with pre-warmed PBS.
  • Add a minimal volume of pre-warmed trypsin-EDTA (or GCDR) to cover the monolayer. Incubate at 37°C for the shortest time required for cell detachment (typically 2-5 minutes). Avoid over-trypsinization.
  • Neutralize trypsin with a generous volume of complete growth medium. Gently pipette the cell suspension 5-10 times to break up small clumps.

• Cell Fixation and Washing:

  • Centrifuge the cell suspension at 300 × g for 5 minutes. Carefully aspirate the supernatant.
  • Critical Step: Re-suspend the cell pellet in a small volume of PBS. While gently vortexing the tube at a low speed, add ice-cold 70% ethanol drop-wise until the final volume is achieved. This technique ensures even fixation and minimizes aggregation [26].
  • Fix cells for at least 30 minutes at 4°C. Fixed cells can be stored in ethanol for several weeks at 4°C for batch processing.
  • Proceed to staining or wash stored cells twice with PBS before staining to remove all ethanol.

• Propidium Iodide Staining for DNA Content:

  • Centrifuge the fixed cell suspension and thoroughly remove the supernatant.
  • Re-suspend the cell pellet in 200 µL of PBS containing RNase A (final concentration ~50 µg/mL). Incubate for 15-30 minutes at 37°C. This step is crucial to ensure PI stains only DNA, not RNA.
  • Add Propidium Iodide to a final concentration of 50 µg/mL. Mix well and incubate for at least 5 minutes at room temperature, protected from light.
  • Analyze the samples on a flow cytometer within a few hours.

Flow Cytometry Analysis and Gating Strategy

• Pulse Processing: To electronically exclude cell doublets and aggregates from analysis, use pulse processing on your flow cytometer. Plot PI pulse area (PI-A) versus PI pulse width (PI-W). Single cells will form a diagonal population, while doublets will have a higher pulse width for a given pulse area. Gate on the single-cell population for all subsequent analysis [26].
• DNA Histogram Analysis: Apply the single-cell gate to the PI-A histogram. Use software algorithms to model the cell cycle phases (G0/G1, S, and G2/M) based on DNA content.

MOB2 and Cell Cycle Arrest: A Research Context

The technical protocols described above are essential for accurately characterizing the cellular phenotype resulting from hMOB2 manipulation. Research has established that hMOB2 plays a critical role in DNA damage response (DDR) and cell cycle progression.

• hMOB2 in DDR and HR Repair: hMOB2 promotes DDR signaling and cell survival after DNA damage. It interacts with the RAD50 component of the MRN complex, facilitating the recruitment of DNA repair machinery to damaged chromatin [6]. Furthermore, hMOB2 is required for the stabilization of RAD51 on resected DNA, a key step in Homologous Recombination (HR) repair [7].
• Consequence of hMOB2 Loss: Under normal conditions, loss of hMOB2 leads to the accumulation of endogenous DNA damage, which triggers a p53/p21-dependent cell cycle arrest primarily at the G1/S phase [6] [7]. This arrest is the key phenotype that a well-optimized cell cycle assay must reliably detect, a task made difficult by cell aggregation.

Diagram: hMOB2 Deficiency Triggers G1/S Arrest

Research Reagent Solutions

Table 2: Essential Reagents for Cell Cycle Arrest Assays

Reagent	Function/Application	Example
Propidium Iodide (PI)	DNA-intercalating dye for quantifying DNA content by flow cytometry.	Abcam protocol [26]
RNase A	Degrades RNA to prevent non-specific staining with PI.	Included in PI staining kits [26]
Anti-Clumping Agent	Additive to reduce aggregation in suspension cultures of sensitive cell lines.	Not specified, various commercial products [35]
Gentle Cell Dissociation Reagent (GCDR)	Enzyme-free solution for dissociating sensitive cells, minimizing damage.	Used in 3D culture passaging [37]
Palbociclib	CDK4/6 inhibitor for reversible synchronization of cells at the G1/S restriction point.	Used in RPE-1 cell synchronization [36]
shRNA Plasmids	For stable knockdown of target genes like MOB2 in cell cycle studies.	pTER constructs against hMOB2 [6]

Addressing High CV Values and Poor G0/G1 Peak Resolution

In cell cycle analysis via flow cytometry, high Coefficient of Variation (CV) of the G0/G1 peak and poor resolution between G0 and G1 populations are common technical challenges that can compromise data interpretation. These issues are particularly critical when studying subtle cell cycle arrests, such as those induced by the knockdown of Mps one binder 2 (MOB2), a protein implicated in DNA damage response (DDR) and cell cycle progression [6]. Robust methodology is essential to accurately distinguish the quiescent G0 state from the proliferative G1 phase, thereby enabling the precise characterization of cellular phenotypes in response to genetic or therapeutic interventions. This protocol details optimized procedures to achieve low CV values and clear G0/G1 separation, specifically framed within the context of MOB2 knockdown assays.

---

Understanding CV and G0/G1 Resolution

The Coefficient of Variation (CV) is a key metric in flow cytometry, expressing the standard deviation of a peak as a percentage of its mean fluorescence intensity. A low CV indicates a tight, well-defined peak, which is crucial for accurately quantifying the proportion of cells in each cell cycle phase.

Simultaneously, distinguishing the quiescent G0 cell population from the G1 phase is vital for a complete understanding of cell cycle dynamics. While both G0 and G1 cells have the same 2n DNA content, they are functionally distinct. G0 cells are reversibly arrested and do not proliferate, a state often characterized by low RNA content and the absence of proliferation markers like Ki-67 [38] [39].

The following table summarizes the core concepts and biological context, including the role of MOB2:

Table 1: Key Concepts in Cell Cycle Analysis

Concept	Description	Importance in MOB2 Research
CV (Coefficient of Variation)	Measure of the precision and spread of a fluorescence peak. Lower CV values indicate higher data quality and resolution [38].	Essential for detecting subtle G1 phase shifts or arrests resulting from MOB2 knockdown, which is known to affect cell cycle progression and DDR [6].
G0 Phase	A quiescent, non-proliferative state with 2n DNA content, characterized by low RNA and absence of Ki-67 antigen [38] [39].	MOB2 loss can trigger a p53/p21-dependent G1/S cell cycle arrest; proper G0 identification helps distinguish this arrest from general quiescence [6].
G1 Phase	The first growth phase of the cell cycle, where cells prepare for DNA synthesis. Cells have 2n DNA content but are actively cycling.
MOB2 Protein	A regulator of the DNA damage response, facilitating the recruitment of the MRN complex and activated ATM to damaged chromatin [6].	Knockdown of MOB2 can lead to accumulated DNA damage and a subsequent cell cycle arrest, underscoring the need for precise cycle analysis [6].

Diagram 1: MOB2 Knockdown Induces Cell Cycle Arrest

---

Troubleshooting High CV and Poor G0/G1 Resolution

Achieving high-quality flow cytometry data requires meticulous attention to sample preparation and instrument setup. The table below outlines common causes and solutions for high CV and poor G0/G1 peak resolution.

Table 2: Troubleshooting Guide for High CV and Poor G0/G1 Resolution

Problem	Potential Cause	Recommended Solution
High CV Value	Cell clumping and aggregation.	- Fix cells in cold 70% ethanol by adding it dropwise to a single-cell suspension while gently vortexing [38].- Filter samples through a cell strainer (e.g., 35-70 µm nylon mesh) before analysis.
	Inconsistent staining.	- Ensure an adequate and consistent incubation time with the DNA dye (e.g., 20-30 min for PI).- Keep staining steps in the dark to prevent dye degradation.- Use a sufficient concentration of RNase to eliminate RNA interference.
	Suboptimal flow cytometer setup.	- Use a low flow rate (< 400 events/sec) for optimal signal stability and resolution [38].- Ensure core stream stability and properly adjust time delays for the instrument.
Poor G0/G1 Resolution	Inability to distinguish G0 from G1 by DNA content alone.	- Employ a dual-staining approach: Ki-67 vs. DNA content or Hoechst 33342 (DNA) vs. Pyronin Y (RNA) [38].- Ki-67 is highly expressed in proliferating cells (G1, S, G2/M) but absent in G0 [38].
	Spectral overlap of fluorophores.	- Use fluorescent dyes with minimal spectral overlap (e.g., FITC for Ki-67 and PI for DNA).- Apply appropriate electronic compensation during acquisition to correct for spillover [38].
	Analysis not excluding doublets.	- During analysis, create a bivariate plot of pulse Area vs. Width or Height (for FSC, SSC, or DNA fluorescence).- Gate on the single cell population, which forms a diagonal pattern, to exclude aggregated cells [38].

Diagram 2: Workflow for Optimal Cell Cycle Analysis

---

Quantitative Data for Method Selection

Different staining methods offer varying capabilities for cell cycle resolution. The table below compares common approaches to help select the most appropriate protocol for your research question.

Table 3: Comparison of Staining Methods for Cell Cycle Analysis

Staining Method	Principle	Discriminates G0 from G1?	Best Use Case
DNA Content Only (e.g., PI, DAPI)	Binds stoichiometrically to DNA, distinguishing G0/G1 (2n), S (2n-4n), and G2/M (4n) phases.	No	Basic cell cycle distribution analysis where G0 identification is not required.
Ki-67 / DNA Dual Stain	Ki-67 protein is expressed in all active phases (G1, S, G2/M) but absent in G0 [38].	Yes	Quantifying the resting (G0) versus proliferating cell fraction in a heterogeneous population.
Hoechst 33342 / Pyronin Y	Hoechst stains DNA, while Pyronin Y stains RNA. G0 cells have lower RNA levels than G1 cells [38].	Yes	Identifying quiescent stem cells or studying cell cycle exit and re-entry dynamics.

---

Detailed Protocol: Ki-67 and DNA Content Staining for G0 Analysis

This protocol is optimized for analyzing cell cycle status in MOB2 knockdown cells, enabling clear discrimination of G0 arrest.

Materials

• Solutions and Reagents:
  • 1X Phosphate Buffered Saline (PBS)
  • 70% Cold ethanol (-20°C)
  • FACS Buffer (e.g., PBS with 1-2% FBS or BSA)
  • PI Staining Solution (PBS containing Propidium Iodide and RNase)
  • FITC-conjugated Ki-67 antibody
• Special Equipment:
  • Flow cytometer equipped with a 488 nm blue laser and filters for FITC (530/30 nm) and PI (610/20 nm).

Procedure

• Harvest, Fix, and Permeabilize Cells:

  • Harvest MOB2 knockdown and control cells. Pellet (1 \times 10^6) cells by centrifuging at (200 \times g) for 5 min.
  • Wash cells with 10 ml PBS and centrifuge again.
  • Resuspend the cell pellet in 0.5 ml PBS.
  • Crucially, add 4.5 ml of pre-chilled 70% ethanol (-20°C) dropwise to the cell suspension while gently vortexing to minimize clumping [38].
  • Fix cells for at least 2 hours at -20°C. Fixed cells can be stored for several weeks.

• Stain Cells with Ki-67 Antibody and PI:

  • Pellet the fixed cells (300 × g for 3 min) and carefully remove the ethanol.
  • Wash cells twice with 5 ml FACS buffer.
  • Resuspend the cell pellet in 100 µl FACS buffer.
  • Add 10 µl of pre-diluted FITC-conjugated Ki-67 antibody. Incubate for 30 minutes at room temperature in the dark.
  • Wash cells twice with 5 ml FACS buffer to remove unbound antibody.
  • Remove the supernatant and resuspend the cells in 500 µl PI staining solution. Incubate for 20 minutes at room temperature in the dark. No further washing is required.

• Perform Flow Cytometry:

  • Set up the flow cytometer with a 488 nm laser.
  • Adjust detection filters: 530/30 nm bandpass for FITC (Ki-67) and 610/20 nm bandpass for PI.
  • Set a low flow rate (less than 400 events/second) for optimal PI resolution [38].
  • Collect data, ensuring to exclude doublets by gating on a plot of PI-Area vs. PI-Width.

Data Analysis

• Create a bivariate dot plot of Ki-67 (FITC, log scale) versus DNA content (PI, linear scale).
• The Ki-67-negative and DNA content 2n population represents the G0 arrested cells.
• The Ki-67-positive and DNA content 2n population represents the G1 phase cells.

---

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Reagents for Cell Cycle Analysis

Reagent / Dye	Function	Key Feature
Propidium Iodide (PI)	DNA intercalating dye that stains double-stranded nucleic acids. Requires RNase treatment.	Inexpensive, widely used; excited by 488 nm laser [38].
Hoechst 33342	Cell-permeable DNA dye that binds preferentially to AT-rich regions. Can be used on live cells.	Requires a UV or 405 nm laser for excitation [38].
Anti-Ki-67 Antibody	Binds to the Ki-67 nuclear protein, a marker for all active phases of the cell cycle (G1, S, G2, M).	Gold standard for identifying and excluding G0 quiescent cells [38].
Pyronin Y	Intercalates into cellular RNA. Used in combination with Hoechst 33342 to distinguish G0 (low RNA) from G1 (high RNA) [38].	Provides a functional assessment of cell state beyond DNA content.
DRAQ5	Cell-permeable far-red fluorescent DNA dye. Can be used in live cells and is excitable by a 633 nm laser [38].	Useful for multiplexing with fluorophores like FITC and PE.
LCS-1	LCS-1, CAS:41931-13-9, MF:C11H8Cl2N2O, MW:255.10 g/mol	Chemical Reagent
EWP 815	EWP 815, CAS:20231-01-0, MF:C12H22N4S4, MW:350.6 g/mol	Chemical Reagent

Ensuring Proper RNase Treatment and Dye Saturation

This application note provides a detailed framework for integrating optimized RNase treatment and nuclear dye saturation protocols within knockdown MOB2 cell cycle arrest assays. The precise quantification of nucleic acids and accurate cell cycle profiling are critical for investigating the role of hMOB2 in DNA damage response (DDR) and cell cycle progression. We present standardized methodologies, complete with quantitative data tables and workflow visualizations, to ensure experimental reproducibility and reliability for researchers and drug development professionals studying DDR pathways.

The Mps one binder 2 (MOB2) protein is an evolutionarily conserved regulator of essential signaling pathways with recently identified critical functions in the DNA damage response (DDR) and cell cycle progression [6]. Research demonstrates that hMOB2 promotes DDR signaling, cell survival, and cell cycle arrest following exogenously induced DNA damage [6]. Under normal growth conditions, hMOB2 prevents the accumulation of endogenous DNA damage and subsequent p53/p21-dependent G1/S cell cycle arrest [6]. Furthermore, hMOB2 interacts with RAD50, a key component of the MRE11-RAD50-NBS1 (MRN) complex, facilitating its recruitment to damaged chromatin and supporting homologous recombination (HR) repair [6] [7].

Knockdown of MOB2 in research models leads to genomic instability and heightened sensitivity to DNA-damaging agents, making it a significant target for cancer therapeutic research [7]. Within this context, proper RNase treatment is essential for accurate gene expression analysis during cell cycle arrest assays, while optimal dye saturation is critical for precise nuclear staining and cell cycle profiling. This note provides detailed protocols to ensure data integrity in these foundational techniques.

The Scientist's Toolkit: Research Reagent Solutions

The following table catalogs essential reagents for conducting MOB2 knockdown and cell cycle analysis experiments, along with their specific functions in the experimental workflow.

Table 1: Essential Research Reagents for MOB2 Cell Cycle Studies

Reagent	Function/Application	Key Characteristics
TO-PRO-3 [40]	Nuclear counterstain for fixed cells	Cell-impermeant, far-red fluorescence (Ex/Em: 642/661 nm), binds dsDNA.
RNase R [41]	Degrades linear RNAs for circular RNA validation	Processive 3'→5' exoribonuclease; resistant to circRNAs.
DNase-free RNase A [42]	Removes RNA from DNA samples	Degrades RNA contaminants; specific activity: 0.1 mU degrades 1 μg RNA in 30 min at 37°C.
S9.6 Antibody [43]	Immunoprecipitation of DNA-RNA hybrids	Recognizes RNA-DNA hybrid structures; used in DRIP protocols.
RNase H [43]	Negative control for hybrid detection	Specifically degrades RNA in RNA-DNA hybrids.
RNase If [44]	Distinguishes dsRNA from ssRNA	Preferentially digests single-stranded RNA over double-stranded RNA.

Quantitative Data for Experimental Optimization

Successful experimentation requires careful optimization of reagent concentrations and conditions. The following tables summarize critical quantitative data for RNase treatments and nucleic acid staining.

Table 2: Optimization Parameters for RNase Treatments

RNase Type	Typical Working Concentration	Incubation Conditions	Application Notes	Source
RNase A (DNase-free)	0.1 mU to degrade 1 μg RNA (in 50μL)	30 min at +37°C	Active in water, Tris, or NaCl buffers; no specific buffer required.	[42]
RNase R	Protocol-dependent	Variable (optimized)	High concentrations can partially degrade circRNAs; cleanup is essential post-treatment.	[41]
RNase If	Reaction-dependent	Incorporated into qPCR	Preferentially digests ssRNA, enabling specific quantitation of dsRNA.	[44]
RNase H	5 U/μL	30 min at 37°C	Specific for RNA in RNA-DNA hybrids; used as a negative control in DRIP.	[43]

Table 3: Staining Parameters for TO-PRO-3 Nuclear Dye

Parameter	Recommended Value or Range	Notes
Stock Solution Dilution	1:1,000 in PBS (1 μM)	This is a standard starting point.	[40]
Optimal Concentration Range	100 nM to 5 μM	Must be determined empirically for each cell type.	[40]
Incubation Time	15–30 minutes	Must be performed protected from light.	[40]
Excitation/Emission	642 nm / 661 nm	Far-red fluorescence, minimizes autofluorescence.	[40]
Microscope Filter Set	Cy5 or Far-Red	Compatible with standard far-red filter sets.	[40]

Experimental Protocols

Protocol 1: RNase R Treatment for Effective Linear RNA Removal

This protocol outlines an optimized workflow for treating total RNA with RNase R to degrade linear RNAs, which is a critical step for the subsequent validation of circular RNAs (circRNAs) by RT-qPCR [41].

Key Considerations:

• Avoid Excessive Enzyme Concentrations: Using too high a concentration of RNase R can lead to partial degradation of the target circRNAs.
• Implement a Cleanup Step: A post-treatment cleanup is essential to remove the enzyme and reaction buffers, which can inhibit downstream applications like RT-qPCR.

Procedure:

• RNA Preparation: Dilute 1–2 μg of total RNA in a suitable nuclease-free buffer.
• RNase R Reaction: Add RNase R to the RNA sample. The optimal enzyme concentration and incubation time should be determined empirically to balance complete linear RNA degradation with circRNA preservation.
• Incubation: Incubate the reaction at 37°C for a defined period (e.g., 15–20 minutes).
• Purification: Purify the RNase R-treated RNA using a standard RNA cleanup kit (e.g., silica-membrane based columns) according to the manufacturer's instructions. Elute the RNA in nuclease-free water.
• Quality Assessment: Analyze the purified RNA for quantity and quality using a spectrophotometer or bioanalyzer.
• Downstream Application: Proceed with reverse transcription and qPCR using circRNA-specific primer sets.

Protocol 2: Nuclear Staining with TO-PRO-3 for Fixed Cells

This protocol describes the use of TO-PRO-3 iodide for staining nuclei in fixed and permeabilized cells, ideal for fluorescence microscopy in cell cycle arrest studies [40].

Key Considerations:

• Cell Permeabilization is Mandatory: TO-PRO-3 is cell-impermeant and requires cells to be fixed and permeabilized for nuclear access.
• Optimize Dye Concentration: The optimal staining concentration (100 nM to 5 μM) should be determined for each specific cell line and application.
• Handle with Care: Treat all nucleic acid binding dyes as potential mutagens and use appropriate personal protective equipment.

Procedure:

• Cell Preparation: Culture and plate cells on an appropriate sterile, glass-bottomed dish or chamber slide.
• Fixation and Permeabilization: Fix and permeabilize the cells using a protocol suitable for your sample (e.g., 4% paraformaldehyde followed by 0.1% Triton X-100).
• Washing: Wash the fixed/permeabilized cells 1–3 times with phosphate-buffered saline (PBS).
• Staining Solution Preparation: Dilute the TO-PRO-3 stock solution in PBS to a working concentration of 1 μM (a 1:1000 dilution) as a starting point.
• Staining: Add sufficient staining solution to completely cover the cells.
• Incubation: Incubate for 15–30 minutes at room temperature, protected from light.
• Removal and Washing: Carefully remove the staining solution and wash the cells 3 times with PBS to remove any unbound dye.
• Imaging: Image the cells using a fluorescence microscope equipped with a far-red filter set (e.g., Cy5).

Workflow and Pathway Visualizations

Experimental Workflow for MOB2 Knockdown Assay

The following diagram illustrates the integrated experimental workflow, from cell preparation to data analysis, for a MOB2 knockdown cell cycle arrest assay.

hMOB2 in the DNA Damage Response Pathway

This diagram outlines the molecular mechanism by which hMOB2 regulates the DNA damage response and cell cycle progression, based on recent research findings.

Discussion and Technical Notes

Critical Considerations for RNase Treatments

The choice of RNase and optimization of its use are pivotal for specific applications. RNase R treatment must be carefully calibrated, as excessive enzyme or prolonged incubation can lead to the degradation of target circular RNAs, yielding false-negative results in RT-qPCR [41]. For distinguishing double-stranded RNA (dsRNA) from single-stranded RNA (ssRNA), RNase If is the preferred reagent due to its strong preference for digesting ssRNA, which enables accurate quantitation of dsRNA by qPCR [44]. In DNA-RNA hybrid immunoprecipitation (DRIP) experiments, RNase H serves as an essential negative control, as its specific activity against RNA in RNA-DNA hybrids should abolish the S9.6 antibody-mediated signal [43].

Importance of Dye Saturation and Optimization

While TO-PRO-3 provides a robust nuclear stain, its optimal concentration varies (100 nM to 5 μM) and must be determined empirically for each cell type and fixation condition to ensure specific nuclear staining without excessive background [40]. Furthermore, TO-PRO-3 staining can be combined with other fluorescent probes, such as Alexa Fluor 488 phalloidin for actin visualization, enabling multiplexed analysis of cytoskeletal and nuclear changes in response to MOB2 knockdown and DNA damage [40]. Its far-red fluorescence emission (661 nm) is a key advantage, as it falls outside the range of common tissue autofluorescence, thereby improving the signal-to-noise ratio in fluorescence microscopy [40].

Robust and reproducible results in MOB2 knockdown cell cycle arrest assays are contingent upon meticulous attention to protocol details, particularly in RNase treatment and nuclear dye saturation. The optimized methods and quantitative guidelines provided here—for reagents including RNase R, RNase If, and TO-PRO-3—are designed to ensure the accuracy of nucleic acid analysis and cell cycle profiling. Adherence to these protocols will enable researchers to reliably investigate the novel functions of hMOB2 in DNA damage response, homologous recombination repair, and cell cycle checkpoint control, ultimately advancing its potential as a biomarker for patient stratification in HR-deficiency targeted therapies [6] [7].

Troubleshooting Absent G2/M Phase and Suboptimal Cell Culture Conditions

Within the context of research on Mps one binder 2 (MOB2) and its role in cell cycle regulation, a consistently absent G2/M phase in cell cycle analysis can significantly hinder progress. This application note details the primary causes and evidence-based solutions for this common issue, with a specific focus on experiments involving MOB2 knockdown. The hMOB2 protein has been identified as a promoter of DNA damage response (DDR) signaling and cell cycle progression, with its loss leading to the accumulation of endogenous DNA damage and subsequent p53/p21-dependent G1/S cell cycle arrest [6]. Understanding and troubleshooting the absence of G2/M is therefore critical for accurately interpreting the outcomes of MOB2 manipulation assays.

Core Problem: Absent G2/M Phase in Cell Cycle Analysis

An absent G2/M phase in flow cytometry data indicates that cells are not progressing to or through mitosis under the experimental conditions. This can be a genuine biological effect, such as a robust cell cycle arrest, or a technical artifact. Key factors are summarized in the table below.

Table 1: Common Causes and Solutions for an Absent G2/M Phase

Category	Specific Cause	Impact on Cell Cycle	Recommended Solution
Culture Conditions	Contact inhibition due to over-confluent culture [45]	Cells enter quiescence (G0), halting proliferation.	Ensure cells are seeded at an appropriate density to maintain logarithmic growth; do not allow cultures to become over-confluent.
Culture Conditions	Suboptimal culture conditions or insufficient nutrition [45]	Cell growth is slowed, preventing cycle progression.	Optimize culture medium, use fresh reagents, and ensure proper concentrations of supplements and serum.
Technical Artifacts	Cell Aggregation [45]	Clumped cells are misinterpreted by flow cytometry as high-ploidy (e.g., tetraploid, 8-ploid) populations.	Filter cells through a mesh before analysis; use doublets discrimination (e.g., PI-A vs. PI-W or PI-H plot) during flow cytometry data analysis.
Biological Reality	Genuine G2/M Arrest	A potent experimental treatment (e.g., drug, gene knockdown) induces a complete block at the G2/M checkpoint.	Validate with complementary assays (e.g., Western blot for G2/M markers like phospho-histone H3).
Cell Model	Use of non-proliferating cells (e.g., peripheral blood lymphocytes) [45]	Cells are naturally quiescent in G0 phase.	Confirm that the chosen cell line or primary cells are capable of active division under the culture conditions used.

MOB2 and Its Role in the Cell Cycle and DNA Damage Response

Research into hMOB2 provides a critical biological context for cell cycle arrest phenotypes. While initially characterized as an inhibitor of NDR kinases, hMOB2 has been shown to play an NDR-independent role in promoting the DNA damage response (DDR). hMOB2 interacts directly with RAD50, a core component of the MRE11-RAD50-NBS1 (MRN) complex, which is a primary sensor of DNA double-strand breaks. This interaction facilitates the recruitment of the MRN complex and activated ATM kinase to sites of DNA damage [6].

The following diagram illustrates the pivotal role of MOB2 in the DNA damage response pathway and the consequences of its knockdown.

Diagram: MOB2 facilitates the DNA damage response via RAD50 interaction. MOB2 knockdown leads to accumulated DNA damage and a G1/S arrest, which can preempt a G2/M population.

Therefore, in the context of MOB2 knockdown assays, an absent G2/M phase might not be the primary readout. Instead, the literature demonstrates that hMOB2 loss triggers a p53/p21-dependent G1/S arrest under normal growth conditions, as a consequence of endogenous DNA damage accumulation [6]. This G1/S arrest would naturally reduce the number of cells entering subsequent S and G2/M phases.

Detailed Experimental Protocol: Cell Cycle Analysis by Flow Cytometry

This protocol is optimized for detecting cell cycle phases, including G2/M, and is applicable for analyzing the effects of MOB2 knockdown.

Materials and Reagents

Table 2: Research Reagent Solutions for Cell Cycle Analysis

Item	Function/Description	Example/Catalog
Propidium Iodide (PI)	Fluorescent DNA intercalating dye that stoichiometrically binds DNA.	Thermo Fisher Scientific P3566
RNase A	Degrades RNA to prevent false-positive staining from PI binding to RNA.	Qiagen 19101
Cell Culture Medium	Appropriate for cell line (e.g., DMEM, RPMI-1640) with necessary supplements.	Gibco
Phosphate-Buffered Saline (PBS)	Salt solution for washing cells without disrupting osmolarity.	Sigma-Aldrich D8537
Ethanol (70%, ice-cold)	Fixative that permeabilizes cells allowing PI to enter and bind nuclear DNA.
Flow Cytometer	Instrument for quantifying fluorescence intensity of single cells.	BD FACSCelesta

Step-by-Step Procedure

• Cell Harvesting and Washing:

  • Gently trypsinize adherent cells (e.g., RPE1-hTert, U2-OS) from culture flasks. Crucially, ensure cells are in log-phase growth and sub-confluent (ideally 60-80%) at the time of harvesting [45].
  • Neutralize trypsin with complete medium and transfer the cell suspension to a conical tube.
  • Pellet cells by centrifugation at 300 × g for 5 minutes.
  • Carefully aspirate the supernatant and resuspend the cell pellet in 1-2 mL of ice-cold PBS.

• Cell Fixation and Permeabilization:

  • While gently vortexing the cell suspension, slowly add 3-4 volumes of ice-cold 70% ethanol dropwise to prevent cell clumping.
  • Fix cells at -20°C for a minimum of 2 hours or overnight. Fixed cells can be stored at -20°C for several weeks.

• Staining for DNA Content:

  • Pellet the fixed cells by centrifugation at 500 × g for 5 minutes.
  • Carefully remove the ethanol and wash the cell pellet with 2 mL of PBS to remove residual ethanol.
  • Resuspend the cell pellet (~1 × 10^6 cells) in 500 µL of PI/RNase staining solution (e.g., from Cell Cycle Assay Kits).
  • Incubate for 15-30 minutes at room temperature in the dark.

• Flow Cytometry Acquisition and Analysis:

  • Filter the cell suspension through a 35-70 µm cell strainer cap into a flow cytometry tube to remove aggregates.
  • Acquire data on a flow cytometer using a 488 nm laser for excitation and detecting PI fluorescence with a 585/42 nm or 610/20 nm bandpass filter.
  • Collect data for at least 10,000 single-cell events.
  • During analysis, use a PI-A (area) vs. PI-H (height) or PI-W (width) plot to gate strictly on single cells and exclude doublets or aggregates [45].
  • Analyze the DNA content histogram of the single-cell population using cell cycle modeling software (e.g., ModFit LT, FlowJo's cell cycle platform). The G2/G1 peak ratio should be set to 2.0.

Complementary Assays for Validation

To confirm cell cycle findings and investigate the role of MOB2, employ these additional protocols.

Immunofluorescence for DNA Damage and G2/M Markers

• Cell Seeding and Treatment: Seed cells on glass coverslips and perform MOB2 knockdown using validated siRNAs or shRNAs as described in literature [6].
• Fixation and Permeabilization: After 48-72 hours, wash cells with PBS and fix with 4% paraformaldehyde for 15 minutes. Permeabilize with 0.2% Triton X-100 in PBS for 10 minutes.
• Staining: Incubate with primary antibodies against γH2AX (a marker for DNA double-strand breaks) and Phospho-Histone H3 (Ser10) (a specific marker for mitotic cells) for 1 hour. After washing, incubate with appropriate fluorescently-labeled secondary antibodies.
• Mounting and Imaging: Mount coverslips with DAPI-containing mounting medium to visualize DNA. Image using a fluorescence microscope. Co-staining for γH2AX and phospho-histone H3 can help distinguish a DNA damage-induced G2/M arrest from other causes.

Western Blot Analysis of Cell Cycle Regulators

• Cell Lysis: Harvest control and MOB2 knockdown cells. Lyse cells in RIPA buffer supplemented with protease and phosphatase inhibitors [6].
• Gel Electrophoresis and Transfer: Separate proteins by SDS-PAGE and transfer to a PVDF membrane.
• Antibody Probing: Probe the membrane with antibodies against key regulators:
  • p21 Waf1/Cip1 and phospho-p53 (Ser15) to confirm a DNA damage-induced G1/S arrest [6].
  • Cyclin B1 and phospho-Cdk1 (Tyr15) to assess the status of the G2/M transition machinery [46].
  • Use GAPDH or β-Actin as a loading control.
• Detection: Use chemiluminescent substrate and image the blot. Upregulation of p21 and p-p53 in MOB2 knockdown cells would support the findings of a G1/S arrest.

Successfully troubleshooting an absent G2/M phase requires a systematic approach that differentiates between technical artifacts and genuine biological effects. For researchers studying MOB2, it is essential to recognize that its knockdown primarily induces a G1/S arrest via a p53/p21-dependent pathway. By employing optimized cell culture practices, rigorous flow cytometry protocols, and complementary assays for DNA damage and cell cycle markers, researchers can accurately characterize cell cycle phenotypes and advance their understanding of MOB2's critical functions in genome maintenance and cell cycle progression.

Within cell cycle research, the accuracy of data acquisition and analysis is paramount, particularly when investigating phenotypes resulting from experimental manipulations such as gene knockdown. This application note details protocols for validating flow cytometer settings and calculating the G2:G1 ratio, a critical metric for identifying cell cycle arrest, within the context of research on MOB2 knockdown. The Mps one binder 2 (MOB2) protein is a conserved regulator of essential signaling pathways with defined roles in DNA damage response and cell cycle progression [6]. Its depletion triggers a p53/p21-dependent G1/S cell cycle arrest and impairs the cellular response to exogenously induced DNA damage [6]. This document provides a standardized framework to ensure the reliability of cell cycle data in studies focusing on MOB2's function.

The Role of MOB2 in Cell Cycle Regulation

MOB2 is an important regulatory protein implicated in maintaining genomic integrity. Key aspects of its function include:

• DDR and Cell Survival: hMOB2 promotes DNA damage response signaling, cell survival, and cell cycle arrest following DNA damage [6].
• Prevention of Endogenous Damage: Under normal growth conditions, MOB2 prevents the accumulation of endogenous DNA damage, thereby averting a p53/p21-mediated G1/S arrest [6].
• NDR-Independent Function: Mechanistically, MOB2 interacts with RAD50, a component of the MRE11-RAD50-NBS1 (MRN) complex. This interaction facilitates the recruitment of the MRN complex and activated ATM to sites of DNA damage, a function that appears independent of its known role in NDR kinase signaling [6].
• Tumor Suppressor Potential: MOB2 is downregulated in several cancers, including glioblastoma (GBM), where it acts as a tumor suppressor by inhibiting malignant phenotypes like clonogenic growth, migration, and invasion [47].

The following diagram illustrates the role of MOB2 in cell cycle regulation and DNA damage response, highlighting the phenotypic outcomes of its knockdown.

Experimental Protocol: Cell Cycle Analysis via Flow Cytometry

This protocol is designed for assessing cell cycle distribution in MOB2-knockdown cells using propidium iodide (PI) staining and flow cytometry.

Sample Preparation and Staining

• Cell Culture and Transfection: Culture cells (e.g., RPE1-hTert, U2-OS) and transfect with MOB2-targeting siRNAs or non-targeting scrambled controls using an appropriate transfection reagent (e.g., Lipofectamine RNAiMax) [6]. Confirm knockdown efficiency via immunoblotting.
• Harvesting: 48-72 hours post-transfection, harvest cells by trypsinization. Include any floating cells in the culture supernatant to avoid bias.
• Fixation: Wash cell pellet with ice-cold PBS. Resuspend cells in 70% ethanol added drop-wise while vortexing gently. Fix at -20°C for a minimum of 2 hours or overnight.
• Staining: Pellet fixed cells and wash with PBS. Resuspend in a PI/RNase staining solution (e.g., 50 µg/mL PI, 100 µg/mL RNase A in PBS). Incubate for 15-30 minutes at 37°C or 30 minutes at room temperature in the dark [48] [49].

Data Acquisition and Instrument Validation

• Instrument Setup: Use a calibrated flow cytometer equipped with a 488 nm laser. Collect PI fluorescence using a long-pass filter (e.g., >600 nm or 613/20 nm bandpass) [50].
• Quality Control:
  • Doublet Discrimination: Collect pulse-width and pulse-area signals for PI to gate out cell doublets and aggregates, ensuring analysis of single cells only [50].
  • Voltage Standardization: Use fluorescent beads to ensure consistent laser delay and PMT voltages across experimental runs.
  • Control Samples: Include an unstained cell sample to set the fluorescence baseline and a single-color PI-stained control for compensation (though PI typically requires no compensation when used alone) [50].
• Acquisition: Acquire a minimum of 10,000 singlet events per sample. For rare populations or greater precision, acquire 20,000-50,000 events [50].

Gating Strategy and G2:G1 Ratio Calculation

A rigorous gating strategy is fundamental for accurate data interpretation. The workflow below outlines the sequential steps to identify single cells and define cell cycle phases for subsequent G2:G1 ratio calculation.

• Data Analysis: Analyze data using flow cytometry software (e.g., FlowJo, FCS Express).
• Gating:
  • Apply a gate on intact cells based on Forward Scatter (FSC) and Side Scatter (SSC).
  • From this population, create an FSC-Area vs. FSC-Height plot to gate on single cells.
  • On the singlet population, plot a histogram of PI fluorescence (area signal).
• Modeling: Use softwares' cell cycle modeling algorithms (e.g., Watson pragmatic, Dean-Jett-Fox) to quantify the percentage of cells in G1, S, and G2/M phases.
• G2:G1 Ratio Calculation: Calculate the ratio using the modeled cell populations. > G2:G1 Ratio = (% Cells in G2/M Phase) / (% Cells in G1 Phase)

Critical Validation Parameters for Data Accuracy

Validating Instrument Settings

Consistent instrument configuration is non-negotiable for reproducible G2:G1 ratios.

• Table 1: Key Flow Cytometer Settings for PI-Based Cell Cycle Analysis

  Parameter	Specification	Purpose and Validation Method
  Laser	488 nm blue laser	Standard excitation source for PI [50].
  Emission Filter	613/20 nm or 575/25 nm bandpass	To collect PI fluorescence [50].
  PMT Voltage	Optimized per experiment	Voltage must be set so the G1 peak is clearly separated from debris and within the linear scale. Validate using control samples.
  Doublet Discrimination	FSC-W vs. FSC-H or PI-W vs. PI-A	Critical for excluding cell doublets, which can be misclassified as G2/M cells, artificially inflating the ratio [50].
  Event Count	≥ 10,000 singlet events	Ensures statistical precision [50].

Interpreting the G2:G1 Ratio in MOB2 Research

The G2:G1 ratio provides a snapshot of cell cycle distribution. In the context of MOB2 research:

• A significant decrease in the G2:G1 ratio in MOB2-knockdown cells compared to controls would support the finding that MOB2 loss induces a G1/S arrest, resulting in a relative depletion of the G2 population [6].
• The expected baseline G2:G1 ratio for a normal, asynchronous mammalian cell population is typically less than 0.5, as a larger proportion of cells reside in G1 [48]. The exact value is cell line-dependent.
• The ratio should be interpreted alongside the raw percentages and other experimental readouts, such as DNA damage markers (e.g., γH2AX) and p21 expression, to build a cohesive model [6].

The Scientist's Toolkit: Essential Reagents and Materials

• Table 2: Key Research Reagent Solutions for MOB2 Cell Cycle Assays

  Item	Function/Application	Examples and Notes
  MOB2-targeting siRNAs	Specific knockdown of MOB2 gene expression.	Validated sequences from commercial suppliers (e.g., Qiagen) [6]. Always use non-targeting scrambled siRNA as a critical control.
  Propidium Iodide (PI)	DNA intercalating dye for cell cycle analysis by flow cytometry.	Distinguishes G0/G1, S, and G2/M phases based on DNA content [48] [49]. Requires RNase treatment.
  Click-iT EdU Assay Kits	Detection of S-phase cells via incorporation of nucleoside analog EdU.	Superior alternative to BrdU; faster, more sensitive, and does not require DNA denaturation [49]. Can be multiplexed with PI.
  Anti-p21 WAF1/Cip1 Antibody	Immunoblotting or immunofluorescence to confirm p53/p21 pathway activation upon MOB2 knockdown.	Validates the mechanism of G1/S arrest [6].
  Lipofectamine RNAiMax	Transfection reagent for efficient siRNA delivery into mammalian cells.	Commonly used for reverse transfection of adherent cell lines [6].
  Hoechst 33342	Cell-permeant DNA stain for live-cell imaging or end-point analysis.	Can be used with the Click-iT EdU assay for imaging [49] or for DNA content analysis via microscopy [51].

Robust validation of instrument settings and accurate calculation of the G2:G1 ratio are critical techniques for elucidating the role of MOB2 in cell cycle regulation. Adherence to the detailed protocols for sample preparation, data acquisition, and analysis outlined in this document will ensure the generation of reliable and reproducible data. This methodological rigor is essential for confirming that MOB2 insufficiency induces a G1/S arrest, a key phenotype that underscores its function as a regulator of genomic integrity and a potential tumor suppressor.

Translating Findings: Biomarker Potential and Therapeutic Sensitization

Confirming hMOB2 Knockdown Efficiency and Specificity

Within the framework of a thesis investigating MOB2 knockdown and cell cycle arrest, confirming the efficiency and specificity of the knockdown is a critical foundational step. The protein Mps one binder 2 (MOB2) is an evolutionarily conserved regulator implicated in essential cellular processes, including cell cycle progression, DNA damage response (DDR), and cell migration [6] [24]. Reliable knockdown is prerequisite for functional studies, as hMOB2 deficiency has been shown to trigger a p53/p21-dependent G1/S cell cycle arrest and increase cellular sensitivity to DNA-damaging agents [6] [7]. This application note details standardized protocols for validating hMOB2 knockdown, providing a essential resource for research and drug development.

The Role of hMOB2 in Cellular Processes

hMOB2 participates in multiple signaling networks. Understanding these pathways is essential for designing appropriate assays to confirm that observed phenotypes are specific to hMOB2 loss.

Key hMOB2-Associated Pathways

The diagram below illustrates the primary signaling pathways involving hMOB2 and the expected cellular consequences of its knockdown.

Experimental Rationale

Knockdown of hMOB2 can be achieved via short hairpin RNA (shRNA) or small interfering RNA (siRNA). A comprehensive validation strategy must include:

• Efficiency Measurement: Quantifying the reduction in hMOB2 mRNA and protein.
• Specificity Confirmation: Verifying the knockdown does not inadvertently affect related proteins or pathways.
• Functional Validation: Correlating the level of knockdown with an expected early phenotypic outcome, such as the accumulation of DNA damage markers [6] [7].

Experimental Protocols

Protocol 1: Validating Knockdown via Western Blotting

This protocol confirms hMOB2 protein depletion.

• Step 1: Cell Lysis. Harvest transfected cells (e.g., SMMC-7721, RPE1-hTert, U2-OS) under non-denaturing conditions. Rinse with ice-cold PBS and lyse using RIPA buffer supplemented with protease and phosphatase inhibitors. Sonicate briefly and centrifuge to collect supernatant [52] [23].
• Step 2: Protein Separation and Transfer. Separate 20-50 µg of total protein via SDS-PAGE (10-12% gel). Transfer proteins to a PVDF or nitrocellulose membrane using standard wet or semi-dry transfer systems [52].
• Step 3: Immunoblotting. Block membrane with 5% non-fat milk in TBST. Incubate with primary antibodies (see Table 4.1) overnight at 4°C. Use anti-MOB2 at 1:500-1:1000 dilution. After washing, incubate with an appropriate HRP-conjugated secondary antibody (1:2000-1:5000). Detect bands using enhanced chemiluminescence (ECL) [52] [24].
• Step 4: Analysis. Normalize hMOB2 band intensity to a loading control (e.g., GAPDH). Calculate knockdown efficiency as a percentage reduction compared to non-targeting siRNA/scrambled shRNA controls.

Protocol 2: Functional Validation by Cell Cycle Analysis

This protocol uses flow cytometry to detect the G1/S arrest, a functional consequence of successful hMOB2 knockdown [6] [52].

• Step 1: Cell Preparation. Harvest control and hMOB2-knockdown cells (e.g., 72-96 hours post-transfection) by trypsinization. Wash cells once with ice-cold PBS [26].
• Step 2: Fixation and Permeabilization. Gently resuspend the cell pellet in ice-cold PBS. Add 70% ethanol drop-wise while vortexing to fix cells. Fix for at least 30 minutes at 4°C. Ethanol-fixed cells can be stored at 4°C for several weeks [26].
• Step 3: RNase Treatment and Staining. Pellet ethanol-fixed cells and wash twice with PBS. Resuspend the cell pellet in a PBS solution containing RNase A (100 µg/mL) and Propidium Iodide (PI, 50 µg/mL). Incubate for 15-30 minutes at 37°C or 30 minutes at room temperature protected from light [26].
• Step 4: Flow Cytometry and Analysis. Analyze the PI-stained cells using a flow cytometer with a 488 nm laser and a 605/35 nm bandpass filter. Collect data from at least 10,000 single-cell events (use pulse processing to exclude doublets). Analyze the DNA content histograms to determine the percentage of cells in G0/G1, S, and G2/M phases [26].

The workflow for the cell cycle analysis is outlined below.

Expected Results and Data Interpretation

Quantitative Benchmarks for Knockdown

A successful experiment should yield data falling within the following benchmarks.

Table 4.1: Expected Results for Key Assays Following hMOB2 Knockdown

Assay	Target/Marker	Expected Change with hMOB2 KD	Quantitative Benchmark	Citation
Western Blot	hMOB2 Protein	↓	>70% reduction in protein level vs. control	[52] [23]
Cell Cycle (PI)	G0/G1 Population	↑	Significant increase in G1 phase cells; correlating with KD efficiency	[6] [52]
Immunofluorescence	γH2AX / p21	↑	Increased nuclear foci or intensity indicating DNA damage and arrest	[6] [7]
Clonogenic Assay	Survival Fraction	↓	Reduced colony formation, enhanced sensitivity to PARPi	[7] [23]

Specificity Controls and Data Interpretation

Key considerations for interpreting validation data:

• Phenocopy Validation: The gold-standard functional validation is the observation of a significant G1/S arrest in the absence of exogenously induced DNA damage [6]. This phenotype should be corroborated by increased protein levels of p53 and p21 [6].
• Specificity Controls: The knockdown should not reduce the expression of other MOB family members (e.g., MOB1). Furthermore, the G1/S arrest phenotype is not phenocopied by direct manipulation of NDR kinases, confirming the role of hMOB2 in this context is independent of canonical NDR signaling [6].
• Rescue Experiments: For definitive proof of specificity, a rescue experiment is recommended. This involves co-expressing an hMOB2 cDNA ( resistant to the siRNA/shRNA) with the knockdown construct. Restoration of wild-type cell cycle profiles confirms phenotype specificity [23].

The Scientist's Toolkit

Table 5.1: Essential Research Reagents for hMOB2 Knockdown Studies

Reagent / Solution	Function / Application	Example & Notes
Anti-MOB2 Antibody	Detection of hMOB2 protein by Western Blot / Immunofluorescence	Rabbit anti-MOB2 monoclonal antibody (e.g., Santa Cruz Biotechnology) [52].
Propidium Iodide (PI)	DNA intercalating dye for cell cycle analysis by flow cytometry. Requires RNase treatment. Compatible with 488 nm laser excitation [26].
Lipofectamine RNAiMax	Lipid-based transfection reagent for siRNA delivery into mammalian cells.	Suitable for transient knockdown experiments [6].
pSuper.retro.puro / pMKO.1	Retroviral vectors for stable expression of shRNAs. Enable selection of knockdown cells with puromycin [6] [23].
Anti-γH2AX Antibody	Marker for DNA double-strand breaks. Functional validation of hMOB2 KD, which leads to endogenous DNA damage [6] [7].
Anti-p21 Antibody	Marker for p53-mediated cell cycle arrest. Confirms functional onset of G1/S arrest post-KD [6].
PARP Inhibitors (e.g., Olaparib)	Functional assay reagent. hMOB2-deficient cells show heightened sensitivity, validating HR defect [7].

Correlating Cell Cycle Arrest with DNA Damage Markers (e.g., γH2AX)

Within the framework of investigating the functional consequences of MOB2 knockdown, understanding the relationship between DNA damage and cell cycle progression is paramount. The DNA Damage Response (DDR) is a critical mechanism for maintaining genomic integrity, and its activation often leads to cell cycle arrest to allow for DNA repair. This application note details protocols and methodologies for quantitatively correlating key DNA damage markers, with a focus on the histone variant γH2AX, with cell cycle arrest phenotypes, particularly in the context of MOB2 deficiency research. The induction of persistent DNA damage, as marked by γH2AX, can trigger a p53/p21-dependent G1/S cell cycle arrest, a pathway frequently examined in studies involving MOB2 knockdown [6] [53].

Background and Significance

γH2AX as a Keystone DNA Damage Marker

The phosphorylation of the histone H2AX on serine 139, forming γH2AX, is one of the earliest cellular responses to DNA double-strand breaks (DSBs) [54]. This phosphorylation event, primarily mediated by the ATM kinase, occurs within minutes of damage induction and forms discernible foci at the site of each DSB, with a generally accepted ratio of one focus per break [54]. While most γH2AX foci are resolved as DNA is repaired, the presence of persistent γH2AX foci is indicative of unrepaired or irreparable DNA damage, which can lead to cellular senescence or apoptosis [53] [54]. This makes γH2AX an exceptionally robust and quantitative marker for assessing both acute and chronic DNA damage.

The Interplay of DNA Damage and Cell Cycle Checkpoints

The DDR is intrinsically linked to cell cycle regulation through a series of checkpoint controls. Key among these is the G1/S checkpoint, which prevents the replication of damaged DNA. The tumor suppressor protein p53 and its downstream target, the cyclin-dependent kinase inhibitor p21, are central mediators of this arrest [53] [55]. Dysregulation of genes involved in DDR signaling can therefore lead to a characteristic accumulation of DNA damage and subsequent cell cycle arrest, a phenotype that can be meticulously quantified.

The Role of MOB2 in DNA Damage Response

Recent research has established that hMOB2 plays a significant role in the DDR and cell cycle progression. Evidence indicates that under normal growth conditions, the loss of hMOB2 leads to the accumulation of endogenous DNA damage, triggering a p53/p21-dependent G1/S cell cycle arrest [6]. Furthermore, hMOB2 has been identified as a regulator of homologous recombination (HR) repair, where it facilitates the phosphorylation and stabilization of the RAD51 recombinase on resected DNA strands [7]. This function underscores its importance in maintaining genomic stability and positions MOB2 knockdown as a critical intervention for studying DDR and cell cycle dynamics.

Quantitative Correlations: DNA Damage Markers and Cell Cycle Arrest

The table below summarizes key DNA damage markers and their quantitative relationship with cell cycle arrest phases, providing a reference for interpreting experimental outcomes.

Table 1: Key DNA Damage Markers and Their Correlation with Cell Cycle Arrest

Marker	Function/ Significance	Correlated Cell Cycle Arrest Phase	Quantitative Notes	Key Associated Proteins/Pathways
γH2AX	Histone mark for DNA Double-Strand Breaks (DSBs) [54]	G1/S, G2/M [55]	~35 foci per Gy of ionizing radiation in human fibroblasts; persistent foci indicate unrepaired damage [54]	ATM, ATR, DNA-PKcs; MDC1, 53BP1 [54]
p53	Tumor suppressor; master regulator of DDR and cell fate [55]	G1/S	Protein stabilization & nuclear accumulation post-damage [53]	p21, MDM2, ATM/ATR
p21	CDK inhibitor; downstream of p53 [55]	G1/S	Transcriptional upregulation; key mediator of p53-dependent arrest [53]	p53, CDK2/Cyclin E
53BP1	DNA repair protein; regulates repair pathway choice [56]	G1	Forms nuclear bodies marking heritable DNA lesions; cleared upon S-phase entry [56]	RIF1, Shieldin complex
Phospho-RPA (pRPA)	Marker of replication stress and resection at DSBs [56]	S, G2/M	Increased levels upon severe replication stress (e.g., ATR inhibition) [56]	ATR, RPA, Single-Stranded DNA

The following pathway diagram illustrates the logical and signaling relationships between DNA damage induction, key marker activation, and subsequent cell cycle arrest, integrating the role of MOB2.

Experimental Protocols

Protocol 1: Combined γH2AX Foci Quantification and Cell Cycle Profiling in MOB2 Knockdown Cells

This protocol allows for the simultaneous assessment of DNA damage and cell cycle position in a population of cells, which is essential for correlating the two phenomena.

A. Materials and Reagents

• Cell Line: Appropriate cell model (e.g., RPE1-hTert, U2-OS) [6]
• Antibodies: Primary anti-γH2AX (mouse or rabbit) [54], Fluorescently conjugated secondary antibody (e.g., Alexa Fluor 488), Anti-p21 antibody [53], Propidium Iodide (PI) or DAPI for DNA staining.
• Buffers: Phosphate-Buffered Saline (PBS), Permeabilization Buffer (0.25% Triton X-100 in PBS), Blocking Buffer (e.g., 1-5% BSA in PBS).
• Other: Cell culture reagents, Transfection reagents for siRNA (e.g., Lipofectamine RNAiMax), Fixative (4% Paraformaldehyde in PBS).

B. Step-by-Step Procedure

• Cell Seeding & Transfection: Seed cells onto glass coverslips in a multi-well plate. Transfert with MOB2-targeting siRNA or non-targeting control siRNA according to manufacturer protocols. Incubate for 48-72 hours to achieve efficient protein knockdown [6].
• Fixation: Aspirate media and wash cells gently with PBS. Fix cells with 4% PFA for 15 minutes at room temperature.
• Permeabilization: Aspirate PFA, wash with PBS, and permeabilize cells with 0.25% Triton X-100 in PBS for 10 minutes on ice.
• Blocking: Incubate cells in Blocking Buffer for 1 hour at room temperature to reduce non-specific antibody binding.
• Immunostaining:
  • Incubate with primary anti-γH2AX antibody diluted in Blocking Buffer overnight at 4°C.
  • Wash 3x with PBS.
  • Incubate with fluorescent secondary antibody and directly conjugated anti-p21 antibody (if performing multiplexing) for 1 hour at room temperature in the dark.
  • Wash 3x with PBS.
• DNA Staining: Incubate with DAPI (e.g., 1 µg/mL) or PI (e.g., 5 µg/mL) for 10-15 minutes to label nuclear DNA. Perform a final PBS wash.
• Mounting and Imaging: Mount coverslips onto glass slides using an anti-fade mounting medium. Image using a high-resolution fluorescence or confocal microscope [57]. Acquire z-stacks for accurate foci counting.
• Image Analysis:
  • γH2AX Foci Quantification: Use image analysis software (e.g., ImageJ/Fiji with custom macros or commercial packages) to count the number of discrete γH2AX foci per nucleus. A threshold of ≥10 foci/cell is often used to indicate significant damage [54].
  • Cell Cycle Profiling: Use the intensity of the DNA stain (DAPI or PI) to determine the DNA content of each nucleus. Gate populations into G1, S, and G2/M phases based on fluorescence intensity histograms.
  • Correlation: Correlate the γH2AX foci count (or intensity) with the cell cycle phase for each individual cell.

Protocol 2: Live-Cell Tracking of DNA Damage and Cell Cycle Progression

This advanced protocol leverages endogenously tagged proteins to track DNA damage and cell cycle dynamics in real-time across multiple generations, providing unparalleled temporal resolution [56].

A. Materials and Reagents

• Engineered Cell Line: Cells with endogenously tagged 53BP1-mScarlet (damage marker) and PCNA-mEmerald (cell cycle marker) generated via CRISPR-Cas9 [56].
• Live-Cell Imaging: MatTek dishes or µ-Slide dishes, Phenol-red free culture medium, Environmental chamber to maintain 37°C and 5% COâ‚‚ during imaging.
• Image Analysis Software: Custom scripts or commercial software for automated cell tracking and segmentation (e.g., TrackMate, CellProfiler).

B. Step-by-Step Procedure

• Cell Preparation: Seed the engineered cells into imaging dishes and allow to adhere overnight.
• Time-Lapse Imaging: Place the dish in the live-cell imaging system. Acquire images of the 53BP1-mScarlet and PCNA-mEmerald channels every 15-30 minutes for 48-72 hours.
• Cell Tracking and Lineage Analysis: Use computational tools to track individual cells and their progeny over time, constructing multigenerational lineage trees [56].
• Data Extraction:
  • Cell Cycle Staging: Classify cell cycle phase based on the PCNA-mEmerald pattern: homogeneous nuclear signal (G1), numerous bright foci (S-phase), homogeneous signal (G2), and chromosome condensation (M-phase) [56].
  • DNA Damage Kinetics: Quantify the appearance, duration, and disappearance of 53BP1-mScarlet nuclear bodies in relation to cell cycle phase and division events.
• Endpoint Immunofluorescence: After live imaging, cells can be fixed and subjected to iterative staining for markers like p53 and p21 to combine dynamic live-cell data with endpoint molecular readouts (Live+QIBC) [56].

The workflow for this multi-modal analysis is summarized below.

Table 2: Key Research Reagent Solutions for DNA Damage and Cell Cycle Studies

Reagent / Resource	Function / Application	Specific Example / Note
CRISPR-Cas9 Engineered Cell Lines	Endogenous tagging of proteins for live-cell imaging.	Cells with endogenously tagged 53BP1-mScarlet and PCNA-mEmerald for simultaneous damage and cycle tracking [56].
γH2AX-Specific Antibodies	Immunofluorescence detection and quantification of DNA DSBs.	Validate antibody specificity for recognizing the phosphorylated Ser139 epitope; essential for accurate foci counting [54].
MOB2-Targeting siRNAs/shRNAs	Efficient knockdown of MOB2 expression to study its functional loss.	Use validated siRNA sequences or pTER/shRNA constructs in inducible (Tet-on) systems for controlled knockdown [6].
Cell Cycle Inhibitors	Inducing replication stress or DNA damage for mechanistic studies.	Aphidicolin (APH): Low doses (e.g., 200 nM) induce mild replication stress. ATR Inhibitors (ATRi): Cause severe replication fork collapse and damage [56].
Custom Computational Tracking Tools	Automated segmentation and tracking of single cells in multi-generational live-cell imaging data.	Custom-designed scripts and algorithms are often required for robust analysis of Lineage Trees and PCNA pattern classification [56].

Data Analysis and Interpretation

When analyzing data from MOB2 knockdown experiments, key expectations based on published research include:

• Increased γH2AX Foci: MOB2-deficient cells should show a significant increase in the number of endogenous γH2AX foci compared to controls, indicating accumulated DNA damage [6].
• G1/S Arrest: This damage should correlate with a higher proportion of cells in the G1 phase of the cell cycle, as determined by DNA content analysis. This arrest is typically p53/p21-dependent [6] [53].
• HR Repair Defect: In response to induced DSBs, MOB2 knockdown cells may display impaired RAD51 foci formation, confirming a role in homologous recombination [7].
• Sister Cell Asymmetry: Live-cell tracking might reveal increased heterogeneity in damage inheritance and cell fate decisions between daughter cells following MOB2 knockdown, contributing to cellular heterogeneity [56].

The precise correlation of DNA damage markers like γH2AX with cell cycle arrest is a powerful approach for dissecting the molecular functions of genes like MOB2. The protocols outlined here, ranging from standard immunofluorescence to sophisticated multigenerational live-cell tracking, provide a comprehensive toolkit for researchers. Applying these methods in the context of MOB2 knockdown solidifies its role in maintaining genomic stability through the DNA damage response and homologous recombination repair, with significant implications for understanding cancer biology and developing targeted therapies.

hMOB2 as a Predictive Biomarker for PARP Inhibitor Sensitivity

Homologous recombination (HR) deficiency is a well-established predictor of sensitivity to PARP inhibitor (PARPi) therapy, creating a state of synthetic lethality in cancer cells. While BRCA1/2 mutations are the most characterized biomarkers in this context, a significant proportion of patients with homologous recombination deficiency (HRD) do not harbor these mutations, prompting the search for additional predictive biomarkers [8] [58]. Recent research has identified hMOB2 (human Monopolar spindle ONE Binder protein 2) as a crucial regulator of the HR pathway and a promising candidate biomarker for stratifying patients for PARPi treatments [9] [59].

hMOB2 functions as a component of the DNA damage response (DDR) signaling network, specifically promoting double-strand break (DSB) repair via homologous recombination [9]. Its deficiency creates a BRCA-like phenotype characterized by impaired HR repair capability, genomic instability, and consequent sensitivity to PARP inhibition. This application note details the experimental evidence supporting hMOB2's biomarker potential and provides detailed protocols for its assessment in a research setting, framed within the context of a broader thesis investigating MOB2 knockdown and cell cycle arrest assays.

Scientific Rationale and Key Evidence

The Role of hMOB2 in HR-mediated DNA Repair

hMOB2 plays a direct role in the HR repair pathway by facilitating the phosphorylation and accumulation of the RAD51 recombinase on resected single-strand DNA (ssDNA) overhangs [9]. RAD51 is essential for the strand invasion step of HR, and its proper loading is critical for error-free DSB repair. Studies demonstrate that hMOB2 is required for the stabilization of RAD51 on damaged chromatin, thereby ensuring efficient HR repair [9]. In hMOB2-deficient cells, this process is disrupted, leading to an accumulation of unresolved DNA damage and replication stress.

Table 1: Functional Role of hMOB2 in DNA Damage Response

Function	Molecular Mechanism	Consequence of hMOB2 Loss
RAD51 Regulation	Supports phosphorylation & accumulation of RAD51 on ssDNA [9]	Impaired RAD51 foci formation; defective strand invasion
HR Repair	Promotes error-free repair of DNA double-strand breaks [9]	HR deficiency; genomic instability
Cell Cycle Checkpoint	Prevents accumulation of endogenous DNA damage [59]	Activation of p53/p21-dependent G1/S cell cycle arrest
Cancer Cell Survival	Supports survival in response to DSB-inducing agents [9]	Increased sensitivity to DNA-damaging chemotherapy and PARPi

hMOB2 Deficiency and PARPi Sensitivity: Preclinical Evidence

Experimental data firmly establish that loss of hMOB2 sensitizes cancer cells to PARP inhibition. hMOB2 deficiency renders ovarian and other cancer cells more vulnerable to FDA-approved PARP inhibitors, including olaparib, rucaparib, and veliparib [9]. This sensitization occurs because hMOB2-deficient cells already possess a compromised HR system; PARPi application induces additional DNA lesions through PARP trapping, creating an intolerable burden of DNA damage that leads to synthetic lethality.

Table 2: Quantitative Evidence of PARPi Sensitivity in hMOB2-Deficient Models

Experimental Finding	Measurement/Outcome	Significance
Cell Survival Post-PARPi	Significant reduction in survival of hMOB2-deficient cells [9]	Demonstrates synthetic lethality
In Vivo Correlation	Reduced MOB2 expression correlates with increased overall survival in ovarian carcinoma patients [9]	Supports clinical relevance as a prognostic biomarker
Specificity of Effect	Sensitivity potentiated with DSB-inducing agents (bleomycin, mitomycin C, cisplatin) [9]	Confirms role in DSB repair pathway
Biomarker Potential	Proposed as a candidate stratification biomarker for PARPi treatments [9] [59]	Identifies patient populations most likely to benefit from therapy

Experimental Protocols for hMOB2 Functional Assessment

Protocol 1: hMOB2 Knockdown and Cell Cycle Arrest Assay

This protocol is designed to assess the functional impact of hMOB2 depletion on cell cycle progression and checkpoint activation, providing a foundation for understanding its role in DNA damage response.

Research Reagent Solutions:

• Cell Lines: Ovarian cancer cell lines (e.g., OVCAR8, SKOV3), U2OS, HCT116, RPE1-hTert [9]
• siRNAs: Validated hMOB2-targeting siRNAs (sequences available upon request from Qiagen) [9]
• Transfection Reagent: Lipofectamine RNAiMax (Invitrogen) [9]
• Antibodies: Anti-hMOB2 (rabbit monoclonal, produced in collaboration with Epitomics), anti-γH2AX, anti-p53, anti-p21 [9]
• Cell Culture: DMEM supplemented with 10% fetal calf serum (FCS) [9]
• Analysis Instrument: INCUCYTE Kinetic Imaging System or similar for live-cell imaging [9]

Methodology:

• Cell Seeding and Transfection: Seed appropriate ovarian cancer cells (e.g., OVCAR8) in 6-well plates at 30-40% confluency. The following day, transfert cells with either hMOB2-targeting siRNA or non-targeting control siRNA using Lipofectamine RNAiMax, following the manufacturer's instructions [9].
• Incubation and Protein Knockdown Verification: Incubate transfected cells for 48-72 hours at 37°C with 5% COâ‚‚. Harvest a subset of cells and verify hMOB2 knockdown efficiency via immunoblotting using a specific anti-hMOB2 antibody [9].
• Cell Cycle Analysis: For flow cytometry-based analysis, harvest trypsinized cells, fix in 70% ethanol, and stain with propidium iodide (PI) solution containing RNase A. Analyze DNA content using a flow cytometer to determine cell cycle distribution (G1, S, G2/M phases).
• Checkpoint Marker Assessment: In parallel, prepare cell lysates from control and hMOB2-deficient cells. Perform immunoblotting to assess the expression levels of key proteins, including p53, phosphorylated p53 (Ser15), and p21, to evaluate G1/S checkpoint activation [59].
• Data Interpretation: hMOB2-deficient cells are expected to show an accumulation in G1 phase and increased expression of p21 and phosphorylated p53, indicating a p53/p21-dependent G1/S cell cycle arrest in response to endogenous DNA damage accumulation [59].

Protocol 2: PARPi Sensitivity and Clonogenic Survival Assay

This protocol measures the long-term survival and proliferative capacity of hMOB2-deficient cells following PARP inhibitor treatment, directly testing the synthetic lethality hypothesis.

Research Reagent Solutions:

• PARP Inhibitors: Olaparib (AZD-2281, Enzo/Axxora), Rucaparib (AG-014699, Selleckchem), Veliparib (ABT-888, Selleckchem) [9]
• Cell Lines: hMOB2-deficient vs. proficient isogenic cell lines [9]
• Staining Reagents: Crystal violet or Giemsa stain
• Equipment: Cell culture incubator, clonogenic assay software or manual colony counter

Methodology:

• Cell Preparation: Generate hMOB2-knockdown or knockout cells and corresponding controls using stable or transient methods as in Protocol 1.
• Plating for Clonogenic Assay: Plate a low density of cells (200-1000 cells, depending on line) into 6-well plates. Allow cells to attach for 12-16 hours.
• PARPi Treatment: Add a range of concentrations of the selected PARP inhibitor (e.g., olaparib from 1 nM to 10 µM) to the culture medium. Include a DMSO vehicle control. Refresh the drug-containing medium every 3-4 days.
• Colony Formation and Staining: Incubate plates for 10-14 days, or until visible colonies (typically >50 cells) form in the control wells. Aspirate the medium, wash with PBS, and fix cells with methanol or ethanol. Stain colonies with 0.5% crystal violet or Giemsa.
• Quantification and Analysis: Count the number of colonies manually or using an automated colony counter. Calculate the surviving fraction relative to the control. hMOB2-deficient cells are expected to show a significant reduction in clonogenic survival compared to controls at lower concentrations of PARPi, demonstrating enhanced sensitivity [9].

Visualizing the Signaling Pathway and Experimental Workflow

The following diagrams illustrate the molecular mechanism of hMOB2 in HR repair and the logical flow of experiments to validate its role as a biomarker.

Diagram 1: hMOB2 in HR Repair and PARPi Synthetic Lethality. This pathway illustrates how hMOB2 promotes RAD51-mediated homologous recombination. Its deficiency causes HR impairment, and PARP inhibition synthetically kills these HR-deficient cells.

Diagram 2: Experimental Workflow for hMOB2 Biomarker Validation. This workflow outlines the key steps from model generation to functional validation, linking in vitro findings to clinical correlation.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagent Solutions for hMOB2 and PARPi Studies

Reagent / Resource	Function / Application	Example Sources / Identifiers
hMOB2-targeting siRNAs	Specific knockdown of hMOB2 gene expression to study loss-of-function phenotypes [9]	Qiagen (sequences available upon request)
Anti-hMOB2 Antibody	Detection and validation of hMOB2 protein levels via immunoblotting or immunofluorescence [9]	Rabbit monoclonal; Epitomics (custom)
PARP Inhibitors	Induce synthetic lethality in HR-deficient cells; tools for testing sensitivity [9]	Olaparib (AZD-2281), Rucaparib (AG-014699), Veliparib (ABT-888)
Ovarian Cancer Cell Lines	In vitro models for studying hMOB2 biology and PARPi response in a relevant tissue context [9]	OVCAR8, SKOV3, HOC7, IGROV1
Lipofectamine RNAiMax	Transfection reagent for efficient delivery of siRNAs into mammalian cells [9]	Invitrogen
INCUCYTE System	Real-time, live-cell analysis of cell proliferation, confluence, and death kinetics [9]	Essen BioScience

hMOB2 emerges as a compelling candidate predictive biomarker for PARP inhibitor efficacy, functioning through its essential role in the homologous recombination repair pathway. Loss of hMOB2 induces a state of HR deficiency, sensitizing cancer cells—particularly in ovarian carcinoma—to PARP inhibition via synthetic lethality. The experimental protocols outlined here, including knockdown assays, functional HR assessment, and PARPi sensitivity testing, provide a robust framework for researchers to validate hMOB2's biomarker potential in specific cellular and clinical contexts. Integrating hMOB2 assessment into the broader biomarker landscape, which includes genomic scars and other functional assays like RAD51 foci formation, may significantly improve the precision of patient stratification for PARPi therapy, ultimately overcoming resistance and improving treatment outcomes.

Homologous recombination deficiency (HRD) is a critical determinant of tumor biology and therapeutic response, particularly to PARP inhibitors (PARPi) and platinum-based chemotherapies [60] [61]. Accurate identification of HRD status is therefore essential for effective patient stratification and treatment planning. While established HRD markers like genomic scar scores and BRCA1/2 mutations are used clinically, the discovery of new biomarkers can improve detection accuracy and provide functional insights. Among these emerging biomarkers, Mps one binder 2 (MOB2) has recently been characterized as a novel regulator of the DNA damage response and homologous recombination repair [6] [7]. This application note provides a comparative analysis of hMOB2 against established HRD markers and details experimental protocols for its investigation in knockdown cell cycle arrest assays, framed within broader thesis research on DNA repair mechanisms.

Background on HRD and Its Clinical Importance

Homologous recombination (HR) is a high-fidelity pathway for repairing DNA double-strand breaks (DSBs). HRD occurs when this pathway is compromised, leading to genomic instability and the accumulation of specific genomic scars [60] [61]. This state creates a vulnerability that can be therapeutically exploited through synthetic lethality with PARP inhibitors. HRD can arise from various mechanisms, including:

• Germline or somatic mutations in BRCA1, BRCA2, and other HR-related genes (PALB2, RAD51C, etc.)
• Epigenetic silencing via promoter hypermethylation (e.g., BRCA1 or RAD51C promoter methylation)
• Other indirect mechanisms that disrupt HR function, collectively termed "BRCAness" [60] [61]

The clinical necessity for robust HRD biomarkers stems from the variable patient responses to PARP inhibitors. Identifying HRD-positive tumors, even beyond those with BRCA1/2 mutations, is crucial for expanding the population that might benefit from these targeted therapies [62] [60].

Established HRD Markers and Detection Technologies

Current Standard HRD Biomarkers

Table 1: Established HRD Markers and Their Characteristics

Marker Category	Specific Marker/Score	Molecular Basis	Detection Method	Key Characteristics
Gene Mutations	BRCA1/2 mutations	Inactivation of core HR genes	NGS (Germline/Somatic)	Companion diagnostic for PARPi; does not capture all HRD cases [60]
Genomic Scars	HRD Score (GIS)	Composite score of LOH, TAI, and LST	NGS (WES/WGS)	Represents historical genomic instability; FDA-approved tests exist (MyChoiceCDx) [60] [63]
Genomic Scars	Loss of Heterozygosity (LOH)	Irreversible loss of one parental allele	NGS	LOH ≥ 14% (LOHhigh) classifies tumors as HRD [60]
Genomic Scars	Telomeric Allelic Imbalance (TAI)	Subtelomeric allelic imbalance not crossing centromere	NGS	NtAI ≥ 22 correlates with cisplatin sensitivity [60]
Genomic Scars	Large-Scale Transitions (LST)	Chromosomal breaks between adjacent regions (>10 Mb)	NGS	≥ 15 LSTs (near-diploid) indicates HRD [60]
Methylation	BRCA1 / RAD51C promoter methylation	Transcriptional silencing of HR genes	Bisulfite sequencing, GM-seq	Functional knock-out without mutation [62] [60]
Mutational Signatures	SBS3, ID6, SV3	Patterns of single-base substitutions, indels, and structural variants	WGS	Historical record of mutagenic processes; best detected with WGS [64]
Transcriptional Signatures	228-gene signature (example)	Expression profile associated with HRD and BRCA1/2 defects	RNA-seq	Captures current tumor state; applicable to single-cell data [64]
Emerging Markers	lncRNAs (e.g., ENSG00000272172.1)	Differential expression linked to HRD status	RNA-seq (Tissue/Plasma)	Potential for minimally invasive liquid biopsy [65]

Advanced and Emerging Detection Platforms

HRD detection technologies are rapidly evolving. The GM-seq (genomic methylation sequencing) pipeline uses TET-assisted bisulfite-free methylation sequencing, enabling simultaneous identification of methylated modifications and genetic variations from a single assay, thus providing a more comprehensive view of HRD etiology [62]. Another advancement involves multi-scale characterization that combines mutational signatures with a 228-gene transcriptional signature, allowing for HRD assessment even from single-cell RNA-sequencing data and revealing interactions with the tumor microenvironment [64]. Furthermore, long non-coding RNAs (lncRNAs) show promise as biomarkers detectable in formalin-fixed tissue and plasma, suggesting potential for minimally invasive monitoring of HRD status [65].

MOB2 as a Novel HRD Regulator and Biomarker

Molecular Functions of MOB2 in DNA Damage Response

Human MOB2 is a conserved protein recently identified as a novel regulator of the DNA damage response (DDR) and homologous recombination. Its functions are distinct from established markers:

• Interaction with the MRN Complex: hMOB2 directly interacts with RAD50, a core component of the MRE11-RAD50-NBS1 (MRN) complex, which is the primary sensor for DNA double-strand breaks. This interaction facilitates the recruitment of the entire MRN complex and activated ATM kinase to damaged chromatin, initiating the DDR signaling cascade [6].
• Promotion of HR-mediated Repair: hMOB2 is required for the efficient phosphorylation and stabilization of the RAD51 recombinase on resected single-stranded DNA (ssDNA) overhangs. RAD51 is essential for the strand invasion step of homologous recombination, placing hMOB2 in a critical position to support error-free DSB repair [7].
• NDR Kinase-Independent Role: Unlike its previously known functions, hMOB2's role in the DDR is independent of its binding to NDR kinases, indicating a novel mechanistic pathway [6].

Comparative Value of MOB2 Against Established Markers

Table 2: MOB2 in Comparison with Other HRD Markers

Feature	MOB2	Genomic Scars (HRD Score)	BRCA1/2 Mutation Status	Transcriptional Signatures
Functional Role	Direct regulator of HR (RAD51 stabilizer) [7]	Consequence of past HRD (genomic scar) [60]	Cause of HRD (core HR gene) [61]	Snapshot of current cellular state [64]
Temporal Relevance	Reflects current HR capacity	Historical record, can become obsolete [60]	Static (unless reversion occurs)	Real-time, dynamic
Mechanistic Insight	High (reveals functional step in HR pathway)	Low (indicates instability, not specific mechanism)	High (identifies root cause in known genes)	Medium (reflects downstream expression changes)
Therapeutic Prediction	Knockdown sensitizes to PARPi [7]	Predicts PARPi/platinum response [60] [63]	Strong predictor of PARPi response [60]	Associated with PARPi response [64]
Key Advantage	Potential functional biomarker and therapeutic target	Clinically validated, composite measure	Strongest validated predictive marker	Can capture tumor heterogeneity and microenvironment [64]
Key Limitation	Research phase, requires clinical validation	Does not reflect current HR status, cost	Misses ~50% of HRD cases (BRCAness) [60]	Complex, requires robust model training

The primary advantage of MOB2 is its role as a functional biomarker. While genomic scars reflect the history of HRD, and BRCA1/2 status identifies a cause, MOB2 expression and function can provide a snapshot of the current HR capacity of a cell. hMOB2 deficiency impairs HR, and its loss sensitizes cancer cells to PARP inhibitors, suggesting its potential not only as a biomarker but also as a candidate for therapeutic targeting [7]. Furthermore, in ovarian carcinoma, reduced MOB2 expression correlates with increased overall survival, underscoring its clinical relevance [7].

Experimental Protocols for MOB2 Knockdown and Cell Cycle Analysis

This section details a core methodology for investigating MOB2 function, aligning with thesis research on knockdown-induced cell cycle arrest.

MOB2 Knockdown and DNA Damage Induction

Objective: To deplete MOB2 in cultured cells and assess the resulting cellular phenotype after induction of DNA damage.

Workflow:

Materials and Reagents:

• Cell Lines: hTert-immortalized retinal pigment epithelial cells (RPE1-hTert), U2-OS (osteosarcoma), or other relevant cancer cell lines [6] [7].
• siRNAs: Validated hMOB2-targeting siRNAs and non-targeting negative control siRNAs (e.g., from Qiagen) [6].
• Transfection Reagent: Lipofectamine RNAiMax (Invitrogen) or equivalent [6].
• DNA-Damaging Agents: Doxorubicin (Sigma) or access to an X-ray irradiator [6].

Procedure:

• Cell Seeding: Seed exponentially growing cells at a consistent confluence in appropriate culture vessels.
• Transfection: Transfect cells with hMOB2-targeting siRNA or non-targeting control siRNA using Lipofectamine RNAiMax according to the manufacturer's instructions [6].
• Incubation: Incubate transfected cells for 48-72 hours to allow for maximal MOB2 protein depletion.
• DNA Damage Induction: Treat cells with a predetermined optimal concentration of doxorubicin (e.g., 0.5-1 µM) or expose them to ionizing radiation (e.g., 2-10 Gy) [6].
• Harvest: Harvest cells at appropriate time points post-treatment for downstream analyses.

Cell Cycle Analysis by Flow Cytometry

Objective: To quantify cell cycle distribution and DNA content in MOB2-deficient cells following DNA damage, detecting any induced cell cycle arrest.

Workflow:

Materials and Reagents:

• DNA Stain: Hoechst 33342 (2.5 µg/mL) [66].
• Viability Dye: Zombie NIR Viability Dye or equivalent (1:1000 dilution in PBS) [66].
• Buffers: Phosphate-Buffered Saline (PBS), PBS containing 2% Fetal Bovine Serum (FBS).
• Equipment: Flow cytometer capable of detecting Hoechst fluorescence (e.g., Sony ID7000) [66].
• Analysis Software: FlowJo software with cell cycle module [66].

Procedure:

• Harvesting and Staining:
  • Harvest cells by dissociation using Accutase or trypsin.
  • Wash cells with PBS.
  • Resuspend cell pellet in complete medium containing Hoechst 33342 at a final concentration of 2.5 µg/mL. Incubate for 30 minutes at 37°C [66].
  • Optional: To improve data quality, incubate cells with a viability dye (e.g., Zombie NIR, 1:1000 dilution) to label and subsequently exclude dead cells from the analysis [66].
  • Wash cells with PBS and resuspend in PBS containing 2% FBS for acquisition.

• Flow Cytometry and Analysis:
  • Transfer stained cell suspension to appropriate tubes for flow cytometry.
  • Acquire data on a flow cytometer (e.g., Sony ID7000) at a low event rate (e.g., 200 events per second) to ensure accuracy [66].
  • Analyze the acquired data using FlowJo software.
  • Use the cell cycle analysis module and apply the Watson (Pragmatic) model for cell cycle quantification.
  • Distinguish G1, S, and G2/M phases based on the intensity of the Hoechst signal. The model should be constrained by setting the G1 peak to "n" and matching the coefficient of variation (CV) of the G2/M peak to that of the G1 peak. Select the final model based on a low root mean square deviation (RMSD) value [66].

Expected Outcome: hMOB2 knockdown in the presence of DNA damage is expected to cause a significant increase in the population of cells in the G1 phase of the cell cycle, indicating a p53/p21-dependent G1/S arrest, compared to control-treated cells [6].

The Scientist's Toolkit: Key Research Reagents

Table 3: Essential Reagents for MOB2 and HRD Research

Reagent / Assay	Specific Example	Function in Experiment
Targeting siRNAs	hMOB2-targeting siRNAs (Qiagen) [6]	Specific knockdown of MOB2 gene expression to study loss-of-function phenotypes.
DNA-Damaging Agents	Doxorubicin (Sigma), X-ray Irradiation [6]	Induce controlled DNA double-strand breaks to challenge the DNA repair system.
Flow Cytometry Dyes	Hoechst 33342, Zombie NIR [66]	Quantify DNA content for cell cycle analysis and exclude non-viable cells.
Antibodies	anti-RAD51, anti-γH2AX, anti-p21, anti-p53	Detect DNA repair foci (IF), checkpoint activation, and protein levels (WB).
Clonogenic Assay Reagents	Crystal Violet, Methanol/Acetic Acid	Assess long-term cell survival and proliferative capacity after damage.
HRD Score Assay	Myriad MyChoiceCDx or GM-seq pipeline [62] [60]	Benchmark MOB2 status against the clinical standard for genomic instability.

The comparative analysis reveals that MOB2 represents a distinct class of HRD marker with significant potential. Unlike static genomic scars or mutation status, MOB2 provides functional insight into the HR mechanism itself, influencing RAD51 stability and MRN complex recruitment [6] [7]. Its ability to predict sensitivity to PARP inhibition and its correlation with patient survival in ovarian cancer position it as a promising stratification biomarker and a potential therapeutic target [7]. Integrating MOB2 assessment with established markers like genomic scar scores and BRCA1/2 status could yield a more robust, multi-faceted model for predicting patient responses to DNA-damaging therapies. The provided protocols for MOB2 knockdown and cell cycle analysis offer a foundational methodology for researchers to functionally validate this protein's role in HR and its relevance to cancer biology and treatment.

Mps one binder 2 (MOB2) is an evolutionarily conserved protein implicated in vital cellular signaling pathways. While initially characterized as an inhibitor of NDR kinase activity, recent evidence has emerged revealing its significant role in human carcinogenesis. This application note synthesizes current research establishing MOB2 as a tumor suppressor across multiple cancer types, with particular emphasis on its clinical correlation with patient survival outcomes. The content is framed within broader research on MOB2 knockdown and cell cycle arrest assays, providing essential context for researchers and drug development professionals investigating cell cycle regulation and cancer therapeutics.

Clinical Evidence: MOB2 Expression and Survival Outcomes

Extensive clinical analyses across multiple cancer types have established a significant correlation between MOB2 expression levels and patient survival outcomes.

Table 1: MOB2 Expression and Survival Correlations in Human Cancers

Cancer Type	Expression in Tumor Tissue	Survival Correlation	Hazard Ratio / P-value	Reference
Glioblastoma (GBM)	Significantly downregulated in GBM vs. normal brain and low-grade gliomas	Low MOB2 mRNA significantly correlated with poor prognosis	p = 0.00999	[23]
Ovarian Carcinoma	Reduced expression correlates with therapy vulnerability	Increased overall survival with low MOB2 expression	Information Not Specified	[7]
Various Cancers (TCGA)	Loss of heterozygosity in >50% of bladder, cervical, ovarian carcinomas	Suggests tumor suppressor function	Information Not Specified	[6]

The prognostic significance of MOB2 expression is particularly well-documented in glioblastoma. Immunohistochemical analysis of patient specimens reveals that MOB2 expression is largely undetected in GBM samples while remaining abundant in low-grade gliomas and normal brain tissue [23]. Bioinformatic analysis of The Cancer Genome Atlas (TCGA) dataset confirms that low MOB2 mRNA expression significantly correlates with poor prognosis in glioma patients [23]. Beyond glioma, reduced MOB2 expression appears to confer vulnerability to DNA-damaging agents and PARP inhibitors in ovarian and other cancers, suggesting MOB2 expression may serve as a candidate stratification biomarker for patients undergoing HR-deficiency targeted therapies [7].

MOB2 in Cellular Function and Signaling Pathways

Molecular Functions of MOB2

MOB2 regulates multiple critical cellular processes through distinct mechanistic pathways:

• NDR Kinase Regulation: MOB2 competes with MOB1 for binding to NDR kinases, thereby blocking NDR activation and influencing cell cycle progression [6].
• DNA Damage Response (DDR): MOB2 interacts directly with RAD50, facilitating recruitment of the MRE11-RAD50-NBS1 (MRN) DNA damage sensor complex and activated ATM to damaged chromatin [6].
• Homologous Recombination Repair: MOB2 supports the phosphorylation and accumulation of the RAD51 recombinase on resected single-strand DNA overhangs, playing a critical role in DSB repair via HR [7].
• FAK/Akt and cAMP/PKA Signaling: In GBM, MOB2 negatively regulates the FAK/Akt pathway involving integrin and participates in cAMP/PKA signaling-mediated inhibition of cell migration and invasion [23].

Signaling Pathways Regulated by MOB2

The following diagram illustrates the key signaling pathways through which MOB2 exerts its tumor-suppressive functions:

Experimental Models: MOB2 Functional Analyses

In Vitro and In Vivo Functional Evidence

Functional studies demonstrate MOB2's tumor-suppressive capabilities across various experimental models:

Table 2: Functional Consequences of MOB2 Manipulation in Experimental Models

Experimental System	MOB2 Overexpression	MOB2 Depletion	Reference
In Vitro Phenotypes (GBM cells)	Suppressed clonogenic growth, migration, invasion, and anoikis resistance	Enhanced proliferation, migration, invasion, clonogenic growth, and anoikis resistance	[23]
In Vivo Metastasis (CAM model)	Decreased GBM cell metastasis	Increased GBM cell metastasis with tumor strands invading host tissue	[23]
Mouse Xenograft Model	Significant decrease in tumor growth	Not Reported	[23]
DNA Damage Response	Promotes cell survival and cell cycle arrest after DNA damage	Accumulation of endogenous DNA damage, p53/p21-dependent G1/S arrest	[6]
Therapeutic Vulnerability	Not Reported	Increased sensitivity to DNA-damaging agents and PARP inhibitors	[7]

Protocol: MOB2 Knockdown and Cell Cycle Analysis

This protocol details the methodology for investigating MOB2 function through knockdown and subsequent cell cycle analysis, as derived from cited studies.

MOB2 Knockdown Using shRNA

Materials:

• Lentiviral shRNA constructs targeting MOB2 (e.g., pLKO.1 vector)
• Scramble shRNA control construct
• Appropriate packaging plasmids (psPAX2, pMD2.G)
• HEK293T cells for virus production
• Target cell lines (e.g., LN-229, T98G for GBM)
• Polybrene (8 μg/mL)
• Puromycin for selection

Procedure:

• Generate lentiviral particles by transfecting HEK293T cells with MOB2-shRNA or scramble shRNA constructs along with packaging plasmids using standard transfection methods.
• 48-72 hours post-transfection, collect viral supernatant and filter through 0.45μm membrane.
• Incubate target cells with viral supernatant supplemented with 8 μg/mL Polybrene for 24 hours.
• Replace viral medium with fresh complete medium and allow recovery for 24 hours.
• Select transduced cells with puromycin (concentration determined by kill curve) for 5-7 days.
• Validate MOB2 knockdown efficiency via immunoblot analysis using anti-MOB2 antibodies.

Cell Cycle Analysis by Flow Cytometry

Materials:

• MOB2-knockdown and control cells
• Phosphate-buffered saline (PBS)
• 70% ethanol (in PBS, -20°C)
• Propidium iodide (PI) staining solution: 0.1% Triton X-100, 0.2 mg/mL RNase A, 0.02 mg/mL PI in PBS
• Flow cytometry tubes
• Flow cytometer with 488nm excitation and >600nm emission filter

Procedure:

• Harvest MOB2-knockdown and control cells by trypsinization and count cells.
• Wash cells once with cold PBS and resuspend 1×10^6 cells in 1 mL PBS.
• Fix cells by adding 3 mL of cold 70% ethanol dropwise while vortexing gently.
• Fix at 4°C for at least 2 hours or overnight.
• Pellet fixed cells (300×g, 5 minutes) and wash once with PBS.
• Resuspend cell pellet in 0.5 mL PI staining solution and incubate at 37°C for 30 minutes in the dark.
• Analyze samples by flow cytometry, collecting at least 10,000 events per sample.
• Determine cell cycle distribution using appropriate software (e.g., ModFit, FlowJo).

Expected Results: As reported in [6], MOB2 depletion under normal growth conditions leads to accumulation of endogenous DNA damage and a subsequent p53/p21-dependent G1/S cell cycle arrest. Following DNA damage induction, MOB2-deficient cells exhibit impaired cell cycle checkpoint activation.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagents for MOB2 Functional Studies

Reagent	Function/Application	Specific Example
MOB2 shRNAs	Stable knockdown of MOB2 expression	Lentiviral shRNA constructs targeting MOB2 [23]
MOB2 Expression Vectors	Ectopic MOB2 expression	V5-tagged MOB2 in pCDH vector [23]
Anti-MOB2 Antibodies	Detection of MOB2 by immunoblot, IHC	Not specified in sources
DNA Damage Inducers	Activate DDR pathways to study MOB2 function	Doxorubicin [6]
Pathway Modulators	Investigate MOB2-mediated signaling	Forskolin (cAMP activator), H89 (PKA inhibitor) [23]
Flow Cytometry Reagents	Cell cycle analysis	Propidium iodide, RNase A [6] [67]

MOB2 represents a significant tumor suppressor protein with demonstrated clinical relevance across multiple cancer types. The consistent correlation between low MOB2 expression and poor patient survival outcomes highlights its potential value as a prognostic biomarker. Mechanistically, MOB2 regulates critical cellular processes including DNA damage response, homologous recombination repair, and cell migration through integration with key signaling pathways. The experimental protocols outlined herein provide a framework for investigating MOB2 function, particularly through knockdown approaches and cell cycle analysis. For researchers focusing on knockdown MOB2 cell cycle arrest assays, the evidence indicates that MOB2 deficiency impairs DNA damage response signaling and leads to dysregulated cell cycle progression, offering insights into its tumor-suppressive mechanisms and potential therapeutic applications.

Conclusion

The knockdown of hMOB2 unequivocally induces a G1/S cell cycle arrest by compromising the DNA damage response, specifically through impaired recruitment of the MRN complex and RAD51 to damage sites. This foundational mechanism provides a powerful experimental tool for studying cell cycle checkpoints and unveils significant clinical implications. The demonstrated role of hMOB2 in sensitizing cancer cells to PARP inhibitors positions it as a compelling predictive biomarker for tailoring cancer therapies, particularly in ovarian carcinoma. Future research should focus on elucidating the full interactome of hMOB2, developing standardized clinical assays for its detection, and advancing combination treatment strategies that exploit hMOB2 deficiency to improve therapeutic outcomes.

References

• 1. MOB: Pivotal Conserved Proteins in Cytokinesis, Cell ... [https://www.mdpi.com/2079-7737/9/12/413]
• 2. MOB in Cytokinesis, Cell Architecture and Tissue ... [https://encyclopedia.pub/entry/49249]
• 3. Mob Family Proteins: Regulatory Partners in Hippo and ... [https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2020.00161/full]
• 4. Mapping the MOB proteins' proximity network reveals a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10480535/]
• 5. Crystal structure of a human Mob1 protein - PubMed - NIH [https://pubmed.ncbi.nlm.nih.gov/12962634/]
• 6. Regulation of DNA damage responses and cell cycle ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4276419/]
• 7. hMOB2 deficiency impairs homologous recombination- ... [https://www.sciencedirect.com/science/article/pii/S0898656821001959]
• 8. Predictive biomarkers for the efficacy of PARP inhibitors in ... [https://www.nature.com/articles/s44276-025-00122-9]
• 9. hMOB2 deficiency impairs homologous recombination ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8514680/]
• 10. Regulation of DNA damage responses and cell cycle ... [https://www.sciencedirect.com/science/article/abs/pii/S0898656814003702]
• 11. MRN complex is an essential effector of DNA damage repair [https://pmc.ncbi.nlm.nih.gov/articles/PMC7818010/]
• 12. The Possible Crosstalk of MOB2 With NDR1/2 Kinases in Cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5321467/]
• 13. Cell Cycle Arrest by a Natural Product via G2/M Checkpoint [https://www.medsci.org/v02p0064.htm]
• 14. p21 is necessary for the p53-mediated G1 arrest in human ... [https://pubmed.ncbi.nlm.nih.gov/7585571/]
• 15. Differential NDR/LATS Interactions with the Human MOB ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2937529/]
• 16. Criteria for effective design, construction, and gene ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC1409772/]
• 17. Resources - AUM Biotech [https://www.aumbiotech.com/resources]
• 18. CRISPRoff epigenome editing for programmable gene ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12052198/]
• 19. Gene Expression Profiling Regulated by lncRNA H19 ... [https://cgp.iiarjournals.org/content/21/6/608]
• 20. Quantitative Analysis of DNA Double-Strand Breaks in ... [https://pubmed.ncbi.nlm.nih.gov/41108608/]
• 21. New method visualises DNA damage in the human genome [https://hest.ethz.ch/en/news/news-and-events/2025/11/new-method-visualises-dna-damage-in-the-human-genome.html]
• 22. New Technique for Measuring DNA Damage Could ... [https://www.nist.gov/news-events/news/2025/08/new-technique-measuring-dna-damage-could-improve-cancer-therapy-and]
• 23. MOB2 suppresses GBM cell migration and invasion via ... [https://www.nature.com/articles/s41419-020-2381-8]
• 24. Monopolar spindle-one-binder protein 2 regulates the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5840656/]
• 25. Comprehensive interrogation of synthetic lethality in the ... [https://www.nature.com/articles/s41586-025-08815-4]
• 26. Cell cycle analysis with flow cytometry and propidium iodide [https://www.abcam.com/en-us/technical-resources/protocols/flow-cytometry-with-propidium-iodide-staining]
• 27. Rapid Profiling Cell Cycle by Flow Cytometry Using ... [https://en.bio-protocol.org/en/bpdetail?id=2517&type=0]
• 28. Protocols [https://moorescancercenter.ucsd.edu/research/shared-resources/flow-cytometry/protocols.html]
• 29. Cell Cycle Mapping Using Multiplexed Immunofluorescence [https://pubmed.ncbi.nlm.nih.gov/38393480/]
• 30. High-plex immunofluorescence imaging and traditional ... [https://www.nature.com/articles/s43018-023-00576-1]
• 31. Multispectral Immunofluorescence (mIF) [https://www.roswellpark.org/shared-resources/advanced-tissue-imaging-shared-resource/multispectral-immunofluorescence]
• 32. Quantitative benchmarking of nuclear segmentation ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12125308/]
• 33. Protocol for the quantitative analysis of images retrieved by ... [https://www.sciencedirect.com/science/article/pii/S0143400424006556]
• 34. Cell cycle mapping in tumors with advanced multiplexing ... [https://www.abcam.com/en-us/webinars/cell-cycle-mapping-tumors-multiplexing-spatial-profiling]
• 35. Troubleshooting Cell Aggregation in Culture [https://www.linkedin.com/pulse/troubleshooting-cell-aggregation-culture-pricella-ceoie]
• 36. High resolution profiling of cell cycle-dependent protein and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11910661/]
• 37. Scaling Up and Differentiating hPSCs in 3D Suspension ... [https://www.isctglobal.org/telegrafthub/blogs/ken-ip1/2025/03/12/scaling-up-and-differentiating-hpscs-in-3d-suspens]
• 38. status using flow cytometry - PMC Assaying cell cycle [https://pmc.ncbi.nlm.nih.gov/articles/PMC4516267/]
• 39. Genomic hallmarks and therapeutic implications of G ... 0 cell cycle [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-023-02963-4]
• 40. TO-PRO-3 Stain Protocol | Thermo Fisher Scientific - US [https://www.thermofisher.com/us/en/home/references/protocols/cell-and-tissue-analysis/protocols/to-pro-3-protocol.html]
• 41. Validation of Circular RNAs Using RT-qPCR After Effective ... [https://pubmed.ncbi.nlm.nih.gov/34232572/]
• 42. , DNase-free RNase Protocol [https://www.sigmaaldrich.com/US/en/technical-documents/protocol/genomics/dna-and-rna-purification/rnase-dnase-free]
• 43. DNA-RNA immunoprecipitation (DRIP) protocol | Abcam [https://www.abcam.com/en-us/technical-resources/protocols/dna-rna-immunoprecipitation]
• 44. RNase If -treated quantitative PCR for dsRNA quantitation of ... [https://bmcbiotechnol.biomedcentral.com/articles/10.1186/s12896-018-0413-6]
• 45. Three Common Problems and Solutions of Cell Cycle ... [https://www.elabscience.com/resources/topics/978?srsltid=AfmBOoot2X-kWPUy4cj5jZm1kDXdCLZmxwePZWdlSN_AdDcEU764r3-D]
• 46. G2/M cell cycle arrest in the life cycle of viruses - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7103309/]
• 47. MOB2 suppresses GBM cell migration and invasion via ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7156523/]
• 48. The palette of techniques for cell cycle analysis - PMC - NIH [https://pmc.ncbi.nlm.nih.gov/articles/PMC9261528/]
• 49. Assays for Cell Enumeration, Cell Proliferation and ... [https://www.thermofisher.com/us/en/home/references/molecular-probes-the-handbook/assays-for-cell-viability-proliferation-and-function/assays-for-cell-enumeration-cell-proliferation-and-cell-cycle.html]
• 50. Publishing flow cytometry data - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC2822558/]
• 51. Blue intensity matters for cell cycle profiling in fluorescence ... [https://www.nature.com/articles/labinvest201713]
• 52. Growth-inhibitory effects of MOB2 on human hepatic ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3544031/]
• 53. Quantitative Model of Cell Cycle Arrest and Cellular ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3413708/]
• 54. A promising molecular marker of DNA damage and aging [https://www.sciencedirect.com/science/article/abs/pii/S1383574215000435]
• 55. A comprehensive review of computational cell cycle ... [https://www.nature.com/articles/s41540-024-00397-7]
• 56. Multigenerational cell tracking of DNA replication and ... [https://www.nature.com/articles/s41586-025-08986-0]
• 57. Real-time visualization of chromatin modification in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5612227/]
• 58. PARP Inhibitor Applicability: Detailed Assays for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8885121/]
• 59. hMOB2 deficiency impairs homologous recombination- ... [https://pubmed.ncbi.nlm.nih.gov/34363951/]
• 60. Homologous recombination deficiency (HRD) testing landscape: clinical applications and technical validation for routine diagnostics - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC11846297/]
• 61. Biomarkers for Homologous Recombination Deficiency in Cancer - PMC [https://ncbi.nlm.nih.gov/pmc/articles/PMC8304859]
• 62. Comprehensive assessment of homologous recombination ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12512315/]
• 63. Comparative Assessment of Diagnostic Homologous Recombination Deficiency-Associated Mutational Signatures in Ovarian Cancer - PubMed [https://pubmed.ncbi.nlm.nih.gov/34380641/]
• 64. Multi-scale characterisation of homologous recombination deficiency in breast cancer | Genome Medicine | Full Text [https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-023-01239-7]
• 65. Long non-coding RNAs as a biomarker for homologous ... [https://www.nature.com/articles/s42003-025-08836-9]
• 66. Cell Cycle Analysis by Flow Cytometry [https://www.protocols.io/view/cell-cycle-analysis-by-flow-cytometry-ha3gb2gjx.html]
• 67. Development of a G2/M arrest high-throughput screening ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8732089/]